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BACKGROUND
Online literature collections such as Medline, with over 19 million scientific publications, 
are of high importance in biomedical research. It provides the biologist information 
needed in multiple stages of the scientific discovery process. The knowledge extracted 
from these publications is used to define the biological question or for selecting proteins 
and genes for follow-up studies [1].
The rapid accumulation of new publications makes it difficult to keep up-to-date with 
all the relevant literature, even when the topic is within the biologist's field of expertise 
(Figure 1). In addition, the focus of biological research is rapidly shifting from individual 
genes to entire biological systems and therefore the biologist must increasingly be able to 
link information from multiple research domains, making it even harder to keep up with 
the latest developments. This requires the skill to systematically compare large data sets 
with all the knowledge that is derived from the published data to interpret the results. 
The bottleneck is often not the lack of information present in the literature on the topic 
of interest, but it lies within the time-consuming task of processing, linking and filtering 
relevant information from the vast amount of data that is available. To automate and 
structure these tasks, text mining has evolved as an essential tool to aid biologists in 
identifying and extracting information from the scientific literature [1, 2].
Figure 1 - Number of published articles. This 
figure shows the total number of articles 
published between 1950 and 2010. The graph 
indicates that there is an increase in the number 
of articles being published each year.
Information on gene function enclosed in the biomedical literature is an important 
primary source for academic and industrial research and is, for instance, of great 
value for unraveling and understanding disease mechanisms. One such area in which 
the biomedical literature has a prominent place is in the research and development 
of the pharmaceutical industry. The literature holds important information for the 
pharmaceutical industry needed for the development of new drugs. The information 
extracted from the biomedical literature is used in various stages of the drug discovery 
process; to gain information on novel and actual protein targets and for the interpretation 
of experimental results.
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Nowadays, microarray-based gene expression profiling is well integrated in the drug 
discovery process to assess the toxicity and efficacy of candidate drugs. A microarray is a 
powerful tool to measure the expression of thousands of genes simultaneously and is the 
platform of choice to identify genes that are differentially regulated upon drug exposure. 
The resulting drug-specific gene expression fingerprint enables drug efficacy and drug 
toxicity evaluation by comparing this fingerprint with that from model and competitor 
drugs. These gene expression fingerprints also give insight in the cellular processes 
affected by the drug and provide information on the mode of action and, if adverse 
events are observed, mode of toxicity of the drug. A particular microarray experiment 
can identify several hundreds of genes differentially regulated, which makes gene by 
gene interpretation of the results almost impossible. Therefore, several text mining tools 
were developed that can analyze large gene sets to aid in the interpretation of microarray 
data [3-5].
In the following section an introduction in text mining in the biomedical literature will 
be given, covering the various aspects of information retrieval, named entity recognition 
and information extraction. Furthermore, the various stages in the drug discovery 
and development process will be discussed, the use of microarrays in toxicogenomics 
and pharmacogenomics experiments, and how text mining can be applied for the 
interpretation of microarray data generated in these experiments.
TEXT MINING THE SCIENTIFIC LITERATURE
Text is the predominant medium for the biologist for scientific communication, most 
often in the form of published articles, patents or reports [6]. Due to the fast increase 
in the volume of the biomedical literature, it is becoming difficult to efficiently retrieve 
and manage relevant information without the use of text mining tools. Text mining can 
be defined as the use of automated methods for exploiting the enormous amount of 
knowledge available in the (scientific) literature [7]. Text mining tools enable the biologist 
to identify relevant papers, in a process called information retrieval (IR), allow named 
entity recognition (NER), in which the biological entities that are mentioned in these 
papers (for example, genes and proteins) are recognized, and enable specific facts to 
be pulled out from papers in a process called information extraction (IE). In the next 
paragraphs each aspect of text mining will be discussed in more detail.
Information retrieval: track papers of interest
Information retrieval (IR) systems aim to retrieve the most relevant documents from a 
text collection, referred to as a text corpus (plural: text corpora). Documents selected 
from the text corpus match a user-provided query containing one or several keywords 
covering the topic of interest, and are often ranked by relevance. PubMed [8] is the best- 
known free IR system for accessing the Medline database of abstracts and some full-
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text articles on biomedical topics. Each Medline article is indexed according to multiple 
fields, including title, abstract, author names, journal name, etc. Medline is also indexed 
using a controlled vocabulary; called Medical Subject Headings (MeSH), describing the 
topics discussed in the article and are assigned manually to an article by domain experts 
[9]. PubMed takes advantage of these MeSH terms and provides thereby more sensitive 
searches.
PubMed combines two IR methods to retrieve the most relevant papers; the Boolean 
methodology and the vector space methodology [10]. The Boolean method allows the 
retrieval of all documents that contain user-defined keyword combinations by using logical 
operators. For example, if a biologist is interested in documents on the drug prednisolone 
and its effect on inflammation, a typical search statement might be [prednisolone AND 
inflammation]. By contrast, the vector space method represents each document as a 
vector of weighted terms [11]. A strategy often used to give a certain weight to a term, 
is to assign high weights to terms that occur frequently in a document but infrequently 
elsewhere [10]. The document vectors are compared to the user-defined query vector 
and documents are ranked by similarity. The document vectors can also be compared to 
each other to calculate document similarity, a method implemented in PubMed as the 
'related articles'-feature, and other document-clustering methods [12-14].
Named entity recognition: identifying biomedical concepts in text
Named entity recognition (NER) is the task of identifying biomedical concepts that are 
mentioned in documents, such as gene and proteins names, diseases, drugs, etc. NER can 
be divided into two subtasks; first, recognizing biomedical terms that are mentioned in 
the document and secondly, uniquely link the biomedical term to the correct biomedical 
concept being referred to in the document. The NER task seems to be a simple and 
straightforward task, but it is one of the most difficult and essential steps within the 
text mining process. It has a large influence on the information quality extracted from 
text; wrongly assigned biomedical concepts in documents can lead to incorrect biological 
assumptions.
Many NER systems rely on thesaurus-based keyword matching methods in documents. A 
thesaurus is a comprehensive list of biomedical concepts describing primary names and 
synonyms of each concept. Keyword matching using a thesaurus makes it possible to 
identify not only the primary name of a gene, but also all its aliases in text. For example, 
the human gene ABCA1 can also be found in literature with ABC1 or its full gene name 
'ATP-binding cassette transporter, type A, member 1'. Furthermore, most NER systems 
allow variation in how the names are written, for example ABCA1, ABC-A1 or abca1 will 
also be recognized in text [15].
The most difficult task is to uniquely identify biomedical concepts in text; this is especially 
true for genes which are known to share aliases, for example N-acetyltransferase 1 and 
Noradrenaline transporter 1 both share the symbol Nat1. Furthermore, some gene
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symbols are common English words (e.g. 'hairy') or are homonyms for non-biological 
entities, for example the gene symbol for the estrogen receptor ESR is also an abbreviation 
for the erythrocyte sedimentation rate. In recent years several methods were developed 
for symbol disambiguation, which drastically improve the accuracy of NER [16-18].
Information extraction: mining the literature for relationships
The aim of information extraction (IE) is to retrieve facts from the literature, this in 
contrast to IR systems, which aim to retrieve texts that concern a certain topic. IE systems 
are in particular used to extract relationships between biomedical concepts from text. 
For example, an IE system could identify that Akt phosphorylates Foxo1, which facilitates 
binding of the 14-3-3 protein to Foxo1 and leads to inactivation of Foxo1. There are 
two fundamental different approaches to extract relationships from literature; via co­
occurrence, or by natural-language processing (NLP). Both approaches are currently 
extensively used.
Co-occurrence
The most straightforward method to extract relationships between biomedical concepts 
from literature is via co-occurrence. This approach is based on the simple assumption 
that if two biomedical concepts are mentioned together in an abstract or in the same 
sentence, then there might be a relationship. Two biomedical concepts can co-occur in 
text without having a functional relationship, therefore most co-occurrence-based IE 
systems make use of some sort of frequency-based scoring algorithm to calculate the 
relatedness between the two biomedical concepts [19-23]. Biomedical concepts that 
are often mentioned together are likely to have a functional relationship, although the 
type of the relationship is unknown. Co-occurrence-based IE systems tend to have a 
high recall (i.e. the number of relevant documents retrieved by the search, divided by 
the total number of existing relevant documents), compared to NLP systems, but often 
have a lower precision (i.e. the number of relevant documents retrieved by the search, 
divided by the total number of documents retrieved by the search) [24]. Furthermore, 
co-occurrence-based methods are unable to detect the directionality of the relationship 
between two biomedical concepts. Although co-occurrence-based text mining has some 
flaws compared to NLP, it can identify relationships of any kind and has been successfully 
applied to identify gene-disease and drug-gene relationships, physical protein-protein 
interactions, associations between single nucleotide polymorphisms (SNPs) and disease 
phenotypes, and for biological interpretation of microarray data [5, 21, 25-29].
Natural-language processing
NLP is a more subtle approach to extract biomedical concept relationships from literature. 
NLP is used in order to understand the syntax (the orderly manner in which words are put
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together to form phrases and sentences) and semantics (the meaning that is implied by 
the text) of the analyzed text. The NLP method can be divided into a number of subtasks; 
tokenization of the text, part-of-speech tagging, semantically tagging biological entities 
and rule-based extraction of relationships.
In the first step, the text is 'tokenized' to identify sentence and word-boundaries, which is 
followed by part-of-speech tagging, in which nouns and verbs are tagged in the text. Then 
a so called syntax tree is generated for each sentence to define noun phrases (e.g. Foxol 
binds 14-3-3 protein) and to define their interrelationship (A-binds-B). For each syntax 
tree, the relevant biological entities (e.g. gene, protein, disease) or other keywords (e.g. 
activation, phosphorylation) are semantically tagged by standard ER methods. Finally, a 
rule set is used to extract the relationships on basis of the syntax tree and semantic tags. 
The advantage of NLP-based methods over co-occurrence-based methods for IE is that 
NLP-based methods not only have high precision in identifying relationships, but can also 
extract the type and direction of the relationship. Drawback of NLP-based methods is 
that generally, they are computationally more intensive. NLP-based methods have been 
successfully applied to extract protein-protein interactions, for pathway construction 
and ontology building [30-35].
Knowledge extraction versus knowledge discovery
Text mining is strictly defined as 'the discovery by computer of new, previously unknown 
information, by automatically extracting information from different written resources' 
[36]. Therefore, when this definition is strictly applied most tools do not qualify as text 
mining tools, but are IE tools that are limited to extract information that has already been 
published. Nevertheless, the facts extracted by IE tools are well suited to infer novel 
relationships between biomedical concepts. The trick is to combine facts from different 
publications to infer indirect relationships, in which A leads to B and B leads to C, 
implying that A and C might also have a relationship (Figure 2). In literature, these novel 
relationships are referred to as 'implicit', 'indirect', 'hidden' or 'inferred' relationships, 
and is often called literature-based discovery.
Figure 2 - ABC-principle of hidden relationships in 
literature. Hidden relationships in literature between 
biomedical concepts (e.g., genes, diseases, drugs), 
for which A and C have no direct relationship, but are 
connected indirectly via B-intermediates.
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In the past decades, Swanson acted as a pioneer in literature-based discovery of novel 
associations between biomedical concepts. He applied the ABC-principle to infer that 
fish-oil is beneficial for patients suffering from Raynaud's disease [37], that magnesium 
deficiency has a role in migraine headache [38] and that arginine intake has an effect 
on levels of somatomedin in blood [39]. The first two hypotheses were validated and 
confirmed experimentally a few years later [40, 41]. Inferred literature relationships can 
be used to confirm a hypothesis about a relationship between A and C in a so called 
closed discovery framework or to generate, possibly many, novel hypotheses about a 
relationship between A and C, in a so-called open discovery framework (Figure 2).
DRUG DISCOVERY AND DEVELOPMENT
Because of the versatile application of text mining, it can be used in multiple areas. 
One such area is drug discovery. In the following paragraphs the various stages in drug 
discovery and development will be discussed, and how text mining and genomics can be 
integrated in these processes.
Developing a new drug takes on average ten to twelve years and it is estimated that 
the total costs are around $800 million. Before a new drug reaches the market, it has 
to undergo a long and complex process of selection, testing and development. The 
development of new drugs is very costly, and pharmaceutical companies must make large 
investments in research and development (R&D) over a long period of time. It has been 
estimated that the investment in R&D has been growing by about 13% per year the last 
couple of years. Therefore, pharmaceutical companies are looking for new approaches to 
reduce the cost of each step in the drug discovery and development process. To achieve 
this, the focus is on developing new strategies to remove ineffective drugs as early as 
possible from the drug discovery process and to reduce the time that each drug resides 
in each step. In the last couple of years, the genomics and proteomics technologies had a 
large contribution in improving the process of identifying promising new drug candidates.
The drug discovery and development pipeline
The process from developing a new drug to release on the market is commonly referred 
to as the development pipeline, and consists of a number of distinct steps (Figure 
3). Roughly, six main steps can be distinguished; two biology-based phases: target 
identification and target validation, two chemistry-based phases: lead finding and lead 
optimization, and two development-based phases: pre-clinical and clinical development. 
In the following section each stage will be briefly discussed, with special attention to the 
role that text mining can play in these steps.
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Figure 3 - Drug discovery and development process. Schematic overview of the various stages 
in the drug discovery and development process; from target identification to the start of clinical 
trials.
Target identification and validation
Target-based drug discovery starts with identifying the function of a possible therapeutic 
target and its role in disease. Potential therapeutic targets are mainly picked up from 
the biomedical literature, and therefore text mining is a frequently used tool to extract 
information on associations between proteins/genes and the disease of interest from 
literature. This information provides an overview of what is known about the function 
of the potential therapeutic target and can be used to get insight on its role in inducing 
the disease. Targets are usually proteins, either those occurring within the human body 
of in outside agents such as viruses and other pathogens. Understanding the pathways 
involved in diseases in order to identify the most appropriate protein to be targeted, and 
to identify a compound that modifies the activity of that protein is a challenging task in 
the target discovery process.
In the target validation stage, experiments are conducted to demonstrate that the 
selected target is involved in a disease process and that regulation of the activity of this 
target has a therapeutic effect. First the target is validated in in vitro experiments, which is 
followed by validation of the therapeutic concept in in vivo experiments, which together, 
defines its clinical potential. The information that is gathered from these studies help to 
predict the possible profile of new drugs in patients.
Lead finding and optimization
After successful development of an assay, screening of compound libraries follows. 
Compounds that are able to modify the activity of the target are termed lead compounds. 
The structures of these lead compounds are used as a starting-point for modifications to 
improve potency, selectivity or pharmacokinetic parameters. High-throughput screening 
(HTS) is one of the widely used methods to rapidly screen the activity of a large library of 
compounds on a target. Depending on the assay used, hit rates in the lead finding stage 
typically range between 0.1 percent and 5 percent.
Lead optimization is the process of modifying the chemical structures of promising 
candidate compounds to improve their drug characteristics. From the list of compounds 
that were identified in the lead finding stage one or more are selected from which a set of
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analogs will be synthesized and screened. One approach to screen promising compounds 
for their efficacy is by microarray analysis. Microarrays are artificial grids of DNA, such 
that each element of the grid probes for a specific RNA sequence - that is, each holds 
a DNA sequence that is a reverse complement to the target RNA sequence. There are 
many protocols for conducting a microarray experiment, but all start with the extraction 
of RNA from biological samples in either normal or diseased/treated states. The RNA is 
then copied and tagged with fluorescent nucleotides, hybridized to a microarray and 
scanned under laser light (Figure 4). The end-result is 4,000-50,000 measurements of 
gene expression per biological sample.
Figure 4 - Microarray technology. Schematic overview of the various steps in a microarray 
experiment; isolation of RNA from the tissue of interest, generating labeled cRNA, hybridization 
of the labeled cRNA on the microarray chip and scanning of the hybridized chip to measure the 
fluorescent intensities (Image Courtesy of Bioteach at scq.ubc.ca).
Microarrays can be used to determine the efficacy of a candidate drug by measuring the 
change of overall gene expression in the tissue of interest upon compound administration 
and compare the expression profile with that of other candidate drugs and competitors. 
The use of gene expression technology for compound efficacy evaluation was termed 
pharmacogenomics [42], although pharmacogenomics is also referred to as an approach 
to measure the influence of genetic variation on drug response [43]. In Chapter 6 of this 
thesis, we show how microarray experiments and text mining can be combined to study 
the mechanisms of action of a pharmacological compound.
From the original set of analogs one or more compounds are selected that show sufficient 
target selectivity, potency and favorable drug-like properties and will be proposed for 
drug development. The best of these is generally called the lead compound, while the 
others will be designated as "backups".
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Preclinical and clinical development
The drug discovery phase delivers several lead and backup compounds that have 
promising activity against the drug target. In the next phase, the development phase, the 
candidate drugs are further tested for safety and efficacy. The first step in development 
is the preclinical phase, in which compounds are tested for toxicity to show their safety 
while pharmacokinetic experiments are performed to test their absorption, distribution, 
metabolization and excretion (ADME) from the body. These experiments are traditionally 
conducted in animals, but are increasingly being replaced by in vitro cell assays. At this 
stage two thirds of the candidate drugs fail because of observed toxicity or poor ADME 
properties [44].
Microarrays can not only be used to assess the efficacy of candidate compounds, but 
can also be used to evaluate their toxicity. Gene expression technologies applied to 
toxicology was termed toxicogenomics [42], and is conducted to identify adverse effects 
and predicting risks associated with exposure to the tested compound. Toxicogenomics 
is based on the assumption that compounds that induce toxicity through similar 
mechanisms will evoke similar gene expression profiles. By analyzing the gene expression 
profiles of model compounds, each well-characterized for inducing a specific hepatotoxic 
endpoint, a gene expression signature can be deduced for each type of toxicity [45, 46]. 
Several computational algorithms, such as linear discriminant analysis, artificial neural 
networks and support vector machines have been applied to identify gene sets that can 
classify compounds based on a specific toxicological endpoint [47, 48]. These classifiers 
were successfully applied to assess oxidative stress-associated hepatotoxicity [49], 
microvesicular steatosis [48] and bile duct hyperplasia [50]. In Chapter 5 of this thesis we 
show how gene expression profiling using microarrays in combination with text mining 
can be applied for compound profiling to evaluate the toxicity and mode of toxicity of 
compounds.
In the clinical development phase the candidate drugs that passed the preclinical stage 
are tested for their efficacy and safety in humans in clinical trials. These clinical trials are 
expensive and long; they account for 50 to 70% of the drug discovery and development 
cost and can last many years depending on the therapeutic area. The clinical development 
phase can be divided in four phases. In the first phase a small number of healthy volunteers 
are selected to test for toxicity and side effects and for the correct dosage. In phases two 
and three the experiments are repeated in patients with the disease to be treated. The 
results of these experiments are formulated in a document and reviewed by the FDA 
(US Food and Drug Administration) or EMEA (European Medicines Agency), which decide 
whether the drug gets a market approval. The last phase is done after market approval of 
the drug and is used to test the long-term safety risks and side-effects of the drug.
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TEXT MINING AND DRUG DISCOVERY
In recent years the pharmaceutical and biotech industries have invested heavily in novel 
platform technologies and high-throughput screening methods to identify novel drug 
targets. Despite these investments, perhaps most of the drug targets are still selected 
from the biomedical literature. Therefore, keeping up to date with the latest scientific 
developments presented in the literature is still a key priority in drug discovery. In addition 
to target discovery, identifying potential biomarkers which can monitor compound action 
or disease progression from literature also has become an important task [51].
As discussed earlier, because of the exponential growth of the scientific literature it 
becomes extremely difficult to keep up with the latest discoveries [52]. Therefore, also 
within the pharmaceutical and biotech industry the automatic mining of the literature 
became of high interest to recognize potential drug targets as early as possible to provide 
a business advantage. In recent years, text mining has been applied to derive drug-related 
annotation from literature, such as drug-drug interactions [53], to identify interactions 
of compounds with drug metabolizing enzymes [54] and to identify adverse drug effect 
descriptions [55]. In addition, as drug-protein interactions are at the heart of the drug 
discovery process, several text mining approaches specialized on establishing drug-gene 
relationships from literature [28, 56, 57].
As several studies have already shown, text mining holds promising potentials for target 
discovery, biomarker discovery and drug-gene interaction identification. Therefore, text 
mining is a useful additional tool in the drug discovery process for identifying novel drug 
targets and to gain better insight in drug mode of action.
CoPub
We developed a co-occurrence-based text mining tool named CoPub that uses thesaurus- 
based keyword matching in Medline abstracts to link genes to biomedical concepts 
describing liver pathologies, pathways, Gene Ontology terms, diseases and drugs. It is 
build on the assumption that co-occurrence of a gene and a biomedical concept in the 
same abstract is an indication of a functional link between the gene and the biomedical 
concept. CoPub is a versatile application which can be utilized for various tasks, such 
as target discovery, for finding novel, not yet discovered associations between genes, 
diseases and drugs in literature, and to aid in the biological interpretation of microarray 
data.
CoPub is designed to calculate keyword over-representation for a set of regulated genes 
(e.g. from a microarray study) in a similar fashion to general GO term over-representation 
tools. The difference between GO enrichment and keyword enrichment calculation 
with CoPub is that with CoPub the over-represented keywords are directly retrieved 
from Medline by text mining. CoPub uses the entire Medline library to calculate robust 
statistics for gene-keyword co-occurrence, and is not dependent on pre-clustered gene 
sets to calculate significance for keyword over-representation. In addition to calculating
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over-represented keywords, CoPub also shows the results graphically in an interactive 
network, providing an additional level of insight into the biological mechanisms related 
to a set of regulated genes. CoPub has two other features next to the Microarray data 
analysis option: the Gene search and the BioConcept search. The Gene search and 
the BioConcept search options identify genes and keywords that share occurrences in 
Medline abstracts with a gene or keyword of interest, thereby providing annotation for 
the gene or keyword of interest. CoPub is freely available at http://www.copub.org.
OUTLINE OF THIS THESIS
This thesis can roughly be divided into two parts. First we introduce CoPub, a text mining 
tool that we developed to extract relationships between genes, diseases, pathways and 
drugs from the biomedical literature, we compare text mining in abstracts versus full-text 
articles and we demonstrate how text mining can be used to infer novel relationships 
between genes, diseases and drugs from literature. In the second part we demonstrate 
how CoPub can be applied for the biological interpretation of microarray data by analyzing 
data derived from toxicogenomics and pharmacogenomics experiments.
In Chapter 2 we describe the publicly available CoPub web server, a text mining tool 
that uses thesaurus-based keyword matching to extract relationships between genes, 
diseases, pathways and drugs from Medline abstracts based on co-occurrence, and how 
this information can be used for the interpretation of microarray experiments.
In Chapter 3 we compare the biomedical facts that can be extracted from literature when 
text mining is applied on abstracts versus full-text articles. In this study, we evaluated 
whether abstract information is sufficient for capturing most of the biologically relevant 
biomedical concept associations, also present in full-text articles.
In Chapter 4 we demonstrate that the CoPub database is not only well suited for knowledge 
retrieval but can also be used to infer novel, hidden relationships from literature. We 
used the CoPub database to predict novel gene associations from literature, which were 
validated and confirmed using independent literature-sources, as well as experimentally 
in an in vitro cell proliferation assay.
In Chapter 5 we demonstrate how literature information can be used for compound 
profiling to evaluate the toxicity and mode of toxicity of compounds. In this study, CoPub 
was applied to generate keyword fingerprints from gene expression profiles induced by 
hepatotoxicants, which showed to be compound-specific and match histopathological 
findings.
Chapter 6 describes the genome wide gene expression profiling in liver of prednisolone- 
treated wild type (WT) mice, and of genetically engineered mice that have lost the 
ability to form glucocorticoid receptor dimers (GRdim). In this study, CoPub was applied 
to examine the importance of GR dimerization in regulation of gene expression in mouse 
liver by identifying and comparing the biological processes targeted by prednisolone in 
liver of WT mice and GRdim mice.
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ABSTRACT
Medline is a rich information source, from which links between genes and keywords 
describing biological processes, pathways, drugs, pathologies and diseases can be 
extracted. We developed a publicly available tool called CoPub that uses the information 
in the Medline database for the biological interpretation of microarray data. CoPub allows 
batch input of multiple human, mouse or rat genes and produces lists of keywords from 
several biomedical thesauri that are significantly correlated to the set of input genes. 
These lists link to Medline abstracts in which the co-occurring input genes and correlated 
keywords are highlighted. Furthermore, CoPub can graphically visualize differentially 
expressed genes and over-represented keywords in a network, providing detailed insight 
in the relationships between genes and keywords and revealing the most influential 
genes as highly connected hubs. CoPub is an addition to the bioinformatics toolbox for 
the analysis and biological interpretation of microarray data. CoPub is freely accessible at 
http://www.copub.org.
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INTRODUCTION
Analysis and understanding of microarray data is not a trivial task. Many public and 
commercial bioinformatics tools have been developed to help scientists interpret the 
lists of differentially expressed genes that are the result of microarray experiments. For 
example, Gene Ontology and Pathway Mapping tools [1-4] allow batch input of genes 
and produce lists of GO terms or pathways that are significantly correlated to the input 
set of genes [5-13].
The outcome of these tools is based on well-established relationships between the 
genes and biological processes in which they participate. However, the primary literature 
contains much more information about the functions of genes than is captured in 
structured vocabularies or canonical pathways. To extract this additional information on 
gene function from literature, we used thesaurus-based keyword matching in Medline 
abstracts to link human, mouse and rat genes to biomedical concepts describing liver 
pathologies, pathways, GO terms, diseases, drugs and tissues (Table 1). This approach 
builds on the assumption that co-occurrence of a gene and a biomedical concept in the 
same abstract is an indication of a functional link.
In this paper, we describe a tool named CoPub that calculates keyword over-representation 
for a set of regulated genes in a similar fashion to general GO term over-representation 
tools, but where the over-represented keywords for the gene set are retrieved directly 
from Medline by text mining. Several text mining methods for the analysis of microarray 
data have been published that annotate clustered sets of regulated genes based on 
their literature profile [14-17], or on their expression profile, often based on subsets of 
the total Medline repository [18-21]. CoPub uses the entire Medline library to calculate 
robust statistics for gene-keyword co-occurrence, and is not dependent on pre-clustered 
gene sets to calculate significance for keyword over-representation. Next to calculating 
over-represented keywords, CoPub also shows the results in an interactive network, 
providing an additional level of insight into the biological mechanisms related to a set of 
regulated.
CoPub has two other features: the Gene search and BioConcept search. The Gene search 
and BioConcept search options identify genes and keywords that share occurrences in 
Medline abstracts with a gene or keyword of interest, which provides a kind of annotation 
for the gene or keyword of interest.
In an earlier study [22], we successfully applied CoPub for compound toxicity evaluation 
of a variety of compounds, which shows that CoPub is a useful additional tool for 
microarray data analysis. CoPub is freely accessible at http://www.copub.org.
CoPub web server 29
Table 1 - Overview of the 11 thesauri that were generated to search Medline
Thesaurus category # of keywords Source URL
Genes*
- Human 122.425 
(24.876 genes)
NCBI's Entrez 
Gene Database
www.ncbi.nlm.nih.gov
- Mouse 130.759 
(22.593 genes)
u u
- Rat 73.572 
(12.296 genes)
u 1/
Gene Ontology (GO)
- Biological processes 3.621 Gene Ontology DB www.geneontology.org
- Molecular functions 961 l ! u
- Cellular components 216 u 1/
Liver pathologies 489 Textbooks -
Pathways 817 KEGG, Reactome, 
Encyclopedia of 
Human Genes and 
Metabolism DB
www.genome.jp/kegg
www.genomeknowledge.org
humancyc.org
Diseases 4.164 Karolinska
Institutet
www.mic.ki.se/Diseases/
Alphalist.html
Drugs 5.796 RxList Database www.rxlist.com/top200.htm
Tissues 1.112 ExPASy Proteomics 
server
www.expasy.org/cgi-bin/
lists?tisslist.txt
*Full gene nam es, gene symbols and a lternative  gene nam es and symbols.
The thesauri include genes (human, mouse and rat), Gene Ontology (GO) terms (biological 
processes, molecular functions and cellular components), liver pathologies, pathways, diseases, 
drugs and tissues. Overall, the thesauri contain approximately 250.000 unique keywords.
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The CoPub user-interface offers three analysis methods: the Microarray data analysis, the 
Gene search and the BioConcept search.
The Microarray data analysis option calculates keyword over-representation for a set of 
differentially expressed genes, and offers graphical visualization of the analysis results in 
a literature-based network. Screenshots and workflow of the Microarray data analysis 
are shown in Figure 1 and described below in more detail.
The Gene search identifies genes and keywords that share co-occurrences in Medline 
abstracts with a gene of interest. It provides answers on a question like; "Which diseases 
and drugs are strongly connected to the gene p53"? In a similar manner, the BioConcept 
search identifies genes and keywords that share co-occurrences in Medline abstracts 
with a keyword of interest and provides answers on a question like, "Which pathways 
are associated with Alzheimer's disease?" Screenshots and the workflows of the Gene 
Search and BioConcept search are shown in Figure 2 and described below in more detail.
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Microarray data analysis
Input
The Microarray data analysis option needs as input a list of Affymetrix probe set identifiers, 
either by copy-paste or as a text file (Figure 1-A). Example gene sets are provided. The 
user can select one of two analysis modes for microarray data analysis: the keyword 
enrichment calculator or the matrix generator. For each of the two analysis modes, 
the user needs to specify the correct Affymetrix microarray chip and the categories of 
keywords used for analysis. For the keyword enrichment calculator, thresholds need to 
be specified for the p-value significance level, the minimal number of co-publications, 
the minimal ft-scaled score and the minimal number of submitted genes that have 
linkage with the analyzed keyword in literature (i.e. share abstract occurrences). For 
the threshold settings, sensible defaults are provided. Both analysis modes can either 
be performed with 'species-specific' or 'cross-species' gene information. In the 'cross­
species' mode, full gene names and gene symbols of human, mouse and rat orthologous 
genes are combined. This in contrast to the 'species-specific' mode, in which species- 
specific gene names and symbols are used for analysis.
Output
The matrix generator produces a tab-delimited file in which all co-publication information 
between the uploaded set of genes and the selected keywords are presented in a matrix 
format. The values in the matrix can either be the absolute number of co-publications 
or the ft-scaled score between a gene and a keyword. This matrix is provided as a flat 
format text file, which can be used for any kind of follow-up analysis such as for example 
clustering the genes on basis of their keyword profile. The keyword enrichment calculator 
produces a list of keywords, ranked on p-values (Figure 1-B). This list already provides a 
first impression of the biological processes related to the gene set. The user can drilldown 
into these results by clicking on the hyperlinked number of genes that are significantly 
associated with the analyzed keyword (Figure 1-B). It links to an overview of uploaded 
genes that share co-publications with the analyzed keyword (Figure 1-C), and provides 
access to highlighted Medline abstracts in which they co-occur (Figure 1-D). CoPub can 
also visualize the keyword enrichment results in a scalable vector graphic (SVG) format 
(Figure 1-E). In this interactive network, nodes represent over-represented keywords and 
differentially expressed genes, and edges represent literature links. The nodes and edges 
link to the relevant Medline abstracts in which co-occurring genes and keywords are 
highlighted. This allows for quick retrieval of relevant literature and interpretation of the 
data. Threshold sliders for the ft-scaled score and the literature count can be used to 
reduce the size of the network interactively. Alternatively, the literature-network can be 
re-calculated with new threshold values.
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Figure 1 - Screenshots and workflow of the Microarray data analysis. (A) Input screen for uploading 
Affymetrix probe set identifiers, selection of keyword categories and to specify thresholds (e.g. 
p-value significance level), with which the keyword over-representation analysis will be performed 
(sensible defaults are provided). (B) Output screen which reports on significantly linked keywords 
to the set of submitted genes, ranked on p-values after multiple testing correction. The number 
of genes that are significantly associated with the analyzed keyword, links to an overview of 
uploaded genes that share co-publications with the analyzed keyword (C), which provides access 
to highlighted Medline abstracts in which they co-occur (D). (E) Visualization of the keyword 
over-representation results in an interactive literature network (as scalable vector graphic; SVG), 
in which nodes represent genes and keywords, and edges represent links in Medline abstracts. 
Clicking on an edge retrieves highlighted Medline abstracts in which genes and keywords co-occur 
(D).
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Figure 2 - Screenshots and workflows of the Gene search (A) and the BioConcept search (B).
(A1) Input screen of the Gene search, which requires a single gene name as input. Furthermore, 
the categories of keywords need to be specified for which co-occurrences in literature with the 
gene of interest will be matched and retrieved. (A2) Output screen of the Gene search, which 
reports on the number of keywords that co-occur with the gene of interest, and links to an 
overview of the keywords (A3) and to Medline abstracts in which they co-occur (A4). (B1) Input 
screen of the BioConcept search, which requires a single keyword as input. (B2) Page to specify 
the categories of genes and keywords for which co-occurrences in literature with the keyword 
of interest will be matched and retrieved. (B3) Output screen of the BioConcept search, which 
reports on genes and keywords that co-occur with the keyword of interest in Medline abstracts, 
and with links to these abstracts (B4).
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Gene and BioConcept search
Input
The Gene search option requires a single gene name or symbol (Figure 2-A1), or for the 
BioConcept search, a single keyword as input (Figure 2-B1). Furthermore, for both Gene 
search (Figure 2-A1) and BioConcept search (Figure 2-B2), the categories of keywords 
need to be specified for which co-occurrences in literature with the gene or keyword of 
interest will be matched and retrieved.
In addition, thresholds for the minimal number of co-publications and the minimal 
ft-scaled score between keywords/genes can be specified, and for which sensible defaults 
are provided.
Output
Both the Gene search and BioConcept search return lists of genes and keywords that are 
strongly linked with the input gene or keyword of interest.
The results on these pages are all hyperlinked. This enables the user to navigate through 
various pages that report on how many times genes and keywords co-occurred in 
literature, and provide access to the relevant Medline abstracts (Figure 2-A3/B4).
DISCUSSION AND CONCLUSION
We have developed CoPub, a web-based tool for calculating keyword enrichment in sets 
of regulated genes. It detects keywords that are significantly linked to a set of genes, 
using robust co-occurrence statistics of genes and keywords in Medline abstracts. In a 
study in which gene expression profiles induced by 11 distinct hepatotoxicants were 
analyzed with CoPub, we were able to accurately describe histopathological findings and 
the mode of toxicity of these compounds. This shows that CoPub is a useful additional 
tool in the toolbox for the analysis of microarray experiments [22].
We intend to further develop CoPub by updating its Medline content on a regular basis, and 
by adding new and improved keyword thesauri. Furthermore, we will broaden the scope 
of the keyword over-representation analysis by allowing other identifiers than Affymetrix 
probe set identifiers (IDs) as input for the keyword over-representation analysis, such as 
Entrez Gene IDs, Ensembl Gene IDs, and identifiers from other Microarray platforms. On 
the output side, options for multiple graphical output formats, such as .png and .jpg, as 
well as a connection to Cytoscape files will be offered, allowing for improved downstream 
analysis of the results generated by CoPub.
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METHODS 
Text mining Medline abstracts
Eleven thesauri were generated to search Medline (Table 1). These thesauri contained 
genes (human, mouse and rat), Gene Ontology terms, liver pathologies, diseases, 
pathways, drugs and tissues. The keyword thesauri are based on biological items, which 
represent an instance of a biological concept (e.g., a gene, a pathway), and may contain 
one or more keywords (e.g., a gene is assigned a full gene name and a gene symbol and 
gene aliases).
The full Medline baseline XML files (1966 - May 2007) were obtained from the NCBI 
website (http://www.nlm.nih.gov/bsd/licensee/2007_stats/baseline_doc.html) and 
extracted to small text files containing title, abstract and substances.
Regular expressions were used to search the compiled Medline text files for the presence 
of all keywords (~250.000) from the biological concept thesauri, as described by Alako et 
al. [23]. Keywords that generated a hit in a Medline abstract were stored, together with 
the PubMed identifiers (IDs) of the Medline records in which the hit occurred. For every 
biological item the hits were made non-redundant (note: multiple keywords of a biological 
item can occur in the same Medline abstract), resulting in a PubMed ID-biological item 
list. Gene symbols were curated for ambiguity and gene hits of orthologous genes were 
combined to make the keyword search more comprehensive.
Co-publication of biological items (e.g. a gene with a pathology term) was retrieved from 
the database by matching common Medline abstract occurrences. For every biological 
item pair, an R-scaled score, which describes the strength of a co-citation between two 
keywords given their individual frequencies of occurrence Alako et al. [23], and the 
literature count, which is the number of co-publications between every biological item 
pair, was calculated. Both measures were used to describe the strength of the relation 
between two keywords.
To link gene expression data to literature data, mappings of Affymetrix probe set 
identifiers to Entrez Gene identifiers and orthology information was retrieved from 
Affymetrix human, mouse, rat GeneChip Genome Array annotation files (http://www. 
affymetrix.com).
Keyword enrichment calculation
Keyword enrichment calculation is performed using the Fisher Exact Test, in which the 
association of a given keyword with a set of regulated genes (i.e. co-publications in 
Medline abstracts) is statistically tested against a background set; the set of unchanged 
genes on the microarray. The calculated p-values are corrected using the Benjamini- 
Hochberg multiple testing correction method. All statistical tests are done using the 
R-Statistics package (http://www.r-project.org).
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To generate literature-networks CoPub uses GraphViz (http://www.graphviz.org) to 
calculate the graph layout (neato), and for producing the literature-network in a scalable 
vector graphic (SVG) format. Interactivity in generated SVG networks is implemented 
using Perl and JavaScript.
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ABSTRACT
Medline abstracts represent a rich source for extracting information on biomedical 
concepts (e.g. genes, pathways, diseases, drugs) and their relationships. In recent years 
the number of full articles that become publicly available has grown considerably. This 
led to the development of text mining tools that are not restricted to abstracts, but mine 
the whole content of an article. A drawback of text mining in full-text articles is that it is 
computationally intensive. This raises the question: does text mining in full-text articles 
identify significantly more biomedical concept associations, which otherwise would 
be missed by text mining in abstracts only, or is information extracted from abstracts 
sufficient for thorough interpretation of experimental data without the need to invest 
in computationally demanding full-text mining systems? In this study, we compared 
information from abstract vs. full text-based text mining. This was done by comparing 
pathway reconstruction and microarray data analyses, conducted using abstract-only 
or full-text information. The results show that in full-text articles more biomedical 
concept associations were identified than by text mining in abstracts only, but that the 
associations extracted from abstracts have a higher probability of being biologically 
relevant. Furthermore, analysis of microarray data from glucocorticoid receptor signaling 
experiments showed that gene annotation extracted from abstracts was sufficient to 
identify the main cellular processes known to be affected by the glucocorticoid receptor. 
Taken together, this study showed that abstracts are an adequate source to capture most 
of the biologically relevant biomedical concept associations present in literature.
42 Chapter 3
INTRODUCTION
The Medline database, containing over 18 million abstracts from biomedical and life 
sciences articles, is a rich source for information on gene function, mechanisms behind 
disease and drug mode of action. To capture this valuable information, many text mining 
systems have been developed that automatically extract facts from literature [1-4]. In 
a previous article we described CoPub [5], a text mining tool that we developed that 
automatically extracts relationships between biomedical concepts (e.g. genes, pathways, 
drugs) from Medline abstracts.
Many of the text mining tools that are developed over the years use Medline abstracts 
as primary source for information retrieval. In the last decade however, the number 
of articles for which the full content is made publicly available is growing. This made 
it possible to extend abstract-only text mining towards mining the whole content of an 
article. To exploit the wealth of information that is present in complete articles, several 
text mining tools were developed that use publicly available full-text articles as their 
source to extract biomedical information from [6-8]. This was a breakthrough in the field 
of text mining, because now much more information was available to link biomedical 
concepts together. Text mining in full-text articles however, has the disadvantage over 
text mining in abstracts, which is computationally much more intensive. Therefore it is 
worthwhile to evaluate whether text mining in full-text articles significantly outperforms 
text mining in abstracts; does text mining in full-text articles identify significantly more 
biomedical concept associations, which otherwise would be missed by text mining in 
abstracts only?
In this study, we evaluated whether Medline abstracts are an adequate source to 
capture most of the in literature described biomedical concept associations. For this, we 
performed text mining in full-text articles and in abstracts only, and verified whether both 
sources identify the same biomedical concept relationships. The results show that text 
mining in full-text articles retrieved a higher number of biomedical concept relationships 
than when abstracts were used for text mining, but that the identified relationships 
in abstracts tend to have a higher chance of being biologically relevant. Furthermore, 
analysis of microarray data from glucocorticoid receptor signaling experiments showed 
that gene annotation extracted from abstracts was sufficient to identify the main cellular 
processes known to be affected by the glucocorticoid receptor.
RESULTS 
KEGG pathway reconstruction
Pathway reconstruction analyses were conducted to evaluate whether the same 
biomedical concept associations are identified by text mining in abstracts only, compared 
to mining the full content of an article. For a total of 118 pathways (each containing
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at least 25 genes), literature information from the abstracts or the full-text in the TREC 
2007 article set was used for pathway reconstruction. The methods were evaluated by 
calculating the positive predictive value (PPV; see Material and Methods section) and the 
sensitivity for each used setting.
Figure 1 shows the results of the pathway reconstruction analysis for four KEGG 
pathways; glutathion metabolism, TCA cycle, fatty acid metabolism and ubiquitin 
mediated proteolysis. For these four pathways, the sensitivity is plotted against the PPV 
using abstract information (circles and smooth lines) or full-text information (triangles 
and dotted lines) for the pathway reconstruction, and for several settings of the minimal 
number of gene co-occurrences (1 to 10) in literature.
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Figure 1 - Pathway reconstruction analysis. The pathway reconstruction analysis for four KEGG 
pathways is shown: glutathione metabolism, TCA cycle, Fatty acid metabolism and ubiquitin 
mediated proteolysis. For each pathway, the positive predictive value (PPV) is plotted against the 
sensitivity, using various cutoffs for the minimal number of gene co-occurrences in literature. The 
circles and smooth lines show the results for the pathway reconstruction when using abstract 
information. The triangles and dotted lines show the results for the pathway reconstruction when 
using full-text information. Each circle and triangle represents a selected cutoff for the minimal 
number of gene co-occurrences in literature.
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The plots show that the curves are an extension of each other; this means that text 
mining in full text articles is not significantly better than text mining in abstracts, which 
would be the case when one of the curves would be above the other curve. Depending 
on the purpose, text mining in full-text articles is preferred when a high sensitivity is 
desired, whereas text mining in abstracts is preferred when a high specificity is desired 
for the retrieval of biomedical concept associations.
To evaluate whether the observed PPV and sensitivity trends for the four selected 
pathways is also true for all 118 KEGG pathways, the average PPV and average sensitivity 
over all 118 KEGG pathways was calculated for several settings of the minimal number of 
gene co-occurrences (Figure 2). Figure 2 shows a higher average sensitivity for full-text 
information, whereas a higher average PPV is reached when using abstract information 
only, which was also found for the four selected pathways separately (Figure 1).
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Figure 2 - Average PPV and sensitivity calculated over all 18 KEGG pathways. The average positive 
predictive value (PPV) and average sensitivity, calculated over all 118 KEGG pathways, was plotted 
against the threshold for the minimal number of gene co-occurrences. The smooth blue line and 
dotted blue line represent respectively, the average sensitivity and average PPV calculated based 
on abstract information. The smooth red line and dotted red line represent respectively, the 
average sensitivity and average PPV calculated based on full-text information.
In short, pathway reconstruction analyses indicate that more biomedical concept 
associations can be identified in full-text articles compared to abstracts, but also show 
to have a higher probability of not being biologically relevant. This in contrast to the 
biomedical concept associations found in abstracts, which tend to be of higher quality; 
less biologically irrelevant associations are found.
Comparing co-publication scores in abstract and full article text mining
To study whether the association strengths between biomedical concept pairs identified 
in abstracts and in full-text articles are similar, the calculated ft-scaled scores were 
compared (Figure 3). In Figure 3a, 1000 randomly selected biomedical concept pairs are
Minimal gsne co-ocoumenoes in lileratune
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plotted of which the ft-scaled scores are calculated based on abstract information versus 
full-text information. This figure shows that ft-scaled scores in the lower range (10-30) 
calculated from abstract information tend to be lower than ft-scaled scores calculated 
from full-text information. On the contrary, ft-scaled scores in the higher range (45 and 
higher) calculated from abstract information tend to be higher than ft-scaled scores 
calculated from full-text information. This observation might be explained by the fact 
that the information content of abstracts is much less than the information content of 
full articles and therefore the set of abstracts is probably too small to calculate proper 
statistics.
A
Figure 3 - Comparing abstract and full-text-based R-scaled scoring. The ft-scaled scores of 
biomedical concept pairs calculated based on full-text information is plotted against the ft-scaled 
score calculated based on information from abstracts in the TREC 2007 dataset (a) or based on 
information from abstracts from the CoPub database (b).
B
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To evaluate whether the limited number of abstracts present in the TREC 2007 article 
set explains the differences in the calculated ft-scaled scores with those based on full- 
text information, we compared the full-text-based ft-scaled scores with that calculated 
by CoPub, which contains over 16 million abstracts (Figure 3b). Figure 3b shows that the 
ft-scaled scores for 1000 randomly selected biomedical concept pairs calculated by CoPub 
is comparable with that calculated based on full-text information from the TREC 2007 set. 
This shows that the complete set of Medline abstracts contains sufficient information, 
compared to full-text articles to robustly calculate the strength of a relationship between 
two biomedical concepts.
Microarray data analysis
To assess whether the information present in abstracts is sufficient and comparable 
to full-text information for the interpretation of biological data, keyword enrichment 
analyses were conducted using a set of prednisolone-inducible genes. This gene set was 
derived from a microarray experiment done with liver of prednisolone-treated mice. The 
glucocorticoid (GC) prednisolone is a ligand for the glucocorticoid receptor (GR), which 
upon binding of GCs binds to DNA and initiates gene transcription [9, 10]. Many GR target 
genes are related to the cell cycle and cardiovascular, metabolic and immunological 
processes [9, 11, 12].
Table 1 - Keyword enrichment analysis
Keyword enrichment - Abstracts
Category Keyword
Pathology Hepatoma
Biological processes Gluconeogenesis, Cell migration, Adipocyte 
differentiation, Inflammatory response, Protein 
kinase activity, Endothelial cell differentiation, DNA 
synthesis
Pathways G1 phase, Glucose uptake
Keyword enrichment - Full-text articles (top 10)
Category Keyword
Pathology Hepatoma, Liver regeneration, Inflammation
Biological processes Gluconeogenesis, Cell proliferation, Apoptosis, Cell 
cycle, Cell differentiation, Glucose metabolism
Pathways Akt signaling pathway
Keyword enrichment analysis on a set of differentially regulated genes from a microarray 
experiment. The table shows the results of the keyword analysis, performed using information 
from abstracts only, or when using information from full-text articles.
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In order to identify cellular processes on which prednisolone has a prominent effect, 
keyword enrichment analyses were conducted using the 518 probe sets that were 
differentially regulated in the microarray experiment, using literature information from 
abstracts and full-text articles. With both methods, similar enriched keywords were 
obtained related to metabolism, the cell cycle and inflammation (Table 1). This is in 
agreement with the known role of the GR in regulating these processes. These results 
show that the information extracted from abstracts is sufficient to identify the most 
prominent glucocorticoid-affected cellular processes in the liver. Furthermore, these 
results also show that information extracted from full-text articles is richer for the 
interpretation of experimental data given the higher number of enriched keywords, of 
which most are related to metabolism, the cell cycle and inflammation.
DISCUSSION AND CONCLUSION
In this study, we validated whether text mining in Medline abstracts identifies the same 
biomedical concept associations as when full-text articles are used for text mining. This 
was done using three different approaches; pathway reconstruction, comparing ft-scaled 
scoring of co-occurrences and microarray data analysis.
The results of these approaches show that text mining in full-text articles identifies more 
biomedical concept associations than in abstracts, but that the identified biomedical 
concept associations in abstracts have a higher probability of being biologically relevant 
as was concluded from the pathway reconstruction analysis. The reason higher number of 
less significant biomedical concept associations in full-text articles than in abstracts may 
partly be caused by the method we used. In our method, co-occurrence between two 
biomedical concepts is not restricted to a certain distance or section of the article (e.g. 
abstract, introduction, results); biomedical concept A can be mentioned in the abstract, 
whereas biomedical concept B can be mentioned in the discussion and conclusion section. 
A better method to allow an association between two biomedical concepts is when they 
co-occur in the same section of the article or within a maximum distance from each other 
in the text. This would greatly improve the quality of the identified associations.
The microarray data analysis showed that the abstract content was sufficient to identify 
the main known cellular processes on which the glucocorticoid receptor has an effect. The 
number of only 10 enriched keywords that were found in the analysis however, suggests 
that the information content in the abstracts of the TREC 2007 set was limited, because 
keyword enrichment analysis done with the same set of genes using all Medline abstracts 
identified 68 enriched keywords (data not shown). The limited information content in the 
TREC 2007 abstract set was also observed when ft-scaled scoring of biomedical concept 
pairs was compared between abstracts and full-text articles; the ft-scaled scores did not 
match in the lower and higher range when the TREC 2007 abstracts were used, but were 
similar when all abstracts in the Medline database were used.
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Taken together, the results show that abstracts are an adequate source from which most 
of the biologically relevant biomedical concept associations can be captured. When 
one is interested in the associations within a set of genes or wants to build a biological 
network of biomedical concepts, information from abstracts is suitable for robust 
biological interpretation of the generated networks. However, the results show that text 
mining in full-text articles is more comprehensive in identifying associations between 
biomedical concepts than text mining in abstracts; this makes text mining in full-text 
articles interesting when one wants to capture as many as possible relationships between 
a single gene or a limited set of genes and other biomedical concepts.
Other studies that compared text mining in full-text articles versus abstracts came to 
similar conclusions that abstract and full-text article bodies have different structure and 
contain different content [13-16]. Several of these studies showed that the information 
density is highest in abstracts, but that the information coverage in full text articles is 
higher than in abstracts [13, 14], which is in agreement with our findings. Furthermore, 
one other study showed that text mining in the entire article does not consistently 
outperform text mining in abstracts on retrieving the most relevant articles, but that 
partitioning of the full text article into parts (i.e. into paragraph-sized segments) 
significantly improves the retrieval of relevant articles [15].
Although most of the biological relevant information is present in abstracts, the number 
of articles that become publicly available is growing and text mining systems are 
improving to efficiently analyze large text corpora, which makes that text mining in full- 
text articles will get more attention and eventually become common practice to extract 
all information present in an article, which would otherwise be missed by text mining in 
abstracts only.
MATERIALS AND METHODS 
Keyword thesauri
Six thesauri were generated to search Medline, as described previously [5]. These 
thesauri contained human genes, Gene Ontology biological processes, liver pathologies, 
diseases, pathways and drugs. The keyword thesauri are based on biological items, which 
represent an instance of a biological concept (e.g., a gene, a pathway), and may contain 
one or more keywords (e.g., a gene is assigned a full gene name, a gene symbol and gene 
aliases).
Abstracts and full-text articles retrieval
The full Medline baseline XML files (1966 - February 2009) were obtained from the NCBI 
website (http://www.nlm.nih.gov/bsd/licensee/2009_stats/baseline_doc.html) and 
extracted to small text files containing title, abstract and substances.
Full-text articles were obtained from the Text REtrieval Conference (TREC) 2007 genomics 
document collection (http://trec.nist.gov). This collection consists of full-text HTML
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documents from 49 journals published electronically via Highwire Press that granted 
permission for research use of their articles in the Genomics track and contains 161.501 
articles. These articles were extracted to text files containing title and the full-text body.
Keyword matching and co-occurrence calculation
Together with the 161.501 full-text articles, Medline abstracts were selected from the 
CoPub database that matched the full-text articles for text mining. Regular expressions 
were used to search the compiled 161.501 Medline abstract and full-text article files for 
the presence of all keywords (~250.000) from the biological concept thesauri [17]. Co­
publication of biological items (e.g. a gene with a biological process) was retrieved from 
the database by matching Medline abstract and full-text occurrences. An ft-scaled score, 
which describes the strength of a co-citation between two biological items given their 
individual frequencies of occurrence and the number of co-publications, was calculated 
in order to assign a degree of relation between two biological items [17].
KEGG pathway reconstruction
For each pathway in the KEGG database (http://www.genome.jp/kegg/pathway.html), all 
human genes were retrieved. For pathway reconstruction, randomly 10% of the genes 
were selected present in a (human) KEGG pathway, which were used to search for co­
occurrences with other human genes in literature (literature-neighbors). The retrieved 
literature-neighbors were then evaluated whether they could reconstruct the pathway. 
Pathway reconstruction was evaluated by calculating the positive predictive value (PPV). 
The PPV is a measure to compare the number of literature-identified genes correctly 
assigned to a pathway (true positives; TP), to the number of literature-identified genes 
falsely assigned to that pathway (false positives; FP). The PPV is calculated by dividing 
the number of true positives (TP) by the number of true positives + the number false 
positives (FP); PPV = TP/(TP+FP). TPs represent literature-neighbors that are part of 
the reconstructed pathway, FPs represent literature-neighbors that are not part of the 
reconstructed pathway. The sensitivity represents the percentage of the genes in the 
pathway that were correctly identified. The sensitivity is calculated by dividing the TPs by 
the number of TPs plus the number of false negatives (FNs). PPV/sensitivity-graphs were 
calculated and plotted using the R-statistical package (http://www.r-project.org).
Keyword enrichment calculation
Keyword enrichment calculation was performed using the Fisher Exact Test, in which 
the association of a given keyword with a set of regulated genes (i.e. co-publications in 
Medline abstracts) was statistically tested against a background set; the set of unchanged 
genes on the microarray. The calculated p-values were corrected using the Benjamini- 
Hochberg multiple testing correction method. All statistical tests were done using the 
R-Statistics package (http://www.r-project.org). Microarray data was obtained from 
NCBI's Gene Expression Omnibus (GEO) database (GSE21048).
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ABSTRACT
The scientific literature represents a rich source for retrieval of knowledge on associations 
between biomedical concepts such as genes, diseases and cellular processes. A commonly 
used method to establish relationships between biomedical concepts from literature is 
co-occurrence. Apart from its use in knowledge retrieval, the co-occurrence method 
is also well-suited to discover new, hidden relationships between biomedical concepts 
following a simple ABC-principle, in which A and C have no direct relationship, but are 
connected via shared B-intermediates. In this paper we describe CoPub Discovery, a tool 
that mines the literature for new relationships between biomedical concepts. Statistical 
analysis using ROC curves showed that CoPub Discovery performed well over a wide 
range of settings and keyword thesauri. We subsequently used CoPub Discovery to 
search for new relationships between genes, drugs, pathways and diseases. Several of 
the newly found relationships were validated using independent literature sources. In 
addition, new predicted relationships between compounds and cell proliferation were 
validated and confirmed experimentally in an in vitro cell proliferation assay. The results 
show that CoPub Discovery is able to identify novel associations between genes, drugs, 
pathways and diseases that have a high probability of being biologically valid. This makes 
CoPub Discovery a useful tool to unravel the mechanisms behind disease, to find novel 
drug targets, or to find novel applications for existing drugs.
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AUTHOR SUMMARY
The biomedical literature is an important source of knowledge on the function of genes 
and on the mechanisms by which these genes regulate cellular processes. Several text 
mining approaches have been developed to leverage this rich source of information by 
automatically extracting associations between concepts such as genes, diseases and 
drugs from a large body of text. Here, we describe a new method that extracts novel, 
not yet recognized associations between genes, diseases, drugs and cellular processes 
from the biomedical literature. Our method is built on the assumption that even if two 
concepts do not have a direct connection in literature, they may be functionally related 
if they are both connected to an overlapping set of concepts. Using this approach we 
predicted several novel connections between genes diseases, drugs and pathways. Our 
results imply that our method is able to predict novel relationships from literature and, 
most importantly, that these newly identified relationships are biologically relevant. 
Our method can aid the drug discovery process where it can be used to find novel drug 
targets, increase insight in mode of action of a drug or find novel applications for known 
drugs.
INTRODUCTION
A wealth of knowledge concerning the function of genes and their role in biological 
processes is present in the biomedical literature, embodied in full text articles or the 
Medline abstract database. Various text mining approaches have been developed to 
extract information on gene function from this body of literature [1,2] and these have 
been successfully applied to annotate genes and proteins [3-7] and the interpretation of 
experimental results [8-14].
A common method to establish relationships between biomedical concepts such as 
genes and pathways is co-occurrence [15]. This method is built on the assumption that 
biomedical concepts occurring in the same body of text are in some way biologically 
related. Co-occurrence-based methods can also be used to discover new, hidden 
relationships, assuming that if A and C both are connected with B, A and C might also 
have a relationship, even if there is no published relationship between A and C (Figure 1). 
Swanson has provided a classic example in his study in which he found that fish-oil intake 
is beneficial for patients suffering from Raynaud's disease, a finding that was confirmed 
experimentally a few years later [16,17]. Hidden literature relationships can be used to 
confirm a hypothesis about a relationship between A and C in a so called closed discovery 
process [18-20]. In this process the user provides the hypothesis that A is related to C, 
which is then tested by mining the literature for shared biomedical concepts (B) that 
support the hypothesis (Figure 1). Hidden relationships can also be used to generate 
novel hypotheses about a relationship between A and C, in a so-called open discovery
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process [18,19,21-23]. In this process the user provides a starting point A (e.g. a disease) 
and examines the literature for hidden relationships with other biomedical concepts (C; 
e.g. genes, drugs) that are bridged by intermediates (B) that share co-occurrences with 
A and C (Figure 1).
Figure 1 - ABC-principle of hidden relationships in literature. Hidden relationships in literature 
between biomedical concepts (e.g., genes, diseases, drugs), for which A and C have no direct 
relationship, but are connected indirectly via B-intermediates, can be analyzed in a closed discovery 
or open discovery setting. The inferred R-scaled (Ri) score between A and C, which is a measure 
for the strength of a hidden relationship, is calculated by summation of the R-scaled scores of the 
weakest links (i.e. lowest R-scaled score), divided by the number of intermediates.
The tools that are currently available for performing open discovery experiments are often 
limited to certain biomedical domains, have only limited number of keywords describing 
the biomedical terms, or retrieve hidden relationships formed by uninformative concepts, 
such as "in vitro" or "microarray" which are biologically less interesting [19,22,24]. 
Moreover, a bottleneck with all open discovery tools is to identify true, biologically 
informative, hidden relationships from spurious hits.
In a previous paper we described CoPub [25], a database of co-occurrences of ~250.000 
keywords (including gene names and symbols) in Medline abstracts. CoPub is a database 
in which the statistical relevance of all co-occurrences is pre-computed, which makes 
it possible to perform statistical analyses of the significance of the retrieved hidden 
relationships between biomedical concepts. In addition, CoPub contains several 
categories of controlled vocabularies such as genes, drugs, or diseases etc. As such, this 
database is ideally suited for use in the discovery of hidden relationships.
In this paper we describe CoPub Discovery, a method that uses the CoPub database for 
the open and closed discovery of hidden literature relationships. Statistical analysis of the 
results using ROC curves show that with CoPub Discovery true hidden relationships can 
be distinguished from true negatives. Application of this method in open ended retrieval 
of hidden relations yielded novel hypotheses about gene-disease, drug-disease and
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drug-biological process relationships which were validated bibliographically. Moreover, 
we used CoPub Discovery to identify two novel compounds that would interact with cell 
proliferation. Experimental validation showed that these compounds dose dependently 
inhibited T-cell proliferation.
RESULTS 
CoPub Discovery performance evaluation
As described above the challenge in the discovery of hidden relationships is to robustly 
discriminate true, biologically relevant, relationships (TP) from spurious, false positive 
hits (FP). We used Receiver Operating Characteristic (ROC) curve analyses to evaluate the 
ability of CoPub Discovery to distinguish TP from FP hidden relationships using literature 
partitioning as described in detail in the Materials and Methods section and outlined 
in Figure 2. All the ROC curves had AUCs (Area Under the Curve) higher than the AUC 
of the curve for no discrimination (Figure 3). High AUC's were obtained for all types of 
hidden relationships and a wide range of combinations of settings for inclusion of the 
intermediates. Re-running the analysis with alternative scoring schemes, such as the 
average instead of the minimal R-scaled scores between A and B, and B and C or using 
the average of only the 5 top scoring intermediates or using drugs rather than genes 
as intermediates yielded similar results (data not shown). As an additional measure 
of performance of CoPub Discovery, we calculated the time lag between the average 
publication date of all A-B and B-C intermediates and compared this date with the date of 
first appearance of A and C in the literature (Figure 4). The average time lag was 6.5 years, 
which is an indication to which extent discoveries can be accelerated when this type of 
hypothesis generation is used.
Figure 2 - CoPub Discovery validation by literature-partitioning. A literature-partitioning analysis 
was performed to evaluate CoPub Discovery's ability to filter true positive (TP) from false positive 
(FP) hidden relationships in literature. Abstracts published in the year 2000 up to May 1, 2007 were 
used to validate relationships inferred from abstracts published before the year 2000.
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Figure 3 - CoPub Discovery statistical evaluation. Receiver Operating Characteristic (ROC) curve 
analyses were performed to statistically evaluate the ability of CoPub Discovery to distinguish true 
positive (TP) from false positive (FP) hidden relationships in literature. In this figure, ROC curves are 
shown of gene-disease, drug-disease and drug-biological process hidden relationship analyses for 
several intermediate inclusion criteria. For each tested setting, the false positive rate was plotted 
against the true positive rate for each inferred R-scaled (Ri) score cutoff.
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Figure 4 - Time lag between prediction and first appearance of hidden relationships in literature.
The time lag between the data needed for prediction of a hidden relationship and its actual 
assertion in literature is plotted for 1000 hidden relationships. For each hidden relationship, the 
average publication date of all A-B and B-C literature appearances was calculated and compared 
with the date on which A and C were first mentioned in the literature. Note: the data was derived 
from the literature-partitioning analysis.
Taken together, these results show that CoPub Discovery is a robust method that can be 
applied to quickly detect a variety of biologically relevant hidden relationships.
Case studies
After the formal validation with ROC curves we used CoPub Discovery to study a number 
of cases in an open discovery approach. We now used all Medline abstracts published 
before May 1, 2007 to find hidden relationships between genes, pathways, drugs and 
diseases. For each hidden relationship an inferred R-scaled score (Ri) was calculated. The 
biological rationale of the hidden relations with the highest Ri were studied in more detail 
using the underlying literature that describes the connecting intermediates, as provided 
in the CoPub Discovery output.
Case study 1: disease-gene hidden relationships
Graves' disease (GD) is a complex autoimmune thyroid disorder, which is characterized 
by hyperthyroidism (i.e. over-production of thyroid hormones). Auto-antibodies against 
the thyroid-stimulating hormone receptor were shown to be responsible for the 
hyperthyroidism in GD [26]. The mechanisms behind the onset of GD are not completely 
understood, but it is thought that the development of GD depends on complex interactions 
among environmental and genetic factors [27].
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Table 1 - Prediction of novel relationships between biomedical concepts
a) Graves' Disease - Gene Hidden Relationships
Genes Intermediates Ri
Programmed cell death 1 (PDCD1) 21 34.3
CD74 molecule, major histocompatibility complex class II (CD74) 20 35.4
TAP binding protein (TAPBP) 19 34.4
CD8b molecule (CD8B) 18 34.6
CD84 molecule (CD84) 17 34.4
b) M ilnacipran -  Disease Hidden Relationships
Disease/Disorder Intermediates Ri
Obsessive-Compulsive Disorder 7 37.3
Serotonin Syndrome 5 45.6
Serotonin Syndrome 5 45.6
Drug withdrawal symptoms 5 36.8
Tardive Dyskinesia 5 5 36.2
Attention Deficit Hyperactivity Disorder 5 35.4
c) Pitavastatin - Biological Process Hidden Relationships
Biological process Intermediates Ri
Monocyte Activation 26 36.0
Endothelial Cell Differentiation 25 37.2
Osteoblast Differentiation 22 36.6
Adipocyte Differentiation 22 36.0
Intracellular signalling Cascade 19 37.1
The following intermediate inclusion criteria were used to calculate the hidden relationships: 
minimal number of co-publications between keywords: at least 3; minimal R-scaled score between 
keywords: at least 20; intermediates used: genes (A and B), and genes, pathways and biological 
processes (C); literature: till May 1, 2007. The significance cutoff of Ri scores were set to a maximum 
false-positive rate of 0.1, which was set to 34 for disease-gene and drug-disease relationships, 
and set to 36 for drug-biological processes hidden relationships, as calculated in the literature 
partitioning analysis (Figure 2).
CoPub Discovery was used to identify genes that might play a role in GD, but with no known 
relationship with GD. The analysis was conducted allowing only genes as intermediates. 
Several genes were found in literature with a hidden relationship with GD that had a Ri 
score above the significance cutoff (Table 1a). At the top of the gene list, connected with 
21 genes to GD, is Programmed cell death 1 (PDCD1).
PDCD1 is a cell surface receptor that regulates T-cell proliferation and activation, which 
was linked in earlier studies to autoimmune diseases like type 1 diabetes and rheumatoid
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arthritis [28,29]. Genetic studies, published after May 1, 2007 (which was not used for 
constructing the relationship between PDCD1 and GD) showed that small genetic effects 
within PDCD1 contribute to the development of GD [30,31], and confirms that the 
proposed association between PDCD1 and GD by CoPub Discovery is indeed biologically 
relevant. One of the genes that was identified as an intermediate between PDCD1 
and GD is Cytotoxic T lymphocyte-associated antigen 4 (CTLA4) (Figure 5a). CTLA4, like 
PDCD1, is a negative regulator of T-cell activation [32], and polymorphisms in this gene 
are associated with the onset of GD [33,34]. Studies report that CTLA4 and PDCD1 act 
as co-inhibitors of T-cell proliferation and activation [35,36]. This functional association 
between PDCD1 and CTLA4 explains the relationship between PDCD1 and GD, and 
indicates that the CoPub Discovery predicted association between PDCD1 and GD was 
correctly identified based on biological knowledge.
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Figure 5 - Novel predicted relationships. Hidden relationships are visualized between a) Graves' 
disease and Programmed cell death 1 (PDCD1), b) Milnacipran and obsessive-compulsive disorder, 
and c) Pitavastatin and monocyte activation. A and C biomedical concepts are represented as circles 
(genes) or quares (disease, drug or biological process), whereas B-intermediates are represented 
as circles (genes) and squares (pathways and biological processes). The edges between nodes 
represent co-publications in Medline abstracts.
Case study 2: drug-disease hidden relationships
Milnacipran, a serotonin and noradrenalin reuptake inhibitor (SNRI), is a regularly 
prescribed drug to treat depression [37]. SNRIs prevent the reuptake of serotonin and 
noradrenalin by pre-synaptic cells, and thereby increase the extracellular availability of 
serotonin and noradrenalin to bind to post-synaptic receptors, which enhances their 
biological effect [38].
Depression is often accompanied by chronic pain. Therefore, antidepressants like 
milnacipran also become more widely applied to treat chronic pain [39,40]. Serotonin and 
noradrenalin act as key mediators in various biological processes, and therefore SNRIs, 
due to their dual action of preventing reuptake of both serotonin and noradrenalin, are 
used to treat a range of distinct disorders.
We used CoPub Discovery to predict new applications for milnacipran. Several disorders 
were found by CoPub Discovery that had a significant, hidden relationship in literature 
with milnacipran using genes as intermediates (Table 1b). The top scoring disorder, 
connected with 7 gene intermediates, is obsessive compulsive disorder (OCD).
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OCD is a common chronic anxiety disorder that can have disabling effects on both 
adults and children. OCD is characterized by recurrent obsessions and uncontrolled 
compulsions such as repetitive behavioral or mental acts that are performed in response 
to an obsession [41]. Marble-burying behavior in mice is recognized as a model for OCD
[42]. In this model, inhibition of marble burying is correlated with reduction of anxiety, 
which can be achieved by treatment with selective serotonin reuptake inhibitors (SSRIs)
[43]. Several studies have shown that in addition to SSRIs, SNRIs are also promising drug 
candidates for treatment of OCD [44,45]. Again, to validate the predicted association 
between milnacipran and OCD, we inquired the literature from May 1, 2007 until present 
for studies that report on a functional relationship between milnacipran and OCD. Indeed, 
in a study published after May 1, 2007, milnacipran was found to significantly inhibit 
marble-burying behavior in mice [46], which demonstrates that the inferred relationship 
between milnacipran and OCD by CoPub Discovery appears biologically valid.
Two genes that connect milnacipran and OCD are the norepinephrine transporter SLC6A2 
and the serotonin transporter SLC6A4 (Figure 5b). Milnacipran, SLC6A2 and SLC6A4 are 
linked in literature by studies that report on the inhibitory effect of milnacipran on 
norepinephrine and serotonin uptake [47,48], whereas susceptibility to OCD was linked 
in literature to polymorphisms in SLC6A4 and SLC6A2 [49,50]. These reports underpin 
a functional relationship between milnacipran and OCD, and shows that the predicted 
relationship between milnacipran and OCD by CoPub Discovery can be well explained by 
the biology of the intermediates.
Case study 3: drug - biological process hidden relationship
Pitavastatin is a new synthetic inhibitor of 3-hydroxy-3-methyl glutaryl coenzyme A 
(HMG-CoA) reductase, which was shown to be a potent cholesterol-lowering agent [51]. 
The short-term and long-term lipid-modifying effects of pitavastatin have already been 
investigated in subjects with familial hypercholesterolemia, hypertriglyceridemia and 
type 2 diabetes mellitus [51], and the drug has been in Phase III trials in Europe, US and 
Japan [52].
The primary effect of a drug on its target and on related cellular processes is in many cases 
well known, whereas other beneficial, pleiotropic effects are often less well understood 
or are not immediately clear from literature. To predict additional cellular effects of 
pitavastatin and to understand its mode of action, CoPub Discovery was used predict 
relationships between biological processes and pitavastatin using genes and biological 
processes as intermediates.
It appeared that the four top scoring biological processes represent cell differentiation 
processes (Table 1c). To assess whether pitavastatin indeed affects cell differentiation, we 
inspected the literature from after May 1, 2007 that report on such an association. For 
adipocyte differentiation, indeed a direct link between pitavastatin administration and 
cell differentiation was reported [53]. In this study, pitavastatin was shown to have an
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inhibitory effect on preadipocyte differentiation into mature adipocytes by attenuating 
the expression of Peroxisome proliferator activated receptor gamma (PPARy), a known 
inducer of adipogenesis [54,55] and one of the intermediates in the hidden relationship 
between pitavastatin and adipocyte differentiation. This indicates that the predicted 
linkage between pitavastatin and adipocyte differentiation by CoPub Discovery is very 
likely and merits further research.
Pivastatin is connected to monocyte activation/differentiation with 26 intermediates 
(Table 1c). Activation of monocytes induces monocyte migration to sites of inflammation 
and induces differentiation of monocytes into macrophages, dendritic cells and 
osteoclasts [56,57]. Inspection of the intermediates identified, among others, Chemokine 
(C-C motif) ligand 2 (CCL2, also known as MCP1) and PPARy (Figure 5c). The literature 
that links monocyte activation and differentiation to CCL2 and CCL2 to pitavastatin, show 
that CCL2 is an inducer of monocyte activation and migration [58] and that pitavastatin 
attenuates gene expression of CCL2 in smooth muscle and endothelial cells [59,60]. This 
raises the hypothesis that pitavastatin is able to block monocyte activation and migration 
by downregulation of CCL2 gene expression in CCL2-secreting cells.
Similarly, the literature shows that pitavastatin downregulates the expression of PPARy 
in macrophages [61]. The expression of PPARy is upregulated in activated monocytes/ 
macrophages and PPARy plays a role in induction of differentiation of macrophages 
into foam cells [62], raising the possibility that by downregulating PPARy expression, 
pitavastatin is able to suppress activation and differentiation of monocytes into 
macrophages. The hypothesis that pitavastatin is linked to cell differentiation is in line 
with studies on simvastatin, which is also a HMG-CoA reductase inhibitor, that was shown 
to affect cell differentiation [63,64].
Altogether, pitavastatin is strongly linked to cell differentiation by CoPub Discovery. In 
cardiovascular disease, aberrant differentiation of macrophages into foam cells leads to 
plaque formation at vascular endothelium cells and can cause occlusion of blood vessels 
[65], whereas over-abundance of adipocytes causing obesity is considered to be a major 
risk factor for type II diabetes [66]. Although the beneficial effect of pitavastatin on 
atherosclerosis and diabetes has been well recognized [51], the underlying mechanisms 
on how pitavastatin initiates these effects have remained elusive. Based on the results 
of CoPub Discovery, it might be hypothesized that pitavastatin might prevent foam cell 
formation by blocking monocyte differentiation via suppression of CCL2 and PPARy 
expression. Furthermore, the proposed relationship between pitavastatin and adipocyte 
differentiation, which was confirmed in the literature [53], may explain the beneficial 
effect of pitavastatin on obesity and diabetes [66].
Taken together, the results of CoPub Discovery show that this tool is well-suited to predict 
mechanisms of drug action and to derive hypothesis about the biological pathways that 
are involved.
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Case study 4: biological process - drug hidden relationship
To experimentally test a number of predicted relationships we used CoPub Discovery to 
search for drugs that could interfere with cell proliferation, a process for which assays are 
readily available. Several drugs were found to have a significant hidden relationship when 
using genes as intermediates with the term 'cell proliferation' (Table 2). From this list, 
two top-scoring compounds; dephostatin, a protein tyrosine phosphatase inhibitor [67], 
and damnacanthal, a protein tyrosine kinase inhibitor [68], were selected to test their 
hypothesized association with cell proliferation in an in vitro cell assay.
Table 2 - Prediction of novel links between cell proliferation and drugs using open discovery
Drug - Cell proliferation Hidden Relationships
Drug name Intermediates Ri
Dephostatin 22 36.8
Damnacanthal 15 37.2
Aniracetam 14 36.4
Mizolastine 12 36.2
Betaseron 12 36.2
The following intermediate inclusion criteria were used to calculate the hidden relationships: 
minimal number of co-publications between keywords: at least 2; minimal R-scaled score between 
keywords: at least 20; intermediates used: genes; literature: till May 1st 2007. The significance 
cutoff of Ri scores were set to a maximum false-positive rate of 0.1, which was set to 36 for the used 
settings, as calculated in the literature partitioning analysis (Figure 2).
Human peripheral blood mononuclear cells (PBMCs) were pre-incubated with 
damnacanthal or dephostatin for concentrations ranging from 0.01 to 10 ^M, followed 
by incubation with CD3/CD28 antibodies, which triggers T lymphocyte proliferation. Both 
damnacanthal and dephostatin inhibited proliferation of PBMCs for concentrations in 
the ^M-range, with EC50's of 2.67 ^M and 1.96 ^M respectively (Figure 6). Cell viability 
and apoptosis were not affected by damnacanthal and dephostatin indicating that 
damnacanthal and dephostatin specifically inhibit cell proliferation.
An earlier study showed that damnacanthal inhibits Ras function [69], which provides 
a mechanism of action of how damnacanthal might influence cell proliferation, as Ras 
oncogenes are involved in cell cycle regulation. A study performed prior May 2007 
showed that dephostatin inhibits the growth of Jurkat cells [70], therefore it can be 
argued that the inhibitory effect of dephostatin on cell proliferation was already known. 
However the term cell proliferation' was not mentioned in the abstract of this paper 
and therefore CoPub Discovery qualified the relationship between dephostatin and cell 
proliferation' as novel.
These experiments provide evidence that the predicted hidden relationships with CoPub 
Discovery of damnacanthal and dephostatin with cell proliferation were indeed correct.
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Figure 6 - In vitro cell proliferation assay validates CoPub Discovery's prediction. The predicted 
influence of damnacanthal (red line and bullets) and dephostatin (blue line and triangles) on 
cell proliferation was tested in an in vitro cell assay. For both damnacanthal and dephostatin, 
the percentage of inhibition was measured and plotted against compound concentration. Both 
compounds were shown to inhibit cell proliferation in PBMCs when using concentrations in the 1 
to 10 |JM-range. The EC50 was estimated at 1.96 |aM for dephostatin and for damnacanthal at 2.67 
HM.
DISCUSSION
In this paper we described CoPub Discovery, a web-based tool that mines the Medline 
database for novel relationships between genes, diseases, drugs and pathways. The 
results show that using hidden relationships, we can successfully identify novel disease- 
related genes, generate novel hypotheses on drug mode of action and predict novel lead 
compound applications.
Drug discovery is a difficult and time-consuming process. Despite the strong increase in 
funding of research and development the last decade, the number of drugs that reach the 
market each year is lagging behind [71]. Several strategies have been adopted to bridge 
this gap. The use of systems biology for gaining better knowledge on the mechanisms of 
drug action and toxicity [72-75] and the use of biomarkers that are predictive for a certain 
biological outcome [76-78], are widely used solutions to improve decision making. In 
addition, drug repositioning, which is the use of existing drugs for new applications, is 
another area that is gaining much attention as a means to boost drug development [79]. 
Several text mining solutions have been developed to assist in and speed up the above 
strategies.
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In a recent paper, Compillos et al. showed how text mining of drug labels, can be used to 
infer whether two drugs share the same target [80]. Our study identified several novel 
targets for known drugs, based on a different algorithm and another text corpus. This 
indicates that mining of literature is an interesting and fruitful approach to identify new 
drug-target relations, a first step in developing drugs towards new applications.
Detailed knowledge of the mechanism of action of a drug and the biological processes 
that are targeted by a drug is of importance for fine tuning drugs and biomarker discovery. 
In an earlier study, we showed that the application of text mining on expression data 
from a toxicogenomics experiment yielded detailed insight in the mode of toxicity of the 
tested compounds [13]. With the hidden relationship algorithm presented in this paper 
we provide a text mining tool that is independent of gene expression data, to improve the 
understanding of a drug's mechanism of action and the pathways targeted by that drug. 
Although CoPub Discovery is successful in identifying novel, biologically relevant 
relationships in literature, several improvements may be envisioned. For example, 
incorporation of additional evidence for true relationships between concepts from 
sources other than literature, such as protein-protein interaction data or gene co­
expression data, could help prioritize relationships by biological relevance. Furthermore, 
an additional measure of confidence could come from analyzing the relationships 
between the intermediates that connect A and C. A highly interconnected set of 
intermediates could indicate/validate higher biological relevance compared to a set with 
few interconnections.
Co-occurrence-based text mining does not capture the type of the extracted relationships 
(e.g. A binds, blocks, induces B). Therefore, in the CoPub Discovery web server the results 
are linked to the original abstracts in which the relationships were found. This enables 
the scientist to read the facts to uncover the type of relationship between A and C. A 
good starting point for discovery would be to look for intermediate nodes (B) that have 
the highest ft-scaled scores for both node A and node C, because they have the strongest 
link between A and C. After selecting a few of these nodes, the researcher can perform a 
detailed analysis on the functional association between A and C by reading the abstracts 
in which A and B, and B and C are mentioned. Additionally, incorporation of natural 
language processing in hidden relationship analysis could assist in determining the type 
and direction of the relationship between A and C.
In the validation procedure of CoPub Discovery using ROC curve analysis we define FPs 
as A-C relationships that are predicted in the literature before the year 2000 that were 
not detected in subsequent literature. It might be well true that a FP is in fact a novel 
discovery, but is not yet discovered in subsequent literature. Furthermore, one can argue 
that a high area under the curve (AUC) score indicates that CoPub Discovery discovers 
very little that would not have been eventually discovered without it. In this respect, the 
6.5 year time lag between the CoPub Discovery and the report in literature may be more 
indicative of the true value of CoPub Discovery; it significantly speeds up hypothesis
Hidden relationships in literature - CoPub Discovery 69
generation, filtering and testing as was demonstrated in case example 4 in which we 
exactly followed this approach.
Evaluating the ROC curves in light of the performance of other text mining tools is 
hampered by the fact that not all of the tools are accessible or work on different 
text corpora or use different thesauri. Development of tools for discovery of hidden 
relationships would benefit from the use of expert-curated test and training sets on well- 
defined literature corpora, as is done in the BioCreative text mining challenges.
The statistical underpinning of CoPub Discovery provides a significant advantage over 
existing text mining tools applied in the area of drug development [19,22,24]. It allows 
confidence level calculations for hidden relationships and facilitates the discrimination of 
biologically relevant from biologically less interesting hidden relationships. To ensure the 
quality of the hidden relationships, several stringencies were placed on the biomedical 
concepts used in CoPub Discovery. For example, the biomedical concepts used in 
literature mining were all pre-tested for false positive generation upon inclusion in one of 
the biomedical concept thesauri. Furthermore, only genes and biological processes are 
allowed as intermediates, which avoid relationships being formed by non-informative 
concepts, such as 'protein', 'cell assay', etc.
In short, the results in this paper show that CoPub Discovery is able to identify novel 
associations between genes, drugs, pathways and diseases that have a high probability 
of being biologically valid. The fact that this is done rapidly, in an automated way, makes 
the tool especially useful in areas where large amounts of data need to be analyzed. 
A typical use of this tool could be to quickly rank potential new biomarkers obtained 
from e.g. a microarray experiment, based on their relation to diseases and drugs. CoPub 
Discovery could also help in drug repositioning in which list of drugs are clustered and 
ranked on basis of their relation with diseases and biological processes of interest.
MATERIAL AND METHODS 
Text mining Medline abstracts
Six thesauri containing human genes, Gene Ontology biological processes, liver 
pathologies, diseases, pathways and drugs were used to search Medline XML files 
containing title, abstract and substances (1966 - August 2009, http://www.nlm.nih. 
gov/bsd/licensee/2009_stats/baseline_doc.html), as described previously [13,25]. 
The keyword thesauri are based on biological items, which represent an instance of a 
biological concept (e.g., a gene, a pathway), and may contain multiple keywords (e.g., 
a gene is assigned a full gene name, a gene symbol and gene aliases). Typical full gene 
names contain commas and often additional descriptions in parenthesis, which makes 
a full gene name an inadequate direct search term. Therefore, full gene names were 
processed by deleting all terms included in parentheses and allow a white space for each 
comma in the full name. Two-letter gene symbols and aliases were removed from the
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thesaurus and all other gene symbols were compared to an English dictionary to remove 
common English words (such as "AND", "CELL", etc.).
Regular expressions were used to search the compiled Medline text files for the presence 
of all keywords (~250.000) from the biological concept thesauri. For the full gene name 
descriptions the characters "] [.-)(,:;" and space were allowed preceding and following 
the full gene name and also an optional "s" was permitted to follow the full gene name. 
Any white space in the full gene name was allowed to be a white space or a dash. The 
same regular expressions were applied to the non-gene biomedical concept descriptions 
(e.g. diseases, biological processes).
Keywords that generated a hit in a Medline abstract were stored, together with the 
PubMed identifiers (IDs) of the Medline records in which the hit occurred. For every 
biological item the hits were made non-redundant (note: multiple keywords of a biological 
item can occur in the same Medline abstract), resulting in a PubMed ID-biological item 
list. Gene symbol hits were examined for ambiguity. This was done by matching words 
of the full gene name in the abstract in which the gene symbol had a hit. When parts 
of the full gene name matched in the abstract, the gene symbol hit was regarded as 
a true positive; otherwise the gene symbol hit was discarded. The performance of the 
thesaurus-based keyword matching algorithm including the symbol disambiguation step 
was evaluated by repeating the human gene normalization task of the BioCreative II 
contest (www.biocreative.org). CoPub reached a recall of 0.78 and a precision of 0.68, 
resulting in an F-measure of 0.73. Based on this F-measure, CoPub would have been 
ranked 11th out of 21 participants [81].
Co-publication of biological items (e.g. a gene with a biological process) was retrieved 
from the database by matching Medline abstract occurrences. An ft-scaled score ranging 
from 1-100, which describes the strength of a co-citation between two biological items 
given their individual frequencies of occurrence, was used to assess the significance of 
a co-occurrence [15]. The ft-scaled score is based on the mutual information measure 
(MIM) and was calculated as S = PAB/PA*PB in which PA is the number of hits for biological 
item A divided by the total number of PubMed IDs, PB is the number of hits for biological 
item B divided by the total number of PubMed IDs, and PAB is the number of co­
occurrences between biological item A and biological item B divided by the total number 
of PubMed IDs. The relative score R is produced as a log10 conversion of S (R = 10log S) 
and the 1-100 scaled-log-transformed relative score (ft-scaled score) as R' = 1 + 99 * (R 
- R ) / (R - R ), where R and R are the lowest and highest R values present inmin' ' v max min" min max 1
the biological item co-publication list, respectively. A high ft-scaled score indicates that 
if two biological concepts occur in literature they are often published together, this in 
contrast to a low ft-scaled score which indicates that two biological concepts often occur 
separately in literature and less often together. Based on previous experiences using 
CoPub for the interpretation of microarray data, an ft-scaled score of above 40 can be 
regarded as biologically significant.
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The scoring of hidden relationships between biomedical concepts was adapted from 
Wren's minimal MIM (MMIM) model [82] where we used an ft-scaled score instead of 
a MIM score. The strength of the hidden relationship between A and C is calculated 
using the ft-scaled scores between A and B, and between B and C. This inferred ft-scaled 
(fti) score between A and C is calculated by summation of the ft-scaled scores over the 
intermediates B, taking the lowest score in each pair (AB, BC), and dividing by the number 
of intermediates (Figure 1).
Bibliographic prediction and validation by literature partitioning
Medline was divided into two sets (Figure 2). One set, the background set, contained 
abstracts published before the year 2000. The second set, the test set, contained abstracts 
published from the year 2000 up to May 1, 2007. Biomedical concept pairs were formed 
from the background set, using the following criteria: 1) The members of the pair do 
not co-occur in any abstract. 2) Each member of the pair occurs in at least 10 distinct 
abstracts. 3) The members share at least 5 intermediates.
The test set was then used to evaluate whether the pairs from the background set had a 
true relationship or not. A true relationship for a pair (TP) was defined using the following 
criteria: 1) The pair should have at least 3 co-occurrences in the test set. 2) The ft-scaled 
score for this pair should be >40. All other pairs (FP) were regarded as not having a true 
relationship. CoPub Discovery was then evaluated for the ability to predict TPs from the 
background set. To this end an inferred ft-scaled (fti) score was calculated for each pair 
of the background set and the performance of CoPub Discovery of separating TP from FP 
relationships was measured with ROC curves generated by varying the fti threshold. The 
area under the curve (AUC) of the ROC curve is equal to the probability that a method 
will rank a randomly chosen positive instance higher than a randomly chosen negative 
one [83]. We provide a web service with which the thesauri and publication data can be 
downloaded. The web server and web service implementation of the method described 
in this paper, CoPub Discovery, is available at http://www.copub.org.
In vitro cell proliferation, viability and apoptosis assays
Damnacanthal (3-Hydroxy-1-methoxyanthraquinone-2-aldehyde), Merck Biosciences, 
Cat.No. 251650. 3,4-Dephostatin (3,4-Dihydroxy-N-methyl-N-nitrosoaniline), Merck 
Biosciences, Cat.No. 263202. Cell proliferation assays were performed with human 
peripheral blood mononuclear cells (PBMCs), stimulated with CD3 (OKT3)/CD28 
(pelicluster CD28 clone CLB-CD28/1, Sanquin, the Netherlands) antibodies at a 
concentration of 125ng/ml and 250ng/ml respectively in the presence or absence of 
compounds. Proliferation was determined after 3 days via 3H-thymidin incorporation for 
24 hours. Viability of PBMCs was measured by Alamar Blue cell viability assay (Molecular 
Probes/Invitrogen, Eugene, OR). Apoptosis of PBMCs was measured using caspase GLO 
3/7 activity assay (Promega, Madison, WI).
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ABSTRACT
Introduction: To reduce continuously increasing costs in drug development, adverse 
effects of drugs need to be detected as early as possible in the process. In recent years, 
compound induced gene expression profiling methodologies have been developed to 
assess compound toxicity, including Gene Ontology term and pathway over-representation 
analyses. The objective of this study was to introduce an additional approach, in which 
literature information is used for compound profiling to evaluate compound toxicity 
and mode of toxicity. Methods: Gene annotations were built by text mining in Medline 
abstracts for retrieval of co-publications between genes, pathology terms, biological 
processes, and pathways. This literature information was used to generate compound 
specific keyword fingerprints, representing over-represented keywords calculated in a set 
of regulated genes after compound administration. To see whether keyword fingerprints 
can be used for assessment of compound toxicity, we analyzed microarray data sets of 
rat liver treated with eleven hepatotoxicants. Results: Analysis of keyword fingerprints of 
two genotoxic carcinogens, two nongenotoxic carcinogens, two peroxisome proliferators 
and two randomly generated gene sets, showed that each compound produced a specific 
keyword fingerprint that correlated with the experimentally observed histopathological 
events induced by the individual compounds. By contrast, the random sets produced a 
flat a-specific keyword profile, indicating that the fingerprints induced by the compounds 
reflect biological events rather than random noise. A more detailed analysis of the keyword 
profiles of diethylhexylphthalate, dimethylnitrosamine and methapyrilene (MPy) showed 
that the differences in the keyword fingerprints of these three compounds are based 
upon known distinct modes of action. Visualization of MPy-linked keywords and MPy- 
induced genes in a literature network enabled us to construct a mode of toxicity proposal 
for MPy, which is in agreement with known effects of MPy in literature. Conclusion: 
Compound keyword fingerprinting based on information retrieved from literature is a 
powerful approach for compound profiling, allowing evaluation of compound toxicity 
and analysis of the mode of action.
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INTRODUCTION
In the drug development process, it is important that any toxicity of new compounds is 
recognized as early as possible to guarantee drug safety and to reduce the costs of drug 
development [1]. Classical methods of toxicity evaluation of compounds involve elaborate 
and time-consuming animal experiments in which a number of measurements are carried 
out to evaluate toxicity, including clinical chemistry, hematology, histopathology and in 
vitro assays.
In recent years, toxicogenomics has emerged as a new methodology to evaluate 
compound toxicity. With toxicogenomics, compound induced gene expression profiles 
are analyzed to detect indications of toxicity and, as such, may provide a promising way 
to rapidly screen for adverse drug effects [2,3]. The challenge in this approach is to infer 
toxicity of the compound from the gene expression profiles in order to predict the toxicity 
of a compound and to resolve the underlying mechanism of toxicity.
One approach relies on comparison of observed gene expression profiles with a database 
of expression profiles for reference compounds with known toxic effects [4]. Another 
approach consists of the analysis of the annotation of the genes that are differentially 
expressed in drug-treated sample. Multiple algorithms exists that analyze gene sets 
for the presence of over-represented GO, KEGG or other annotation terms [5,6]. These 
algorithms have been applied successfully to elucidate toxic effects and mode of action 
of a number of compounds [7].
In this paper we want to introduce an additional approach to link gene expression profiles 
to toxicity. We developed a tool named CoPub [101] that is able to calculate keyword 
over-representation in a similar fashion to general GO term over-representation tools 
but, in our approach, the annotation of the genes is retrieved directly from Medline by 
text mining. Medline represents an enormous amount of information on the function of 
genes/proteins and their role in the onset of toxicity, and is therefore an ideal source to 
identify relations between the expression of genes and toxicity endpoints.
Several text mining methods for the analysis of microarray data have been published, 
including methods for the generation of literature neighbourhoods from regulated genes 
[8] and clustering a set of regulated genes based on their literature profile [9-13]. Other 
methods are aimed at annotating gene sets that are obtained by clustering of genes 
based on their expression profile, often based on subsets of the total Medline repository 
[14,15]. CoPub uses the entire Medline library to calculate robust statistics for gene- 
keyword co-occurrence, and is not dependent on pre-clustered gene sets to calculate 
significance for keyword over-representation.
CoPub is built on the assumption that co-citation of a gene and a keyword in the same 
Medline abstract is indicative of a relation between the gene and the keyword and that 
the keyword thus represents some sort of annotation of the gene. Using thesaurus- 
based keyword matching [8,16,17] with thesauri for genes, biological processes, drugs,
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liver pathologies and diseases, all keyword co-publication hits in the Medline abstracts 
database are collected. This co-publication information is then used to calculate keyword 
over-representation in sets of genes that are differentially expressed in compound- 
treated samples. The list of over-represented keywords can be subsequently analyzed to 
assess the toxicity and mode of toxicity of the compounds that are tested.
To demonstrate the value of CoPub, we applied this text mining tool to two microarray data 
sets. In one experiment male Wistar Hanover rats were dosed daily by gavage with four 
nongenotoxic carcinogens; methapyrilene (MPy), diethylstilbestrol (DES), Wy-14643 (Wy) 
and piperonylbutoxide (PBO), and four genotoxic carcinogens; 4-(methylnitrosamino)-1- 
(3-pyridyl)-1-butanone (NNK), 2-nitrofluorene (2-NF), dimethylnitrosamine (DMN) and 
aflatoxin B1 (AB1) [18,19]. In the other experiment, Sprague-Dawley rats were given a 
single dose by oral administration with three peroxisome proliferators; clofibrate (Clo), 
valproic acid (VPA) and diethylhexylphthalate (DEHP) [20]. Histological examination of 
the livers treated with the four genotoxic carcinogens showed increasing necrosis after 
DMN and AB1 treatment, which was accompanied by reactive inflammation in both cases 
[19]. 2-NF induced modest hypertrophy, and NNK showed only weak apoptosis after 14 
days of treatment [19]. On a histopathological level, all four nongenotoxic carcinogens 
showed to induce weak (PBO) to moderate (DES, Wy, MPy) hyperplasia and hypertrophy. 
MPy induced apoptosis with increasing severity over time, causing weak inflammation 
[18]. Histopathological examination of the livers treated with the three peroxisome 
proliferators Clo, DEHP and VPA showed some vacuolation, hypertrophy and increased 
mitotic figures [20].
Using CoPub we generated keyword fingerprints for each of the compounds. Detailed 
examination of the regulated gene sets and their over-represented keywords for a 
genotoxic carcinogen, a nongenotoxic carcinogen, and a peroxisome proliferator revealed 
mechanisms of toxicity for these compounds that correlate well with histopathological 
data. These results show that text mining of gene expression data, as implemented in 
CoPub, is a valuable tool for early screening of compounds for toxic effects.
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RESULTS 
Compound keyword fingerprints
To see whether toxicity of a compound can be assessed from the literature by keywords 
associated with the compound's gene expression profile, two microarray data sets 
including 11 hepatotoxicants were analyzed. One data set was generated by treatment 
of rat liver with eight hepatocarcinogens [18] and the other by treatment of rat liver 
with three peroxisome proliferators [20]. The 11 compounds were analyzed for gene 
expression profiling and included four nongenotoxic hepatocarcinogens: MPy, DES, 
Wy and PBO; four genotoxic hepatocarcinogens: 2-NF, DMN, NNK and AB1; and three 
peroxisome proliferators: Clo, VPA and DEHP. It should be noted that Wy is also known 
as a potent peroxisome proliferator, and that peroxisome proliferators, if chronically 
administered, are carcinogenic (nongenotoxic) in rodents.
We identified sets of regulated genes for each of the 11 compounds using the raw data at 
the time point on which the compounds revealed their effects on histopathological level; 
for the eight carcinogenic compounds this was after 7 days of compound administration, 
and for the three peroxisome proliferators after 2 days of compound administration. 
These gene sets were then analyzed for keyword over-representation, generating a 
keyword fingerprint for each compound.
To study whether keyword fingerprints can be used to discriminate between compounds 
with different mode of actions, we compared keyword fingerprints of two genotoxic 
carcinogens (DMN and AB1), two nongenotoxic carcinogens (MPy and PBO), two 
peroxisome proliferators (DEHP and VPA) and of two randomly generated gene sets (150 
and 250 randomly selected Affymetrix probe set identifiers). For ease of comparison, 
the keywords were categorized into 13 groups: pathogenesis, drug metabolism, 
oxidative stress, DNA damage and response, cell cycle and mitosis, apoptosis and cell 
death, inflammation and immune response, cell differentiation and development, 
steroid metabolism, lipid metabolism, energy metabolism, general cell metabolism, and 
miscellaneous keywords. The profiles of the keyword fingerprints are visualized in Figure
1.
Notable differences in the keyword profiles can be appreciated in Figure 1. The keywords 
of the two peroxisome proliferators DEHP and VPA are mainly grouped into the steroid, 
lipid, and energy metabolism categories. The keyword fingerprints of DMN and AB1 
strongly reflect processes of cell death, accompanied by inflammation, a hallmark of 
most genotoxic carcinogens, whereas oxidative stress, found with many nongenotoxic 
carcinogens, is found predominantly with PBO and MPy. Some categories are hit by all 
compounds, such as drug metabolism, general cell metabolism and, to a lesser extent, 
pathogenesis. Similar profiles were observed for the other compounds, although these 
profiles were less pronounced due to the fact that these compounds induced a smaller 
number of genes. All of the randomly generated gene sets produced flat profiles with
Literature-based compound profiling 87
no keyword enrichment, indicating that the keyword fingerprints of the analyzed 
hepatotoxicants reflect real biological processes rather than random noise. These 
results show that literature associations between genes and keywords can be used to 
discriminate between compounds with distinct biological activities.
t
s
Figure 1 - Keyword profiles of DMN, AB1, MPy, PBO, DEHP and VPA. Visualization of over­
represented keywords (p<0.01), grouped in 13 biological process categories, of two genotoxic 
carcinogens; DMN (dotted red line) and AB1 (solid red), two nongenotoxic carcinogens; MPy (dotted 
blue line) and PBO (solid blue line), two peroxisome proliferators; DEHP (dotted green line) and VPA 
(solid green line), and of two randomly generated gene sets (150 Affymetrix probe set IDs; dotted 
black line and 250 Affymetrix probe set IDs; solid black line). On the y-axis the relative number 
of keywords, compared with the total number of keywords classified in that category, is plotted. 
The categorization of keywords was performed using all keywords present in at least one of the 
keyword fingerprints of the 11 tested compounds. AB1: Aflatoxin B1; DEHP: Diethylhexylphthalate; 
DMN: Dimethylnitrosamine; MPy: Methapyrilene; PBO: Piperonylbutoxide; VPA: Valproic acid.
To see if the observed distinct fingerprints between compounds reflects the biological 
and toxicological effects of the compounds we analyzed the keyword fingerprints of a 
peroxisome proliferator (DEHP), a genotoxic carcinogen (DMN) and a nongenotoxic 
carcinogen (MPy), in more detail (Table 1; Note: To reduce the size of Table 1, we do not 
show p-values).
Keyword fingerprint of DEHP
DEHP is widely used as a plasticizer in manufacturing of a wide variety of polyvinyl 
chloride (PVC)-containing medical and consumer products. DEHP belongs to the class of
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peroxisome proliferators, which induce enlargement and proliferation of peroxisomes, 
resulting in an elevation of fatty acid metabolism, which is characteristic for this class 
of chemicals [24]. This elevated level in lipid metabolism is thought to be caused by the 
activation of the nuclear receptor peroxisome proliferator-activated receptor (PPAR)-a, 
which is the key mediator of lipid metabolism [25]. Peroxisome proliferators, when 
chronically administered, are also known to induce tumor formation in a nongenotoxic 
fashion (i.e. not via direct DNA damage) [24,25], although it is not completely clear by 
which mechanism. On a histopathological level, after two days of DEHP administration 
some vacuolation, hypertrophy, and increases in mitotic figures were observed [20]. 
The observed hypertrophy is due to enlargement of liver cells caused by an increase 
in the number of peroxisomes, most likely via activation of PPAR-a [25]. The observed 
vacuolation is often caused by accumulation of lipids in the cells. The profile of the keyword 
fingerprint of DEHP (Figure 1) shows that DEHP largely has its effect on lipid metabolism 
and energy metabolism, which is in agreement with the observed pathologies and with 
known effects of peroxisome proliferators. Keywords in the fingerprint of DEHP (Table 1) 
support its lipogenic effect, with low p-values for keywords like lipid metabolism, fatty 
acid oxidation, fatty acid p-oxidation and hypertrophy.
Keyword fingerprint of DMN
DMN is a genotoxic carcinogen (i.e. causes direct DNA damage) and is present in cigarette 
smoke and certain foods [26], and its observed toxicity is caused by its metabolites via 
methylation of DNA bases and proteins, eventually leading to the formation of tumors 
[19,27-29]. On a histopathological level, DMN administration results in a reactive 
inflammatory response, necrosis, bile duct hyperplasia, and fibrosis [19,28,30].
DMN is known to induce a strong reactive inflammatory response upon administration in 
reaction to the onset of necrosis [19] and is followed by postnecrotic tissue remodeling 
[31,32]. In this process, macrophages infiltrate the liver to remove necrotic cells and 
activated hepatic stellate cells (HSCs) migrate to necrotic areas to secrete collagen and to 
promote the formation of sinusoidal wall, resulting in the formation of scar tissue [31]. 
The profile of the keyword fingerprint of DMN (Figure 1) is in agreement with the 
observation that DMN causes a strong inflammatory response following necrosis - as a 
relative high number of keywords are grouped in the inflammatory and immune response 
category (e.g., immune system, inflammatory response, inflammation) - and that necrosis 
was one of the keywords with the lowest p-value (Table 1). Furthermore, also a relative 
high number of keywords are grouped in the cell differentiation and development 
category (e.g., cell development, cell differentiation, cell maturation) and, together with 
keywords like cell migration and cell activation (both miscellaneous category), may point 
to tissue remodeling, since migration, activation, and differentiation of various cells occur 
in this process. Interestingly, fibrosis and cirrhosis are two of the DMN-linked keywords in 
the pathogenesis category with low p-values. This might be correlated to the activation 
of HSCs by DMN, since excessive deposition of collagen can lead to fibrosis [33] and can 
result in cirrhosis if it becomes chronic [34].
Category DEHP DMN M Py
Pathogenesis Liver tumor, Necrosis, Cirrhosis, 
Hepatitis, Hypertrophy, Hepatocellular 
carcinoma, Cholestasis, Steatosis, 
Hyperplasia, Pathogenesis, Gallstone 
formation
Hepatocellular carcinoma, Hepatitis, 
Necrosis, Cirrhosis, Adenocarcinoma, 
Pathogenesis, Leukemia, Adenoma, 
Sarcoma, Fibrosis, Malignant tumor, 
Hyperplasia, Granuloma, Liver tumor, 
Angiogenesis, Hypertrophy, Atrophy, 
Edema, Metaplasia, Hyperplastic 
nodule, Ascites, Fever, Liver fibrosis, 
Lymphocytic leukemia, Biliary cirrhosis, 
Oncogenesis, Hypoplasia
Necrosis, Adenocarcinoma, 
Hepatocellular carcinoma, Cirrhosis, 
Hepatitis, Hyperplastic nodule, 
Leukemia, Pathogenesis, Liver tumor, 
Hepatocellular adenoma, Ascites, 
Adenoma, Sarcoma, Telangiectasia, 
Biliary cirrhosis, Fibrosis, Hypertrophy, 
Hyperplasia
Drug metabolism Drug metabolism, Xenobiotic 
metabolism, Drug resistance
Drug metabolism, Drug resistance, 
Xenobiotic metabolism
Necrosis, Adenocarcinoma, 
Hepatocellular carcinoma, Cirrhosis, 
Hepatitis, Hyperplastic nodule, 
Leukemia, Pathogenesis, Liver tumor, 
Hepatocellular adenoma, Ascites, 
Adenoma, Sarcoma, Telangiectasia, 
Biliary cirrhosis, Fibrosis, Hypertrophy, 
Hyperplasia
Oxidative stress Response to oxidative stress, 
Glutathione biosynthesis, Glutathione 
metabolism
DNA damage and 
response
Mutagenesis Mutagenesis, Cell cycle arrest, 
Stabilization of p53, Mismatch repair, 
Nucleotide excision repair, DNA damage 
response
DNA damage response, DNA repair, 
Cell cycle arrest, Stabilization of p53, 
Mismatch repair, Mutagenesis
Apoptosis and cell 
death
Apoptosis, Cell death, Induction 
of apoptosis, DNA fragmentation, 
Programmed cell death
Induction of apoptosis, Cell death, DNA 
fragmentation, Apoptosis, Programmed 
cell death, Caspase activation, Anti- 
apoptosis
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Keyw
ord 
over-representation 
for 
diethylhexylphthalate-, 
dim
ethylnitrosam
ine- 
and 
m
ethapyrilene-regulated 
genes
Category DEHP
Cell Aging, Senescence
differentiation
and development
Cell cycle and Growth, Growth rate
mitosis
Inflammation and Inflammation 
immune response
DMN MPy
Cell development, Aging, Cell Aging, Cell differentiation, Senescence,
differentiation, Cell maturation, Epithelial cell differentiation
Endothelial cell differentiation,
Myogenesis, Embryonic development,
Cytokinesis, Brain development,
Myoblast differentiation
Cell cycle, Growth, DNA synthesis, Cell 
proliferation, Cell growth, Growth rate, 
DNA replication, Cell division, DNA 
amplification, G2 phase, M phase
Immune response, Antigen processing 
and presentation, Inflammatory 
response, Immune system, Antigen 
processing, Inflammation, Antigen 
presentation, Macrophage activation, 
B-cell differentiation, B-cell activation, 
T-cell activation, T-cell proliferation, 
Cytokine biosynthesis, Activation 
of MAPK, Chronic inflammation, 
Lymphocyte activation, Macrophage 
differentiation, Cell recognition, 
Mononuclear cell infiltration, 
Lymphocyte differentiation, Cell- 
mediated immune response, Humoral 
immune response, Cell invasion, 
Inflammatory cell infiltration, Monocyte 
activation, Antiviral response
Cell cycle, Growth, Cell growth, M 
phase, Growth rate, G1 phase, DNA 
synthesis, Pachytene, G2 phase, Cell 
cycle checkpoint, Cell cycle; mitotic, S 
phase, Prophase, Transcription; mitotic, 
DNA replication, Cell proliferation, 
Mitosis, Cell cycle; g2/m checkpoint, 
Chromosome movement, Single­
stranded DNA binding, Telophase, G2/m 
checkpoint, Chromatin remodeling, 
Meiosis, Division
Inflammation, T-cell proliferation,
B-cell activation, Macrophage 
activation, Lymphocyte activation, 
Inflammatory response, Immune 
response, Antigen processing, Cytokine 
biosynthesis, Chronic inflammation, 
Antigen processing and presentation, 
Immune system, B-cell differentiation, 
Macrophage differentiation
Results 
of 
the 
keyw
ord 
over-representation 
calculation, 
perform
ed 
with 
both 
up- 
and 
dow
nregulated 
genes 
after: 
DEHP, 
DM
N 
and 
M
Py 
adm
inistration. 
DEHP: 
D
iethylhexylphthalate; 
DM
N
: D
im
ethylnitrosam
ine; M
Py: M
ethapyrilene.
Category DEHP DMN M Py
Steroid
metabolism
Steroid metabolism, Cholesterol 
metabolism, Sterol metabolism
Steroid metabolism
Lipid metabolism Lipid metabolism, Fatty acid 
metabolism, Lipoprotein metabolism, 
Lipoprotein lipase activity, Fatty acid 
transport
Lipid metabolism, Lipid transport
Energy
metabolism
Fatty acid oxidation, Energy metabolism, 
Pyruvate dehydrogenase, Fatty acid 
beta-oxidation, Glycolysis, Glucose 
metabolism, Pentose phosphate 
pathway, NADH metabolism, Glyoxylate 
metabolism, Electron transport, 
Tricarboxylic acid cycle
Energy metabolism, Respiratory burst, 
Electron transport
Energy metabolism
General cell 
metabolism
Metabolism, Biosynthesis,
Catabolism, Transcription, Excretion, 
Homeostasis, Gluconeogenesis, 
Carbohydrate metabolism, Ethanol 
metabolism, Protein catabolism, 
Nitrogen metabolism, Protein folding, 
Fermentation, Glucose uptake,
Amino acid metabolism, Proteoglycan 
metabolism, Secretion, Protein 
biosynthesis
Metabolism, Phagocytosis, 
Transcription, Biosynthesis, Translation, 
Secretion, Excretion, Glycosylation, 
Peptide transport, DNA méthylation, 
Endocytosis, Phosphorylation, Protein 
stabilization, Homeostasis, Actin 
polymerization, Dephosphorylation, 
mRNA splicing, Autophosphorylation, 
N-glycosylation
Metabolism, Biosynthesis, Translation, 
Transcription, Catabolism, Ribosome, 
Protein biosynthesis, Heme metabolism, 
Response to stress, Cell homeostasis, 
Excretion, Protein metabolism, 
Phosphorylation, Histone acétylation, 
Déphosphorylation, Nitrogen 
metabolism, DNA méthylation, Protein 
dénaturation, Response to heat
Miscellaneous Enzyme activity, Transport, Digestion, 
Conjugation, Blood pressure, 
Development, Biological process
Transport, Digestion, Cell activation, 
Development, Fragmentation, Cell 
adhesion, Cytoskeleton, Recombination, 
Transduction, Migration, Proteasome, 
Cell migration, Signal transduction, 
Memory, Virulence, Chemotaxis, Growth 
pattern, Conjugation, Cell-cell adhesion, 
Blood pressure, Wound healing
Fragmentation, Enzyme activity, 
Transport, Conjugation, Myelination, 
Transduction, Proteasome, Cell 
activation, Development, Digestion, 
Signal transduction, Sensitization, Cell 
adhesion, Heme biosynthesis, Viral 
replication
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Keyword fingerprint of MPy
MPy is a H1 histamine receptor antagonist [35] found in anti-influenza medicine that 
was used in the 1970s until it became known to cause cancer in rats [18,36]. MPy is a 
nongenotoxic carcinogen [37,38] stimulating the development of tumors, most likely via 
cell proliferative initiation and/or oxidative properties of MPy or its metabolites [39,40]. 
On a histopathological level, MPy administration results in inflammation of the liver, 
hepatocellular periportal necrosis, bile duct hypertrophy, periportal lipid vacuolization 
and apoptosis [18,36]. Interestingly, the effect of MPy appears to be species specific; no 
tumor formation is observed in mice, guinea pigs, hamsters, or human [37,41,42].
It has been reported that the cytotoxicity of MPy leads to necrosis, and consequently 
induces regenerative cell proliferation to replace necrotic cells [18,43] and that oxidative 
stress is proposed to be one of the causes for the cytotoxic nature of MPy [44]. These 
findings reflect the profile of the keyword fingerprint of MPy (Figure 1) in that keywords 
related to oxidative stress, apoptosis/cell death, and cell cycle/mitosis is prominent in 
this profile. Furthermore, keywords related to an inflammatory/immune response (e.g., 
inflammation, t-cell proliferation) can be correlated to the observed inflammation after 
MPy administration.
In short, the analysis of the keyword fingerprints of DEHP, MPy and DMN shows that 
the findings agree with the known effects of DEHP, MPy and DMN, and that the distinct 
profiles of the three compounds can be explained by the fact that the three compounds 
have different modes of action, leading to distinct toxic end-points.
Methapyrilene: mode of action
To validate whether compound keyword fingerprints represent a realistic profile for the 
toxic outcome and mode of action of a particular compound, we compared in more detail 
the keyword fingerprint of MPy with observed toxic effects and proposed mode(s) of 
action of MPy, since MPy is a well-described carcinogen in the literature.
For this, we focused on the keyword over-representation results after day 7 of MPy 
treatment, which are shown in Table 1. At this time-point, in total 171 genes are 
differentially expressed, and 118 keywords (p-value < 0.01) are over-represented in this 
set of genes.
Drug metabolism
Four over-represented keywords were classified in the drug metabolism category: 
xenobiotic metabolism, drug resistance, drug transport and drug metabolism (Table 1). 
Genes associated with these keywords are P-glycoprotein/multidrug resistance 1 (Abcb1), 
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 (Abcc3), and Glutathione-S- 
transferase, a-1/2 (Gsta1/Gsta2), and are involved in glucoronidation and secretion of 
xenobiotics into bile [45-47]. These findings most likely indicate the detoxification and 
clearance process of MPy and its metabolites.
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Inflammatory response
The presence of significant keywords that are associated with an immune reaction (e.g. 
inflammation, immune response; Table 1) suggests an inflammatory response upon 
MPy administration. Hamadeh and coworkers treated rats with 100 mg/kg/day MPy for 
seven days [36], and histopathological examination of the livers of these rats showed 
portal inflammation and minimal mononuclear portal infiltrates, indicating the onset 
of an inflammatory response, which is in agreement with the keywords that we find as 
statistical significant in the inflammation and immune response category. Examination of 
genes that are associated with significant keywords in this category are involved in cell 
activation and proliferation, such as IL-15 and RT1 class II, locus Bb (Rt1-Bb) protein.
Pathogenesis
In the pathogenesis category, the highest scoring keyword is necrosis (Table 1); this 
finding is in agreement with histopathological analyses of MPy experiments, carried out 
separately by Hamadeh et al. [36] and Ellinger-Ziegelbauer et al. [18]. These experiments 
showed the occurrence of mild necrosis after 3 days of MPy treatment, which gradually 
increased in severity over time (after 7 and 14 days). Most other keywords in the 
pathology category are associated with carcinogenesis (e.g., hepatocellular carcinoma, 
liver tumour), inflammation (hepatitis), and liver degeneration (cirrhosis). These keywords 
are an indication of the nature of MPy as a nongenotoxic carcinogen. Nongenotoxic 
carcinogens are characterized by their ability to induce cell proliferation, via mitogenic 
or cytotoxic mechanisms [43]. MPy is an example of a cytotoxic carcinogen [43], which 
induces cell proliferation for compensatory, regenerative cell proliferation, most likely 
to replace necrotic cells. The keywords that are statistical significant in the cell cycle 
and mitosis category (e.g., cell cycle, g1/g2/s phase) in combination with the keyword 
necrosis, strengthens the hypothesis that MPy induces regenerative cell proliferation. 
Examination of the regulated genes that are associated with keywords in the cell cycle 
and mitosis category, show genes involved in regulating the cell cycle: cyclin B1 (Ccnbl), 
cyclin D1 (Ccndl), cell cycle division 2 homolog (Cdc2a).
Oxidative stress
The regenerative cell proliferation abilities of MPy alone do not explain the carcinogenic 
nature of this compound, i.e. it needs a trigger. MPy hepatotoxicity is reported to be 
caused by oxidative stress [44]. Oxidative stress is a cellular state in which there is an 
imbalance between free radicals and antioxidants. Oxidative stress can be the result of 
excessive formation of reactive oxygen species on the one hand, and the depletion of 
antioxidants, for example depletion of glutathione due to drug detoxification on the other 
hand. The property of MPy causing oxidative stress might be the trigger, in combination 
with its regenerative cell proliferation abilities, to the onset of carcinogenesis. This can 
be explained by the fact that DNA replication is not error proof, and in combination
94 Chapter 5
with oxidative stress, increases the risk of DNA damage [43,48]. The enriched keywords 
response to oxidative stress and glutathione metabolism, points to a reaction to prevent 
oxidative stress in the cell. Regulated genes associated with these keywords are heme 
oxygenase 1 (Hmoxl), metallothionein 1 (Mtla), and glutathione synthetase (Gss), and 
are known to have a protective effect against oxidative stress [49-51].
DNA damage and response
Oxidative stress can result in a higher DNA damage incidence; this is in agreement with 
the observation that genes involved in DNA repair and the response to DNA damage 
are upregulated after MPy treatment, like the H2A histone family, member X  (H2afx), 
and the DNA-damage inducible transcript 3 (Ddit3) genes. This could explain the over­
represented keywords of the DNA damage and response category (e.g., DNA repair, 
stabilization of p53; Table 1), since MPy is a nongenotoxic carcinogen, thereby implying 
that DNA damage is a secondary effect, possibly caused by oxidative stress. Although, 
some studies demonstrate that MPy and/or its metabolites have a low ability to bind to 
DNA [52,53].
MPy or its metabolites cause mitochondrial damage, resulting in function loss, indicated 
by mitochondrial swelling and losses in cellular ATP. Ratra and coworkers proposed a 
mechanism of MPy hepatotoxicity in which mitochondrial function loss leads to a 
disturbed Ca2+ homeostasis, ultimately leading to cell death [44]. Bcl2-associated X  
protein (Bax) is one of the genes upregulated and associated with the overrepresented 
keywords in the apoptosis and cell death category. Bax is a pro-apoptotic factor proposed 
to play a role in Ca2+ homeostasis, and thereby is a regulator of apoptosis [54].
Visualization of MPy-induced effects in a literature-based network
Applying CoPub to sets of differentially expressed genes gives insight in the separate 
biological processes affected by MPy, but the relations between these processes and 
the most influential genes are not immediately clear. To make these relations visible, a 
network was generated in Cytoscape, shown in Figure 2, in which differentially expressed 
genes, together with over-represented keywords, are mapped. To avoid an over-complex 
network in which all keywords and genes have a relationship, thresholds were set to 
simplify the interpretation of the results. The thresholds were set to at least five co­
publications between keywords and genes, with an R-scaled score of at least 45.
In the generated network, various areas representing distinct biological processes can be 
distinguished (Figure 2). The most influential genes and keywords are highly connected 
hubs. For example the Growth arrest and DNA-damage-inducible 45a (Gadd45a) gene is 
an important node between oxidative stress, DNA damage and response, apoptosis and 
cell death, and cell cycle and mitosis. This gene is known to have a function as a regulator 
of the cell cycle and is activated after DNA damage, helping to trigger apoptosis [55]. 
The relationships between the various biological processes in the network can easily be
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appreciated; biologically, it makes sense that the biological processes oxidative stress 
and, DNA damage and response are in each other vicinity, as well as DNA damage and 
response, cell cycle and mitosis, and apoptosis and cell death. Visualization of regulated 
genes, keywords and their relationships in a network gives an overview of the biological 
processes on which MPy has an effect, and is an informative tool to unravel MPy toxicity 
and its mechanisms of action.
Figure 2 - Literature-based interaction network. Network of differentially expressed genes and 
over-represented keywords after methapyrilene treatment. Red bullets: upregulated genes; green 
bullets: downregulated genes; squares: over-represented keywords. Network based on Medline 
co-publications. Threshold: at least five co-publications and R-scaled score > 45.
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EXPERT COMMENTARY
In this study, we introduced CoPub, a method that uses information from literature to link 
gene expression profiles to toxicity. With microarray data of eight hepatocarcinogens and 
three peroxisome proliferators [18-20], we showed that distinct keyword fingerprints of 
compounds can be generated using literature information.
Comparing the keyword profiles of DEHP, DMN and MPy shows that the keyword 
fingerprints of the three compounds agree with known observed pathologies, suggesting 
that the differences in the keyword fingerprints of the three compounds are based on 
distinct modes of action. This finding, together with the observation that the randomly 
generated gene sets did not result in over-represented keywords, indicates that literature 
information can indeed be used successfully for compound profiling and that keyword 
fingerprints reflect underlying biological processes.
The exact form of the keyword fingerprints that are shown in Figure 1 is partly dependent on 
the manual classification of the keywords in 13 high-level categories. Automatic literature 
based compound profiling would benefit from structured vocabularies. Hierarchically 
ordered ontologies could then be used to calculate a score for every biological process, 
represented by a particular branch in the ontology, analogous to the analysis in which 
gene sets are analyzed for over-represented GO terms. Another possibility is to cluster 
the compounds on individual keywords rather than using higher level categories. We 
found that when we used this approach the clustering result tended to be dominated by 
relatively uninformative keywords like "metabolism", "physiological process" with very 
low p-values (results not shown). A way around this is to use keywords which are very 
specific for the processes that we suspect are most important in describing toxicological 
events. Identification of these terms would require a well-defined set of gene expression 
profiles of toxic compounds with well defined mode of action and toxicological endpoints. 
CoPub is especially helpful for analyzing expression profiles of new compounds with 
an unknown mode of action. The over-represented keywords themselves already give 
a general overview of the affected biological processes without the need for reference 
compounds and an extensive knowledge by the biologist on the upregulated genes. 
Visualization of the keywords and the regulated genes in a network, together with the 
relevant abstracts in which these terms co-occur, gives an adequate impression of the 
affected biological processes by the tested compound and can provide leads for further 
experimental evaluation. For example, if the keyword profile of the tested compound 
shows a relative high number of keywords related to DNA damage, cell death and 
inflammation, then a mutagenicity test could be proposed as a follow-up study, since 
genotoxic carcinogens mostly hit these categories.
At this moment, our pathology thesaurus is primarily based on liver-specific pathology 
keywords. We could improve this thesaurus by adding other organ-specific pathology 
keywords to the list, and thereby broaden our perspective on compound toxicity. With 
this information, the assignment of organ-specific effects to compounds might be within 
reach.
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In conclusion, compound keyword fingerprinting based on information retrieved from 
literature is a powerful approach for compound profiling, enabling compound toxicity 
evaluation and mode of action unraveling, made more informative by visualization of 
over-represented keywords and differentially expressed genes in a literature network.
FUTURE PERSPECTIVE
To reduce growing costs in drug development, reducing the number of compounds 
with undesirable characteristics as early as possible in the development process is an 
effective strategy. In recent years with the development of the microarray technology, 
toxicogenomics has emerged as an important tool for evaluation of toxicity. The current 
challenge is the translation of compound-induced gene expression to the occurrence of 
toxicities. With the development of more sophisticated tools for data mining and gene 
set analysis, of which CoPub is an example, predictive toxicology and rapid compound 
evaluation becomes a feasible approach for reducing compound attrition in the drug 
development pipeline.
HIGHLIGHTS
• Toxicogenomics has emerged as a new methodology to evaluate compound toxicity 
and contribute to guaranteeing drug safety and reduce costs in the drug development 
pipeline.
• We introduced an additional approach for compound toxicity evaluation, in which 
literature information is used for compound profiling.
• Distinct keyword fingerprints were generated for compound profiling, representing 
enriched keywords in a compound-induced gene set.
• Comparing the three keyword fingerprints of diethylhexylphthalate (DEHP), 
methapyrilene (MPy) and dimethylnitrosamine (DMN) revealed that the findings agree 
with known effects of DEHP, MPy and DMN, and that the apparently distinct profiles 
can be explained by the fact that the three compounds have different modes of action, 
leading to distinct toxic end-points.
• MPy-linked keywords agree with known MPy-affected biological processes and 
pathways, showing that keyword fingerprints represent relevant biological information.
• Visualization of MPy-linked keywords and MPy-induced genes in a literature-based 
network enabled us to construct a mode of toxicity proposal for MPy.
• Compound keyword fingerprinting based on information retrieved from literature is a 
powerful approach for compound profiling, allowing evaluation of compound toxicity 
and analysis of the mode of action.
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MATERIAL AND METHODS
Four thesauri were generated to search Medline:
• Genes (human, mouse, rat)
• Liver pathologies
• Biological processes
• Pathways
The keyword thesauri are based on biological items, which represent an instance of a 
biological concept (e.g., a gene, a pathway), and may contain one or more keywords 
(e.g., a gene is assigned a full gene name and/or a gene symbol). Human, mouse and rat 
gene thesauri were compiled from the National Center for Biotechnology Information's 
(NCBI's) Entrez Gene database (release of December 2005) [21,102]. In order to search 
Medline with one or more full gene names, gene symbols and aliases, the gene name 
thesauri were processed as described by Alako et al. [16]. Gene names and symbols 
of orthologous genes were combined to make the keyword search in Medline more 
comprehensive.
The pathology thesaurus contains 406 pathology terms and was compiled from textbooks 
and is particularly focused on liver-specific pathologies (e.g., cholestasis), but also contains 
less specific liver pathologies (e.g., necrosis). The GO biological process thesaurus was 
compiled from the GO database [103] and contains 5515 terms. The pathway thesaurus 
contains 817 pathway names, compiled from the KEGG database [104], the encyclopedia 
of human genes and metabolism database [105], and the Reactome database [106]. The 
full Medline baseline XML files (1966 - April 2006) were obtained from the NCBI website 
[107] and extracted to small text files containing title, abstract and substances.
Regular expressions were used to search the compiled Medline text files for the presence 
of all keywords (~250.000) from the biological concept thesauri, as described by Alako et 
al. [16]. Keywords that generated a hit in a Medline abstract were stored, together with 
the PubMed identifiers (IDs) of the Medline records in which the hit occurred. For every 
biological item the hits were made nonredundant (note: multiple keywords of a biological 
item can occur in the same Medline abstract), resulting in a PubMed ID-biological item 
list. Gene symbols were curated for ambiguity.
Co-publication of biological items (e.g. a gene with a pathology term) was retrieved 
from the database by matching common Medline abstract occurrences. An R-scaled 
score, described by Alako et al. [16], that describes the strength of a co-citation between 
two keywords given their individual frequencies of occurrence and the number of co­
publications between every biological item pair was calculated in order to assign a degree 
of relation between two keywords.
The R-scaled score is based on the mutual information measure and was calculated as 
S = PAB/PA*PB in which PA is the number of hits for biological item A divided by the total
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number of PubMed IDs, PB is the number of hits for biological item B divided by the total 
number of PubMed IDs, and PAB is the number of co-occurrences between biological item 
A and biological item B divided by the total number of PubMed IDs. The relative score is 
produced as a 1-100 scaled log10 conversion (R = 10log S) and the scaled-log-transformed 
relative score (R-scaled score) as R' = 1 + 99 * (R - R ) / (R - R ), where R and Rv ' v min' ' v max min" min max
are the lowest and highest R values present in the biological item co-publication list, 
respectively.
Publicly available microarray data sets from hepatotoxicity studies on genotoxic and 
nongenotoxic carcinogens, and peroxisome proliferators were downloaded from the EBI 
(European Bioinformatics Institute) ArrayExpress database (E-TOXM-16 and E-TOXM-19 
datasets) [22,108]. The downloaded .CEL files were imported in Rosetta Resolver v5.1 
(Rosetta, Seattle, WA, US), and differentially expressed genes (p-value < 0.01, fold- 
change >2 or <-2) were selected with the implemented Rosetta Resolver error-model 
using the corresponding time-matched controls. Control gene sets were generated by 
randomly selecting 2 sets of respectively 100, 150, 200, 250, and 300 Affymetrix probe 
set identifiers from the RG-U34A GeneChip array. Links from Affymetrix ids to Entrez 
Gene ids and orthology information was retrieved from Affymetrix human, mouse, rat 
GeneChip Genome Array annotation files (Sep. 2005) [109].
To determine keywords that are over-represented in a given gene set, all keywords that 
were associated with a gene (defined as having at least five co-citations) were collected. 
The same was done for the background set of genes consisting of non-differentially 
expressed genes on the array. The degree of association between the gene set and a 
keyword was then determined using the Fisher Exact Test. Keywords associated with at 
least four genes in the gene set and with a p-value not more than 0.01 were marked 
as over-represented in the gene set after multiple test correction using the Benjamini- 
Hochberg correction, as implemented in the R-Statistics package [110]. These settings 
were empirically determined following analyzed microarray data sets with known 
biological outcome (data not shown). We did not make a distinction between down- and 
upregulated genes in the regulated gene sets, because a priori it cannot be established 
whether upregulation or downregulation of a gene will contribute to the toxicity.
All statistical tests were done using the R-Statistics package [110]. The literature network 
between over-represented keywords and genes (nodes) and their co-publications (edges) 
were visualized using Cytoscape software [23,111].
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ABSTRACT
Background: Glucocorticoids (GCs) control expression of a large number of genes via 
binding to the GC receptor (GR). Transcription may be regulated either by binding of 
the GR dimer to DNA regulatory elements or by protein-protein interactions of GR 
monomers with other transcription factors. Although the type of regulation for a number 
of individual target genes is known, the relative contribution of both mechanisms to the 
regulation of the entire transcriptional program remains elusive. To study the importance 
of GR dimerization in the regulation of gene expression, we performed gene expression 
profiling of livers of prednisolone-treated wild type (WT) and mice that have lost the 
ability to form GR dimers (GRdim). Results: The GR target genes identified in WT mice were 
predominantly related to glucose metabolism, the cell cycle, apoptosis and inflammation. 
In GRdim mice, the level of prednisolone-induced gene expression was significantly reduced 
compared to WT, but not completely absent. Interestingly, for a set of genes, involved in 
cell cycle and apoptosis processes and strongly related to Foxo3a and p53, induction by 
prednisolone was completely abolished in GRdim mice. In contrast, glucose metabolism- 
related genes were still modestly upregulated in GRdim mice upon prednisolone treatment. 
Finally, we identified several novel GC-inducible genes from which Fam107a, a putative 
histone acetyltransferase complex interacting protein, was most strongly dependent on 
GR dimerization. Conclusions: This study on prednisolone-induced effects in livers of 
WT and GRdim mice identified a number of interesting candidate genes and pathways 
regulated by GR dimers and sheds new light onto the complex transcriptional regulation 
of liver function by GCs.
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BACKGROUND
Naturally occurring glucocorticoids (GCs), such as cortisol, play an important role in the 
regulation of cardiovascular, metabolic and immunological processes. GCs are potent 
suppressors of inflammatory indices and are widely used to treat chronic inflammatory 
diseases such as rheumatoid arthritis and asthma [1-3]. However, chronic use of GCs 
induces side effects, such as diabetes mellitus, fat redistribution, osteoporosis, muscle 
atrophy, glaucoma and skin thinning [4].
One of the aspects influencing the balance between the desired anti-inflammatory 
effects and the side effects of GCs is the activation and repression of gene expression. 
After binding of GCs to the cytosolic GC receptor (GR), the receptor-ligand complex 
translocates to the nucleus where it alters gene expression. Ligand-bound GR can 
influence the expression of target genes, either by binding as a dimer to palindromic GC 
response elements (GRE) or tethering to other DNA-bound transcription factors [5, 6].
It is generally assumed that the anti-inflammatory actions of GCs are mainly driven by 
transrepression, in which ligand-bound GR binds to the pro-inflammatory transcription 
factors NF-kB (Nuclear factor kappa-light-chain-enhancer of activated B cells), AP-1 
(Activator protein 1), IRF-3 (Interferon regulatory factor 3) or other factors, forming 
an inactive transcription machinery complex, which prevents expression of pro- 
inflammatory genes [7-16]. However, recent studies demonstrated that under some 
inflammatory conditions DNA dimer-dependent gene expression could also contribute to 
the anti-inflammatory activities of the GR [17]. The occurrence of side effects has been 
linked mainly to transactivation of gene transcription. The well-documented example of 
GC-induced upregulation of Pckl (Phosphoenolpyruvate carboxykinase 1; also known as 
Pepck) and G6pc (Glucose-6-phosphatase), two genes encoding key enzymes that control 
gluconeogenesis, is one example linking transactivation to metabolic side effects [18-20]. 
One of the mechanisms by which GR activates gene transcription is by binding as a 
homodimer to a GRE in the promoter region of a target gene. GR dimerization involves 
the D loop located in the DNA-binding domain of the GR, in which several amino acids 
interact to facilitate receptor dimer formation. It was shown that an A458T point mutation, 
introduced in the D loop of the GR (GRdim), impairs homodimerization and ablates DNA 
binding [21]. Mice carrying this GRdim mutation are almost as effective as wild type (WT) 
mice in repressing AP-1 and NF-KB-modulated gene transcription, whereas GR-mediated 
Tat (Tyrosine aminotransferase) mRNA induction is largely abolished [21, 22].
The mechanism of dimer-dependent transactivation by the GR has been studied in detail 
for a limited number of GR target genes, including Fkbp5 (FK506 binding protein 5), 
Tat, Pckl and Duspl (Dual specificity phosphatase 1) [23-26], and tethering-facilitated 
transrepression of Mmp1/Mmp13 (Matrix metallopeptidase 1/13), IL-8 (Interleukin 8) 
and others [27-29]. In order to perform a comprehensive study of the genes and cellular 
processes that are affected by GC-treatment and influenced by GR dimerization, we have 
performed genome wide gene expression profiling in liver of prednisolone-treated WT 
and GRdim mice.
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We found that prednisolone predominantly influenced expression of genes involved in 
glucose metabolism, inflammation, the cell cycle and apoptosis. In general, activation of 
transcription, including transactivation of known GR marker genes such as Fkbp5 and Tat, 
was significantly reduced, but not totally absent in the GRdim mutant. However, a total 
absence of transcriptional transactivation upon GC-treatment was observed in GRdim 
mice for a subset of genes, all related to regulation of the cell cycle. In contrast, a small 
subset of genes was found exclusively regulated by GCs in GRdim mice. Furthermore, we 
identified Fam107a (Family with sequence similarity 107, member a; also known as Tu3a 
and Drr1) as a novel GC-inducible gene that completely relies on GR dimerization for 
transactivation.
RESULTS
Clustering of individual samples
In order to chart the gene expression profile induced by prednisolone in WT and GRdim 
mice, 6 mice per group were treated with prednisolone or vehicle. A principal component 
analysis (PCA) on the normalized intensity data showed that the samples clustered into 
four distinct groups (Figure 1). The largest separation, represented by PC1, was observed 
between samples derived from male versus female mice. The genes with the highest 
gender specificity belong to the family of cytochrome P450 proteins, such as Cyp3a41, 
Cyp3a44 and Cyp4a12, which are known for their gender-specific expression [30, 31]. 
In addition to the gender-based separation, a clear separation was observed between 
prednisolone-treated and vehicle-treated WT mice, whereas prednisolone-treated GRdim 
mice clustered closely together with vehicle-treated GRdim and WT mice (PC2). These 
results indicate that there is a significant prednisolone effect in WT mice, which is 
strongly reduced in prednisolone-treated GRdim mice. Genes with high loading scores on 
PC2 include Tat and Fkbp5, which are known GR-regulated genes in liver [32, 33] (Figure 
2).
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Figure 1 - Principal component analysis 
on gene expression intensity data.
A principal component analysis (PCA) was 
performed on normalized gene expression 
intensity data from 12 wild type (WT) mice 
(vehicle and prednisolone treatment) and
12 GRdim mice (vehicle and prednisolone 
treatment). Bullets: W T mice; Triangles: 
GRdim mice. White symbols: vehicle-treated 
mice; Black symbols: prednisolone- 
treated mice. The largest separation was 
seen between samples derived from male 
versus female mice (PC1).
112 Chapter 6
Figure 2 - Intensity profiles of Tat and Fkbp5 in vehicle and prednisolone-treated wild type versus 
GRdim mice. The expression intensities of Tat (Tyrosine aminotransferase) and Fkbp5 (FK506 binding 
protein 5) in vehicle-treated (white bars) and prednisolone-treated (grey bars) wild type (WT) and 
GRdim mice are plotted. Symbols: Bullets: male mice; Triangles: female mice. Both Tat and Fkbp5 are 
known GR marker genes and show strong differential regulation in prednisolone-treated W T mice.
These results show that the transcriptional program that is induced by prednisolone in WT 
mice is strongly reduced in mice carrying the GRdim mutation. This supports the hypothesis 
that the loss of GR dimerization leads to a reduction in transcriptional transactivation 
by the GR and underscores the importance of GR dimerization in induction of gene 
expression. The effect of prednisolone on up and downregulated genes and pathways 
will be discussed in more detail below.
Prednisolone-induced changes in gene expression
To quantify the differences that were seen in the multivariate analysis, differentially 
expressed probe sets were identified for several treatment comparisons (e.g. prednisolone 
versus vehicle-treated WT mice and prednisolone vs. vehicle-treated GRdim mice). Probe 
sets were marked as differentially regulated when the p-value, corrected for multiple 
testing, was below the 0.01 cutoff value.
Prednisolone treatment resulted in a significant differential regulation of 518 probe 
sets in WT mice (347 upregulated and 171 downregulated), whereas in prednisolone- 
treated GRdim mice only 34 probe sets were differentially regulated (29 upregulated and
5 downregulated). Notably, no differentially regulated probe sets were found in the 
comparison between vehicle-treated GRdim and vehicle-treated WT mice, suggesting that 
the GRdim mutation itself does not cause differential gene regulation and that the effects 
between WT and GRdim mice only become apparent after treatment with prednisolone. 
The observation that only 34 probe sets are differentially regulated in GRdim mice
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upon prednisolone treatment, suggests that there is almost no regulation of gene 
expression by prednisolone in GRdim mice. However, a large number of the probe sets 
that are differentially regulated in WT mice showed the same direction of regulation by 
prednisolone in GRdim mice, but did not meet the cutoff value of 0.01 for the p-value. 
This indicates that induction of gene expression by prednisolone in GRdim mice is strongly 
reduced but not completely absent (see below).
Taken together these data are in line with the hypothesis that transactivation of gene 
expression through the GR is significantly reduced in mice carrying the GRdim mutation.
Biological processes targeted by prednisolone in WT mice
In order to identify cellular processes on which prednisolone has a prominent effect, 
a gene set enrichment analysis was conducted using the 518 probe sets that were 
differentially regulated in WT mice by prednisolone. For this analysis we used CoPub, a 
text mining tool that calculates which biological processes are significantly associated to 
a set of genes [34]. It appeared that the differentially regulated genes are predominantly 
involved in three major processes: (glucose) metabolism, cell cycle/apoptosis and 
immune/inflammatory response (Table 1).
In order to gain insight into the relationships between genes and cellular processes a 
network representation was created, in which differentially regulated genes are plotted 
together with enriched keywords. In this representation, cellular processes that are 
affected by prednisolone can be appreciated as separate areas in the network, such as 
cell cycle and apoptosis, acute-phase response, and metabolism-related processes such 
as amino acid metabolism, gluconeogenesis and lipid metabolism. The most influential 
genes appear as highly connected hubs (Figure 3). Important factors that seem to connect 
the gluconeogenesis and the cell cycle and apoptosis subnetworks are the transcription 
factors Foxo1 and Foxo3a (Forkhead box O1 and Forkhead box O3a; see below).
Strong effects of prednisolone treatment on gluconeogenesis, the cell cycle and 
apoptosis are in line with the anticipated effect of the GR in the liver. The fact that 
many inflammation and acute phase response-related genes, such as IL6r (Interleukin
6 receptor) and Cxcl12 (Chemokine (C-X-C motif) ligand 12) were regulated (Figure 3) 
is interesting, given that we analyzed livers from healthy mice, not challenged with 
inflammatory stimuli. The direction and magnitude of prednisolone-induced differential 
regulation of genes involved in gluconeogenesis and the cell cycle was studied in more 
detail to get more insight into these prednisolone-affected processes.
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Table 1 - CoPub keyword enrichment analysis on prednisolone-regulated genes
Biological process # of associated genes
Metabolism
Glucose metabolism / transport 22
Gluconeogenesis 21
Lipid metabolism / glycosylation 21
Glycolysis 14
Carbohydrate metabolism / transport 14
Amino acid metabolism / transport 13
Cell cycle and apoptosis
Apoptosis 77
Cell proliferation 72
Cell cycle 65
Cell growth and-or maintenance, cell growth 63
Homeostasis 58
Cell differentiation 49
Cell cycle arrest 37
Immune /  inflammatroy response
Inflammatory response 31
Acute-phase response 20
CoPub was used to calculate keyword enrichment in the set of prednisolone-regulated probe sets 
in wild type mice. The analysis revealed that the differential regulated genes (non-redundant set) 
are predominantly involved in three main processes: metabolism, cell cycle and apoptosis, and 
immune/inflammatory response. The right column shows the number of differential regulated 
genes associated with a specific enriched keyword.
Gluconeogenesis
Table 2 shows the prednisolone-regulated genes in WT mice identified by CoPub as being 
associated with gluconeogenesis. Among the upregulated genes are Pck1, encoding 
the rate limiting enzyme in gluconeogenesis [35], Ppargc1a (Peroxisome proliferative 
activated receptor, gamma, coactivator 1 alpha), a transcriptional coactivator that 
coordinates the expression of genes involved in gluconeogensis and ketogenesis [36], 
and Sds (Serine dehydratase) and Aass (Aminoadipate-semialdehyde synthase), two 
genes encoding enzymes involved in amino acid catabolism and amino acid utilization for 
gluconeogenesis [37, 38].
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Table 2 - Prednisolone-regulated genes associated with 'gluconeogenesis' in literature
Biological process - Gluconeogenesis
Gene name Symbol Fc WT Fc GRdim*
Insulin-like growth factor binding protein 1 Igßp1 9.7 3.6
Tyrosine aminotransferase Tat 4.1 1.6
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 Pftft3 3.9 2.3
Peroxisome proliferative activated receptor, gamma, 
coactivator 1 alpha
Ppargc1a 3.2 3.2
CCAAT/enhancer binding protein (C/EBP), beta Cebpb 3.1 1.6
Protein-tyrosine sulfotransferase 2 Tpst2 2.7 1.5
Solute carrier family 2 (facilitated glucose transporter), 
member 1
Slc2a1 2.6 1.9
Forkhead box O1 Foxo1 2.2 1.7
Serine dehydratase Sds 2.1 1.5
Aminoadipate-semialdehyde synthase Aass 2.1 1.3
Phosphoenolpyruvate carboxykinase 1, cytosolic Pck1 1.9 1.3
Tryptophan 2,3-dioxygenase Tdo2 1.5 1.2
Aconitase 2, mitochondrial Aco2 1.4 1.3
Transketolase Tkt -1.2 -1.1
Protein kinase, AMP-activated, beta 1 non-catalytic 
subunit
Prkab1 -1.5 1.0
Adiponectin receptor 2 Adipor2 -1.6 -1.3
Purinergic receptor P2Y, G-protein coupled, 5 P2ry5 -1.6 -1.3
Pyruvate kinase liver and red blood cell Pklr -2.1 -1.4
CCAAT/enhancer binding protein (C/EBP), alpha Cebpa -2.3 -1.2
Sterol regulatory element binding factor 1 Srebf1 -3.0 -1.6
Insulin receptor substrate 1 Irs1 -4.0 -1.5
CoPub identified 21 prednisolone-regulated genes in wild type (WT) mice that are associated in 
literature with gluconeogenesis. The identified genes share at least 3 publications and have an 
R-scaled score [34] of at least 35 with keyword 'gluconeogenesis' in Medline abstracts. For each 
gene, the fold change (Fc) in prednisolone versus vehicle-treated WT mice (Fc WT) is given. 
Additionally, for each gene also the Fc in prednisolone versus vehicle-treated GRdim mice (Fc GRdim) 
is shown. *It should be noted that in GRdim mice these genes did not meet the p-value cutoff of 0.01 
for significance after correction for multiple testing, and are mentioned to illustrate a small effect 
of prednisolone on gene expression in GRdim mice.
The set of downregulated genes includes Irs1 (Insulin receptor substrate 1), a downstream 
mediator of the growth factor/insulin signaling pathway that negatively regulates 
gluconeogenesis [39] and Pklr (Pyruvate kinase), which encodes a glycolysis associated 
enzyme known to catalyze the production of pyruvate from phosphoenolpyruvate [40]. 
The direction of regulation and the function of these genes, suggests that in the liver
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of prednisolone-treated WT, glucose metabolism is balanced towards gluconeogenesis, 
which is in line with the reported gluconeogenic effect of glucocorticoids [41, 42]. 
The reduced fold changes in GRdim mice compared to WT mice (Table 2) indicate that 
glucocorticoid-induced gluconeogenesis is reduced in GRdim mice.
Table 3 - Prednisolone-regulated genes associated with 'cell cycle' in literature
Biological process - Cell cycle
Gene name Symbol Fc WT Fc GRdim*
Growth arrest and DNA-damage-inducible 45 gamma Gadd45g 17.8 2.9
Dual specificity phosphatase 1 Dusp1 8.2 1.0
Cyclin-dependent kinase inhibitor 1A (P21) Cdkn1a 8.1 1.0
Growth arrest and DNA-damage-inducible 45 beta Gadd45b 5.1 1.0
Polo-like kinase 3 Plk3 4.5 1.0
Retinoblastoma binding protein 8 RbbpS 4.5 1.3
Bcl2-like 1 Bcl2l1 3.0 1.1
Tensin 1 Tns1 2.6 1.2
Protein tyrosine phosphatase 4a1 Ptp4a1 2.3 1.1
Forkhead box O1 Foxo1 2.2 1.7
PAX interacting protein 1 Paxip1 1.9 1.0
Forkhead box O3a Foxo3a 1.9 -1.1
E1A binding protein p300 Ep300 1.8 1.0
NIMA (never in mitosis gene a)-related expressed kinase 7 Nek7 1.8 1.1
Cell division cycle 2-like 6 (CDK8-like) Cdc2l6 1.8 1.2
Cell division cycle 40 homolog Cdc40 1.4 1.0
Cyclin D2 Ccnd2 -1.5 -1.2
NIMA (never in mitosis gene a)-related expressed kinase 6 Nek6 -1.7 -1.2
CDC28 protein kinase regulatory subunit 2 Cks2 -2.3 -1.3
TSC22 domain family, member 1 Tsc22d1 -4.0 -2.3
CoPub identified 65 prednisolone-regulated genes in wild type (WT) mice that are associated in 
literature with the cell cycle (top 20 shown). The identified genes share at least 3 publications 
and have an R-scaled score [34] of at least 35 with keyword 'cell cycle' in Medline abstracts. For 
each gene, the fold change (Fc) in prednisolone versus vehicle-treated WT mice (Fc WT) is given. 
Additionally, for each gene also the Fc in prednisolone versus vehicle-treated GRdim mice (Fc GRdim) 
is shown. *It should be noted that in GRdim mice these genes did not meet the p-value cutoff of 0.01 
for significance after correction for multiple testing, and are mentioned to illustrate a small effect 
of prednisolone on gene expression in GRdim mice.
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Cell cycle
Table 3 shows the prednisolone-regulated genes in WT mice that CoPub identified as 
being associated with the cell cycle. Upregulated genes include Gadd45b, Gadd45g 
(Growth arrest and DNA-damage-inducible 45 beta and gamma), Cdkn1a (Cyclin- 
dependent kinase inhibitor 1a; also known as p21) and Plk3 (Polo-like kinase 3), which 
are stress sensors involved in cell cycle arrest, DNA repair and apoptosis [43-45]. Other 
upregulated genes are Bcl2l1 (also known as Bcl2-like1 and Bcl-xl), an anti-apoptotic 
protein that is enhanced by binding to the Gadd45 family [46, 47], and Dusp1, a p53 
target gene involved in cell cycle regulation [48].
Amongst the downregulated genes are Ccnd2 (Cyclin D2) and Cks2 (Cdc28 protein 
kinase regulatory subunit 2), both involved in cell cycle progression [49, 50]. Overall, the 
direction of the prednisolone-induced differential regulation of genes associated with the 
cell cycle suggests that prednisolone induces a cytostatic response in liver of WT mice.
Foxo transcription
From the literature-based network, the two transcription factors Foxol and Foxo3a 
appear to be intermediates between the gluconeogenesis and cell cycle and apoptosis 
subnetworks (Figure 3). Foxo transcription factors are key mediators of cell cycle 
progression, apoptosis, glucose metabolism, reactive oxygen species detoxification and 
DNA damage repair [51-54]. Their activity is tightly controlled by the insulin and growth 
factor-inducible Pi3k/Akt pathway. Akt-mediated phosphorylation of Foxo transcription 
factors promotes their translocation from the nucleus to the cytosol and thereby their 
inactivation through binding of 14-3-3 proteins [54-56].
Foxo transcription factors regulate gene expression of enzymes that are important 
regulators of gluconeogenesis, such as Pck1 and G6p [57, 58]. In addition, they suppress 
genes that are involved in glycolysis, the pentose shunt and lipogenesis [59]. Analysis 
of Foxo1-overexpressing mice revealed an increased expression of Igfbp1 (Insulin-like 
growth factor binding protein 1), Pck1, Tat and Tdo (Tryptophan 2,3-dioxygenase) and 
downregulation of Srebf1 (Sterol regulatory element binding factor 1) and Adipor2 
(Adiponectin receptor 2) in liver [59]. Interestingly, these genes are similarly regulated in 
prednisolone-treated WT mice (Figure 3 and Table 2).
Finally, Foxo transcription factors are regulators of cell cycle progression and were shown 
to induce Cdkn1a and Gadd45b [60] and to suppress Ccnd2 [54]. Also these genes show 
the same direction of regulation in prednisolone-treated WT mice (Figure 3 and Table 3). 
These observations suggest that GCs in WT mice induce Foxo transcription factors, which 
in turn may synergize with the GR to modulate the expression of their respective target 
genes.
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Figure 3 - Literature-based network of glucocorticoid-induced effects. A network representation 
of the enrichment results was generated, in which differentially expressed genes together 
with enriched keywords are plotted. Genes are shown as circles (Red: upregulated; Green: 
downregulated), whereas enriched keywords are shown as squares. Connections between 
genes and keywords represent co-publications in Medline abstracts. To avoid an over-complex 
network, thresholds were set to simplify the interpretation of the results. Only keywords and 
genes that share at least 5 publications and have an R-scaled score of at least 45 are plotted in 
the network [34]. Several higher-order biological processes that are affected by prednisolone 
can be appreciated: cell cycle and apoptosis, acute-phase response, stress response, amino acid 
metabolism, gluconeogenesis and lipid metabolism.
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Prednisolone-induced differential gene expression in WT versus GRdim mice
Table 2 and 3 list a number of genes that are significantly regulated by prednisolone in 
WT mice. In the GRdim mice these genes do not meet the significance cutoff for differential 
regulation (p<0.01), but for most of them a small effect of prednisolone on the expression 
level can be observed in GRdim mice. To analyze these differences quantitatively, we 
plotted the log2 ratios of gene expression after prednisolone treatment in WT versus 
GRdim mice (Figure 4). This figure shows that on average, genes in WT mice are more 
strongly regulated than in GRdim mice after prednisolone treatment and confirms that 
induction of gene expression by prednisolone is not abrogated in GRdim mice but reduced 
to on average 33% of the level in WT mice, as indicated by the slope of the dotted line in 
Figure 4.
Figure 4 - Log2 ratio plot of prednisolone-induced differential gene expression in wild type versus 
GRdim mice. Genes on the solid black line show an equal induction of differential gene expression by 
prednisolone in wild type (WT) versus GRdim mice. The black-dotted line indicates the average slope 
of the data and shows that the level of gene regulation in prednisolone-treated GRdim mice is 33% 
of that observed in WT mice. A subset of genes that show obvious differences in the magnitude of 
regulation by prednisolone in W T versus GRdim mice is highlighted, as well as genes that show equal 
magnitude of regulation in WT versus GRdim mice.
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Identification of genes that differentially respond to prednisolone in GRdm mice as 
compared to WT mice
In Figure 4, several genes are highlighted that show a different response upon prednisolone 
treatment in WT mice than in GRdim mice. Unexpectedly, a small subset of these genes 
shows stronger upregulation by prednisolone in GRdim mice compared to WT mice. These 
genes include Car8 (Carbonic anhydrase 8), a protein associated with proliferation and 
invasiveness of colon cancer cells [61], Zdhhc23 (Zinc finger, DHHC-type containing 23), 
a Nitric oxide synthase-binding and activation protein [62], Flvcr2 (Feline leukemia virus 
subgroup C cellular receptor family, member 2), a calcium-chelate transporter [63], and 
Amy2 (Amylase 2), an amylase that catalyzes the endohydrolysis of 1,4-alpha-D-glucosidic 
linkages in oligosaccharides.
Genes that appear to strictly rely on GR dimerization include Duspl, Gadd45b, Cdknla, 
Foxo3a, Plk3 and Fam107a (Figure 4 and 5). As discussed above, Foxo3a, Duspl, 
Gadd45b, Cdknla and Plk3 all participate in cell cycle regulation, apoptosis and DNA 
damage repair [43-45, 52]. The most striking difference in the level of regulation by 
prednisolone between WT and GRdim mice was observed for Fam107a (also known as 
Tu3a and Drrl) (Figure 4, 5 and 6). The expression profile suggests that transcription 
of Fam107a is under direct control of the GR and strictly depends on its dimerization. 
Fam107a encodes a ubiquitously expressed protein that was first described in the 
context of renal cell carcinoma, in which Fam107a expression is reduced or absent due to 
promotor hypermethylation [64-66]. Overexpression of Fam107a in Fam107a-negative 
cell lines leads to growth retardation and apoptosis, indicating that Fam107a might act as 
a tumor suppressor [65, 67]
We also identified a subset of genes that showed an equal induction of gene expression 
by prednisolone in WT and GRdim mice (located on the diagonal black line in Figure 4); 
Dst (Dystonin), a cytoskeletan-interacting protein postulated to cross-link cytoskeletal 
filaments and thereby maintain cellular integrity [68], Gtf2a2 (General transcription factor 
II A, 2), a subunit of the transcription initiation factor TFIIA [69], Agpat6 (l-acylglycerol-3- 
phosphate O-acyltransferase 6), an enzyme involved in triglyceride synthesis [70], Marcks 
(Myristoylated alanine rich protein kinase C substrate), cytoskeletal protein involved in 
cell adhesion and cell motility [71], Obfc2a (Oligonucleotide/oligosaccharide-binding fold 
containing 2A), a single stranded nucleic-acid-binding protein [72], and Ppargcla. 
Prednisolone-induced changes in gene expression in WT and GRdim mice were validated 
by Q-PCR for Fam107a, Duspl, Cdknla and Car8. Figure 6 shows the fold-changes of the 
selected genes in prednisolone versus vehicle-treated WT and GRdim mice. For all four 
genes, the regulation by prednisolone in WT and GRdim mice was qualitatively similar to 
what was found by microarray analysis.
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Figure 5 - Intensity profiles of Plk3, Duspl, Gadd45b, Cdknla, Foxo3a and Fam107a in vehicle 
and prednisolone-treated wild type and GRdim mice. Several genes were identified that showed 
differences between prednisolone-treatment in wild type (WT) and GRdim mice. Amongst those 
genes are Plk3, Duspl, Gadd45b, Cdknla, Foxo3a and Fam107a were differential regulated in 
prednisolone-treated W T mice, but not in GRdim mice. White bars represent vehicle-treated mice, 
whereas grey bars represent prednisolone-treated mice. Symbols; Triangles: female mice, Bullets: 
male mice.
Figure 6 - Validation of microarray-obtained gene expression by Q-PCR. The relative expression 
of Faml07a, Duspl, Cdknla  and Car8 in prednisolone-treated versus vehicle-treated wild type 
(WT) and GRdim mice was validated by Q-PCR. Differences in expression between two samples were 
calculated by the 2AACt method [103, 104]. Mean differences in gene expression between WT 
and GRdim mice were analyzed using the Student's t-test. No expression was observed for Faml07a 
and Cdknla  in vehicle and prednisolone-treated GRdim mice (Ct>30). Asterisks denote p-values as 
follows: *p < 0.05, **p < 0.01 and ***p < 0.001.
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DISCUSSION AND CONCLUSION
In this study we performed liver gene expression profiling of WT and GRdim mice after 
prednisolone administration. Our aim was to chart the biological processes in the liver 
that are affected by GCs and to study their dependence on DNA-binding and dimerization 
of the GR. CoPub keyword enrichment analysis with prednisolone-regulated genes in 
WT mice showed enrichment of keywords associated with glucose, lipid and amino acid 
metabolism, the cell cycle and apoptosis (Table 1 and Figure 3). This is in agreement 
with cellular processes known to be affected by GCs [73, 74]. Interestingly, the forkhead 
transcription factors Foxo1 and Foxo3a are regulators of these cellular processes and 
induced by prednisolone in WT mice. Together with the observation that a subset of 
the prednisolone-induced genes are Foxo1 and Foxo3a target genes and are similarly 
regulated in Foxo1 and Foxo3a expression profiling experiments [54, 59, 60], this suggests 
that the GR synergizes with these transcription factors in mouse liver to control lipid and 
glucose metabolism and the cell cycle. This concept is further supported by the recent 
finding that the MurFl (Muscle RING finger l)  promoter contains adjacent binding sites 
for the GR and Foxo transcription factors and is synergistically activated when both are 
co-expressed [75]. However, it is likely that a subset of the prednisolone-induced genes 
is under direct control of Foxo1 and Foxo3a without the need for synergy with the GR. 
Other studies, addressing small gene sets or individual genes, had also identified a role 
for Foxo1 and Foxo3a in GR-induced gene expression [58, 75-77].
The list of differentially regulated genes by prednisolone in WT mice overlaps with that 
of an earlier study by Phuc Le et al., which combined chromatin immunoprecipitation 
(ChIP) data with gene expression data to identify direct GR target genes in mouse liver 
[78]. Most of the genes found in our study displayed the same up and downregulation 
of gene expression, such as Tat, Foxol and Fkbp5 that are upregulated and Adipor2, 
CCAAT/enhancer binding protein alpha (C/EBPa) and Tkt that are downregulated. From a 
candidate gene set of 302 genes, Phuc Le et al. identified metabolism, cell proliferation 
and programmed cell death as important processes in their GO-term analysis, which is in 
agreement with our findings.
Interestingly, in contrast to our study, Phuc Le et al. did not observe upregulation of bona 
fide GR target genes, such as Pck and Igfpb in fed CD1 mice and explain this by lack of 
response due to a potential inhibition by insulin signaling in the fed state [79]. The fact 
that we observed upregulation of these genes indicates that in our experimental setup, 
which differs in several aspects from the setup used by Phuc Le et al, such as mouse strain 
used for the study, GC dosage and the fed state of the mice, the inhibitory effects of fed- 
induced insulin signaling do not play a role.
The overall induction of gene expression was strongly reduced in prednisolone-treated 
GRdim mice compared to WT mice (Figure 4). Nevertheless, in many cases residual gene 
induction by prednisolone was still observed. This indicates that GR dimerization is indeed
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an important mechanism for activation of these genes, although some regulation can 
take place even in the absence of GR homodimers. In fact, GR monomers are in principle 
capable of binding to GC response elements (GREs) and evoking a basal induction of gene 
expression. However, due to the lack of cooperative binding they are less potent than GR 
homodimers. This is in line with the regulation reported for Pnmt (Phenylethanolamine- 
N-methyltransferase) and Amy2 in which binding of GR monomers to GREs or a GRE 
half-site (i.e. only one-half of the classical palindrome) was sufficient to confer induction 
by GCs [80, 81]. In case of the Pnmt gene, multiple GRE half-site have been identified 
in the promoter region allowing receptor clustering and thereby stable binding of GR 
monomers independent of the DNA-binding domain (DBD) interface [80]. This also 
explains why expression of the Pnmt gene is not compromised in GRdim mice despite the 
lack of GR dimer formation [21]. Another explanation for the residual gene induction by 
prednisolone in GRdim mice is that the mutant GR still forms homodimers but that these 
are far less stable than in WT mice.
A recent study showed that the specific sequence of a GRE differently affects the 
conformation of the GR and thereby its activity towards specific target genes [82]. 
Mutation analysis of overexpressed GR domains that are involved in transcriptional 
activation, namely the dimerization region in the DBD (Dim) as well as AF1 and AF2 
(activation function 1 and 2), showed that the dependency on each of them was specific 
for the sequence of the GR binding site and that genes differed in their dependence on 
dimerization [82]. The fold induction of Tat and Fkbp5 by dexamethasone in the Dim 
mutant was around 30% for Tat and 50% for Fkbp5 of that for WT GR, which is in gross 
agreement with our own observations in vivo (Figure 4).
The effect of the GRdim mutation was found in all major pathways that were induced by 
prednisolone, i.e. for genes in inflammatory pathways, gluconeogenesis and cell cycle. 
Moreover, the attenuating effect of the GRdim mutation was found for genes that were 
upregulated as well as for genes that were downregulated by prednisolone. This suggests 
that genes, which fail to be repressed by prednisolone in GRdim mice, are either regulated 
through GR binding to negative GRE elements (nGREs) or indirectly regulated via other GR 
target genes. Interestingly, analysis of the magnitude of gene regulation by prednisolone 
in WT mice compared to GRdim mice showed that the cell cycle-related genes are more 
dependent on the dim interface than genes related to gluconeogenesis (Table 2 and 3). 
This can also be appreciated in Figure 4; several genes that are on the x-axis (i.e. show no 
differential gene expression upon prednisolone treatment in GRdim mice), are cell cycle- 
related.
We identified several genes that showed strong upregulation by prednisolone in GRdim 
mice compared to WT mice, such as Amy2, Car8 and Zdhhc23, and several genes that 
showed equal induction of gene expression by prednisolone in WT and GRdim mice, 
amongst them are Dst and Ppargcla (Figure 4). These genes are potential candidates 
for having GRE half-sites in their promotor regions, which could explain why these genes
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show equal or even higher induction of gene expression by prednisolone compared to 
WT mice. As mentioned earlier, the presence of GR half-sites in the promotor region 
for Amy2 was indeed experimentally confirmed [81]. For the other genes however, 
we did not find literature evidence for the presence of GR half-sites in their promotor 
regions. Therefore, follow-up studies on these genes to determine the functional GRE 
sites in their regulatory region would be of interest to study the significance of dimer­
interface independent GRE binding. Genes that showed equal or stronger upregulation 
by prednisolone in GRdim mice compared to WT mice can also be secondary response 
genes; under transcriptional control of transcription factors other than the GR. Keyword 
enrichment analysis performed with this set of genes did not identify enrichment for a 
particular cellular process.
We identified several genes that are absolutely dependent on GR dimerization for the 
induction of gene expression by prednisolone, such as Cdknla, Gadd45b, Duspl, Plk3 and 
Foxo3a (Figure 4). Interestingly, all of these have a strong relationship with p53: some are 
under direct transcriptional control of p53 (Cdknla [83], Gadd45b [84] and Duspl [48]) 
or physically interact with p53 (Foxo3a [85, 86] and Plk3 [87]). The cellular responses 
mediated by Foxo3a and p53 are highly similar, share some of their target genes (e.g. 
Cdknla and Gadd45b) and use similar mechanisms to regulate post-translational 
modification [51, 88]. Therefore, Foxo3a and p53 can be regarded as partners that 
positively as well as negatively regulate each other, depending on the context [51]. This 
observation might indicate that GC-induced activation of Foxo3a and/or p53 is hampered 
in GRdim mice. In line with this hypothesis Foxo3a was recently shown to be required for 
GC-induced apoptosis in lymphocytes [89]. Interestingly, this process is defective in GRdim 
mice highlighting a possible link between the GR, Foxo3a and induction of lymphocyte 
apoptosis [21].
Faml07a showed the largest induction of gene expression by prednisolone in WT mice 
(Figure 4 and 5). Analysis of protein-protein interactions revealed that Fam107a interacts 
with Tada2a [90, 91], a protein that together with binding partner Tada3a (Transcriptional 
adaptor 2 and 3 alpha) are core proteins of the histone acetyltransferase (HAT) complex 
[92]. HAT complexes are involved in chromatin structure modification for initiation of 
gene transcription, but can also acetylate non-histone proteins to modify their activity 
and stability [92, 93]. Interestingly, Fam107b a paralog of Fam107a with 84% protein 
similarity (not regulated in mouse liver by prednisolone) was shown to interact with 
Tada3a [94].
The observation that Fam107a inhibits cell proliferation and induces apoptosis when 
overexpressed [65, 67], suggests that Fam107a, like Foxo3a, Dusp1, Gadd45b, Cdkn1a 
and Plk3 play a role in regulating the cell cycle. Furthermore, the association of Fam107a 
with a core protein of the HAT complex might indicate that Fam107a may serve as a 
cofactor in the transcription machinery complex.
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The activity and function of Foxo3a and p53 are strongly modulated by acetylation [51, 88, 
95]. Hence, Faml07a is an interesting candidate gene for follow up experiments to study 
whether it modulates GR-induced gene expression and/or acetylation of GR-associated 
transcription factors such as Foxo3a, p53, C/EBPa and C/EBPP (CCAAT/enhancer binding 
protein, beta).
For a more comprehensive view on GC regulated process in the liver, experiments with 
multiple time points, different doses of GCs and using one or more inflammatory stimuli, 
could be considered.
METHODS 
Animals
All mice (WT and GRdim; Balb/c) were bred at the Institute of Virology and Immunobiology 
at the University of Wurzburg. In total 24 mice (8 male WT, 4 female WT, 8 male GRdim 
and 4 female GRdim) were included in the study. Mice were treated subcutaneously 
with 1 mg/kg prednisolone (5% DMSO and 5% Chremophor in manitol, 10 ml/kg) once 
and sacrificed 150 minutes later by cervical dislocation, which was approved by the 
responsible authorities in Bavaria (Regierung von Unterfranken). All experiments were 
performed in the morning between 9 and 10 AM. The mice were exposed to a regular 
dark-light-cycle (lights on between 6 AM and 6 PM) and had access to water and food ad 
libitum at any time.
RNA isolation
Liver biopsy specimens were collected into aluminum containers, snap freezed in liqN2 
and stored at -80°C before use. RNA isolation was done using Trizol, followed by RNeasy 
clean-up to enhance the A260/A230 ratio. RNA quantity and quality was determined using 
the NanoDrop Spectrophotometer and Agilent Bioanalyzer. For all samples subjected to 
microarray hybridization, the RIN (RNA integrity number) was 9.0 - 10.
Microarray data processing
Processed RNA samples were hybridized on GeneChip Mouse Genome 430 2.0 arrays 
(MOE430-2) from Affymetrix [96]. Processing and downstream statistical analysis of the 
microarray data was done using the R-Statistics package [97]. Data were normalized using 
the gcrma algorithm, pair-wise ratios between treatments were built using the limma 
package and annotation for the probe sets was derived from the mouse430-2 library, 
all as provided in BioConductor [98]. In all contrast matrices, a correction for gender 
type was applied. Data were deposited in the NCBI Gene Expression Omnibus (GEO), 
accession number GSE21048.
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Keyword enrichment analysis
Keyword enrichment analysis on the microarray data was performed using CoPub [34] 
with default settings as provided by the web server [99]. The literature-network between 
enriched keywords and genes (nodes) and their co-publications (edges) were visualized 
using Cytoscape software [100, 101].
Validation of microarray results with Q-PCR
Total RNA (1 ^ g) was reverse transcribed using a commercially available cDNA synthesis kit 
(iScript, BioRad Laboratories, Hercules, CA, USA). Q-PCR was performed by SYBR Green- 
based quantification according to the manufacturer's protocol (Applied Biosystems, Foster 
City, CA, USA). Primers were developed for Faml07a (Family with sequence similarity 
l07, member a; Fw:TCATCAAACCCAAGAAGCTG; Rev: CTCAGGCTTGCTGTCCATAC), Car8 
(Carbonic anhydrase 8; Fw: CACACCATTCAAGTCATCCTG; Rev: ACCACGCTGGTTTTCTCTTC), 
Cdknla (Cyclin-dependent kinase inhibitor la ; Fw: TCTTGCACTCTGGTGTCTGAG; 
Rev: ATCTGCGCTTGGAGTGATAG) and Duspl (Dual specificity phosphatase l ;  Fw: 
GTGCCTGACAGTGCAGAATC; Rev: CCAGGTACAGGAAGGACAGG) using Primer3 [102]. 
All primer pairs were exon-spanning. The gene Azgpl (alpha-2-glycoprotein l , zinc- 
binding; Fw: AAGGAAAGCCAGCTTCAGAG; Rev: ACCAAACATTCCCTGAAAGG) was chosen 
as endogenous control since the expression arrays did not show any differences in 
expression of this gene between the two experimental groups (WT vs GRdim). PCR 
products were selected to be between 80 and 120 bp long. Samples were run on the 
7500 Fast Real-Time PCR System (Applied Biosystems) using the following protocol: 
10 min. denaturation at 95°C, and 40 cycles of 15 sec. denaturation at 95°C, 60 sec. 
annealing and extension at 60°C. All primer pairs were validated in triplicate using serial 
cDNA dilutions. Primer pairs that were 100+/-10% efficient, which implies a doubling of 
PCR product in each cycle, were used to quantify mRNA levels. Threshold cycle numbers 
(referred to as Ct) were obtained using the 7900 HT System SDS software version 2.3 
(Applied Biosystems). All samples were measured for three times and samples with a 
standard deviation (SD) larger than 0.5 were excluded from the analysis. The relative 
quantity (RQ) of the gene-specific mRNA was calculated from the average value of the 
ACt (target gene Ct -  endogenous control gene Ct) for each of the 24 analyzed samples. 
Differences in expression between two samples were calculated by the 2AACt method 
[103, 104]. For Q-PCR, mean differences in expression between groups were analyzed 
using the Student's t-test. A p-value of <0.05 was considered statistically significant in 
each situation.
Protein -  protein interaction data
Protein-protein interaction data were retrieved from the Biological General Repository 
for Interaction Datasets (BioGRID) database [105, 106].
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ABBREVIATIONS
GR: Glucocorticoid receptor, WT: Wild type, GRdim: GR with the A458T point mutation 
in the dimerization region of the DNA-binding domain, GCs: Glucocorticoids, GRE: 
Glucocorticoid response element.
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BACKGROUND
The Medline database represents a valuable source for the biologist to gather information 
on gene function, drug mode of action and molecular mechanisms underlying the onset of 
disease. The number of new articles being published every day is growing exponentially, 
which makes it almost impossible to keep up with the latest developments, even if the 
scientific progress is in one's field of interest. In order to automatically retrieve relevant 
information from articles, text mining systems have been developed to capture and 
structure the biomedical knowledge from literature [1, 2]. In this thesis we introduced 
CoPub, a co-occurrence-based text mining tool that automatically extracts relationships 
between biomedical concepts (e.g. genes, diseases, cellular processes and drugs) 
from Medline abstracts. We demonstrated that CoPub can be applied to infer novel 
relationships between biomedical concepts from literature, but is also well-suited for 
the interpretation of microarray data, generated for example in toxicogenomics and 
pharmacogenomics experiments. In this chapter, the results presented in this thesis will 
be discussed.
THE COPUB DATABASE
We developed the text mining tool CoPub to aid the scientist in gathering information 
on gene function and gene relationships from the biomedical literature. CoPub uses 
thesaurus-based keyword matching to automatically identify and extract biomedical 
concept relationships from Medline abstracts. CoPub is based on the simple assumption 
that if two biomedical concepts are mentioned together in an abstract (i.e. co-occur), then 
there might be a relationship between them. Co-publication-based text mining tools have 
been successfully applied to identify gene-disease and drug-gene relationships, physical 
protein-protein interactions, associations between single nucleotide polymorphisms 
(SNPs) and disease phenotypes, and for biological interpretation of microarray data 
[3-10]. Although co-occurrence based text mining is a powerful tool, there are several 
potential pitfalls in applying this approach.
One of the biggest challenges is the recognition of biomedical concepts, such as genes, 
diseases and drugs in text and to assign it to the correct biomedical concept being referred 
to (i.e. named entity recognition, NER). Genes are among the biomedical concepts of 
which the identification in text is most complex, as many genes have multiple gene names 
and gene symbols. Manual inspection of 1000 symbol-hits after keyword matching in 
Medline by CoPub showed that around 55% of the symbol hits that are extracted from 
Medline are false positives, and in many cases represent non-gene entities. To reduce the 
number of false-positive gene identifications in Medline, CoPub has a build-in symbol­
hit curation procedure. To assess the success of preliminary modifications that we have 
implemented in the symbol-hit curation procedure, the performance of the thesaurus-
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based keyword matching algorithm, including the symbol disambiguation step, was 
evaluated by repeating the human gene normalization task of the BioCreative II contest 
(www.biocreative.org). CoPub would have been ranked 11th out of 21 participants [11] 
if participated in the contest, which shows that CoPub is approaching the top 10 best 
performing text mining tools. New modifications to the symbol-hit curation procedure 
are currently being explored to improve the quality of the extracted information from 
literature,
After solving the NER problem, the co-occurrence method by itself is also prone to generate 
false positive associations between biomedical concepts, because biomedical concepts 
can be mentioned together in an abstract without having a functional relationship. 
Therefore, CoPub assigns to each identified biomedical concept pair a confidence level 
for their relatedness, by calculating an ft-scaled score for each association. This ft-scaled 
score is calculated based on the number of times the two biomedical concepts co-occur 
and how many times each biomedical concept is mentioned separately in literature. 
Biomedical concepts that often appear together in an abstract receive a high ft-scaled 
score, whereas biomedical concepts that appear often separately but sporadically 
together, receive a lower ft-scaled score. Therefore, the ft-scaled score in combination 
with the number of co-occurrences between two biomedical concepts, is a good 
indication whether there is a true functional relationship.
A more sophisticated approach for text mining is natural language processing (NLP). NLP 
not only identifies a relationship between two biomedical concepts but also resolves 
the direction and type of the relationship unlike co-occurrence-based text mining. For 
example, parsing the sentence 'overexpression of CD36 enhances fatty acid oxidation' by 
NLP, identifies that there is an association between CD36 and fatty acid oxidation, and 
that overexpression of CD36 leads to enhanced fatty acid oxidation. NLP-based methods 
are successfully applied to extract protein-protein interactions, for pathway construction 
and ontology building [12-17].
A drawback of NLP is that it is computational more intensive than co-occurrence-based 
text mining, and the complexity of the extracted information is much higher than 
obtained with co-occurrence-based text mining. This makes NLP less suitable for the 
biological interpretation of a large gene set, but is well-suited when detailed information 
is requested for one gene or a small set of genes. However, co-occurrence-based text 
mining and NLP might be an ideal combination when using best of both worlds; when a 
large set of genes needs to be analyzed, co-occurrence-based text mining can be applied 
to capture the biology at a higher level, whereas NLP can be subsequently applied to 
zoom in on a particular area to capture the more fine grained biology on gene by gene 
level. Another advantage of using NLP methods in conjunction with CoPub is that NER 
and the verification of biologically meaningful co-occurrences is greatly facilitated by 
applying NLP. For example, in the phrase "X phosphorylates Y", it is highly likely that X 
and Y are proteins. This knowledge can be used to disambiguate the X and Y terms.
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Another challenge to be tackled by the text mining community is to determine the species 
to which the mentioned gene refers to in text. Because many genes share identical full 
gene names and gene symbols across species it is very difficult, if not in many cases 
impossible, to identify the correct gene that is being referred to in text. One way to 
solve this problem, together with the problems observed in gene entity recognition, is to 
start a publicly available database with correct gene and protein annotation for abstracts 
in the Medline database. This publicly available database could then be maintained, 
updated and curated by the text mining community. Wikiproteins is such an initiative 
which enables community annotation in a Wiki-based system [18]. In addition, authors 
could also be asked prior acceptance of their manuscript to specify which genes are 
mentioned in the abstract or at least to which species these genes belong, just like they 
are asked to add several keywords describing the topic of their research. This would 
make a significant contribution to the scientific progress of text mining, in that research 
projects can then completely focus on the extraction of knowledge from the biomedical 
literature.
COPUB WEB SERVER
In Chapter 2 the CoPub web server was introduced. This web server was build to make 
the data stored in the CoPub database, which was obtained by text mining in Medline, 
publicly available. For easy retrieval of information on relationships between genes and 
other biomedical concepts such as biological processes and pathways, the CoPub web 
server has a gene search and a biomedical concept search option. One of the options 
that CoPub has to offer is the microarray data analysis option. CoPub was one of the first 
publicly available web servers that combined gene annotation obtained from text mining 
with microarray data analysis to interpret sets of differentially regulated genes. To make 
the interpretation of the microarray data analysis more convenient, the results can also 
be displayed by CoPub in a network representation in which relationships between genes 
and biological processes and the strength of their connection is visualized.
Currently, the visualization is based on scalable vector graphics (SVG) and needs the 
discontinued Adobe SVG viewer to be viewed in the Microsoft Internet Explorer web 
browser. A good alternative in which CoPub-built literature networks could be visualized is 
Cytoscape (www.cytoscape.org), which is a java-based open source platform for network 
visualization and interpretation. Furthermore, currently the CoPub web server can only 
handle gene expression data, but it would be attractive if also other data types could be 
uploaded, such as metabonomics and proteomics data. The CoPub database contains 
a metabolite category and gene-protein conversion tables, which makes it possible to 
annotate the metabolites and proteins, and perform keyword enrichment calculations in 
a similar fashion as currently implemented for gene expression data. Other modifications 
that will improve the usability of CoPub: allow users to define a set of user-specific
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keywords, offer a web service to integrate CoPub data in bioinformatics workflows, 
facilitate uploading and mapping of literature information onto next-gen sequencing 
data. An important improvement would be mapping of additional data onto literature 
networks. The analysis in Chapter 6 of this thesis shows that by combining literature 
mining data and expression data, very quickly a detailed insight can be obtained in the 
biological processes that are affected in a microarray data set. With the increasing number 
of keywords that are likely to be incorporated in the database the definition of higher 
order keyword categories becomes more and more important to improve interpretation 
of keyword overrepresentation results. In Chapter 5 of this thesis, higher order categories 
were manually defined but more rational strategies are needed. Currently the enrichment 
tool operates on sets of regulated genes but it might be interesting to offer an interface 
for gene set enrichment analysis (GSEA) methods, in which statistics on predefined gene 
sets are calculated rather than on sets of differentially expressed genes [19]. With the 
above additions, the web server would continue to be an important tool for biologists to 
aid them in answering a wide variety of biological questions.
MINING THE COPUB DATABASE
The CoPub database and the accompanying web server offer a range of possibilities for 
advanced data mining approaches. Chapter 5 and 6 describe these approaches with 
experimental data sets, whereas in Chapter 3 and 4 of thesis, the CoPub database itself 
was mined. In these chapters the construction of biological pathways and the discovery 
of new knowledge from the biomedical literature by hidden relationship analysis are 
described. In Chapter 3 of this thesis, text mining in abstracts versus full-text articles was 
compared. The aim of this study was to evaluate whether text mining in full-text articles 
identifies significantly more biomedical concept associations, which would be missed if 
text mining was applied in abstracts only. To validate whether abstracts are an adequate 
source for retrieval of biological information, three distinct validation approaches were 
conducted; pathway reconstruction, comparing ft-scaled scoring of co-occurrences and 
microarray data analysis. Overall, these three approaches led to the common conclusion 
that text mining in full-text articles identifies more relationships (higher sensitivity) 
between biomedical concepts compared to text mining in abstracts, but that the 
relationships found in abstracts have a higher probability of being biologically relevant 
(higher specificity). Furthermore, the microarray data analysis showed that keyword 
enrichment using abstract-only or full-text information retrieved highly related keywords 
between both methods, which indicates that text mining in abstracts is sufficient to 
capture most of the relevant biomedical concept associations. Other studies that 
compared text mining in full-text articles versus abstracts came to similar conclusions 
that abstract and full-text article bodies have different structure and contain different 
content, and that the information density is highest in abstracts, but that the information
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coverage in full-text articles is higher than in abstracts [20, 21].
Although most of the biological relevant information can readily be extracted from 
abstracts, the number of articles that become publicly available is growing and text 
mining systems are improving rapidly to efficiently analyze large text corpora, which 
makes that text mining in full-text articles will eventually become common practice to 
extract all information present in an article. Current developments in text mining make it 
also possible to mine other large text corpora, such as patent collections [22], drug labels 
[23] and clinical discharge summaries [24].
The case studies discussed in Chapter 4, showed that hidden relationships can be 
successfully applied to identify novel disease-related genes, generate novel hypotheses 
on drug mode of action and predict novel lead compound applications. The application 
of mining the literature for hidden relationships to generate novel hypotheses was 
also demonstrated by others. Wren et al. found, by applying the hidden relationship 
paradigm, that chlorpromazine reduced the progression of cardiac hypertrophy [25], 
Ahlers et al. linked antipsychotic agents with cancer [26], and Jelier et al. used the text 
mining tool Anni 2.0 to reproduce the finding that hepatitis C patients benefit from 
thalidomide treatment, and inferred novel associations between leishmaniasis, listeriosis 
and thalidomide [10].
Hidden relationship analysis was successfully applied to identify novel gene-disease 
associations, drug-disease associations and novel disease-related genes. Yet, there 
are many more opportunities for which hidden relationship analysis can be utilized; to 
search for gene-drug relationships to assist target discovery, to search for drug-drug 
associations to determine the risk for adverse drug-drug interaction or to identify novel 
transcription factor target genes by searching for gene-gene associations.
APPLICATION OF COPUB FOR THE INTERPRETATION OF TOXICOGENOMICS 
AND PHARMACOGENOMICS EXPERIMENTS
In Chapter 5 and 6 of this thesis, CoPub was applied to perform keyword enrichment 
analyses with differentially expressed gene sets from microarray experiments. In 
Chapter 5, it was demonstrated how CoPub was used to link gene expression profiles to 
toxicity. Based on expression profiles of eight hepatocarcinogens and three peroxisome 
proliferators, distinct keyword fingerprints could be generated for each compound and 
showed to hold information on their mode of action and toxic end-points. Furthermore, 
we showed that visualization of regulated genes, keywords and their relationships in a 
network gives an overview of the biological processes on which a compound has an effect, 
and is an informative tool to unravel its toxicity and mechanisms of action.
The overrepresented keywords of all 11 hepatotoxicants were compared by categorizing 
the keywords in 13 higher-order categories. This categorization showed that each 
compound generated a compound-specific keyword fingerprint and that compounds
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with similar toxic end-points had overlapping fingerprint profiles. The categorization of 
the keywords in higher order categories was done manually, and therefore unsupervised 
categorization, for example based on ontologies, would improve categorization of the 
keywords. Furthermore, we observed that some general keywords, like 'metabolism' and 
'transcription' did add noise to lists of overrepresented keywords because these keywords 
were found in almost all keyword fingerprints. Therefore, a publication threshold could 
be applied to avoid too general keywords being selected.
Compound keyword fingerprinting based on information retrieved from literature is a 
powerful approach for compound profiling, allowing evaluation of compound toxicity 
and analysis of the mode of action. To our knowledge, our approach was the first 
published method that linked gene expression and literature information to compound 
toxicity. More recently however, the Comparative Toxicogenomics Database (CTD) was 
developed, which is a knowledgebase and discovery tool that contains chemical-gene 
and chemical-disease interactions identified by text mining [27, 28], and was successfully 
applied to identify interactions between genes and arsenic compounds [29]. The CTD 
tool allows retrieval of curated and non-curated associations between chemicals, genes 
and diseases, and their interaction type (e.g. 'inhibits', 'results in decreased expression', 
etc), but lacks a keyword overrepresentation analysis option for compound profiling as 
implemented in CoPub.
Chapter 6 describes the gene expression profiling we performed in liver of wild type 
and GRdim mice after prednisolone administration. The aim of this study was to chart 
the biological processes in the liver that are affected by glucocorticoids and to study 
their dependence on DNA-binding and dimerization of the glucocorticoid receptor. 
CoPub keyword enrichment analysis in wild type mice showed enrichment of keywords 
associated with glucose, lipid and amino acid metabolism, the cell cycle and apoptosis. 
This is in line with other studies, which also reported a role for the glucocorticoid receptor 
in these cellular processes [30-34].
To get an overview of genes that play a central role in GC-induced effects in the liver, a 
literature network was generated in which differentially expressed genes and enriched 
keywords were plotted. In this network, the transcription factors Foxo1 and Foxo3a 
appear to play a central role in the prednisolone-induced effects seen in the liver; Foxo1 
is a hub for gluconeogenesis and Foxo3a is a hub for apoptosis and the cell cycle. This 
might suggest that the glucocorticoid receptor synergizes with Foxo1 and Foxo3a, both 
key transcription factors involved in energy metabolism and regulation of the cell cycle, 
to evoke a transcriptional program leading to gluconeogenesis and cell cycle regulation. 
This shows that visualization of differentially expressed genes and enriched keywords in a 
network, like in Chapter 5, is a powerful approach for generate novel hypotheses on the 
mode of action of the glucocorticoid receptor.
Prednisolone-induced gene expression in GRdim mice was greatly reduced, but not 
completely absent, compared to the induction of gene expression by prednisolone in wild
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type mice. Interestingly, for a set of genes that all showed to be related to the cell cycle, 
induction by prednisolone was completely absent in GRdim mice, which include Cdknla, 
Gadd45b, Duspl, Plk3 and Foxo3a. In the literature network, Foxo3a was identified as a 
key player in cell cycle and apoptosis regulation, and recently it was shown that Foxo3a 
is required for glucocorticoid-induced apoptosis in lymphocytes [35]. Interestingly, this 
process is defective in GRdim mice highlighting a possible link between the glucocorticoid 
receptor, Foxo3a and induction of lymphocyte apoptosis [36]. This shows once again 
the strength of visualizing experimental results in a literature network to get insight in 
gene and compound mode of action. Furthermore, it also illustrates that mapping of 
gene expression data onto literature information can assist in a better understanding 
of the outcome of an experiment. Therefore, the earlier proposed modifications of the 
CoPub web server to allow mapping of additional data onto experimental data (e.g. gene 
expression data), will further improve the usability of the CoPub web server.
CONCLUSION
We have shown that text mining can advance drug discovery at multiple stages in 
the pipeline. Further development of NLP and systems that can efficiently mine full- 
text articles should further increase the use of text mining tools to unlock the wealth 
of information that is present in the biomedical literature to advance not only drug 
development but also other areas of the life sciences.
146 Chapter 7 
REFERENCES
1. Krallinger M, Valencia A, Hirschman L: Linking genes to literature: text mining, 
information extraction, and retrieval applications for biology. Genome Biol 2008, 
9 Suppl 2:S8.
2. Zweigenbaum P, Demner-Fushman D, Yu H, Cohen KB: Frontiers of biomedical text 
mining: current progress. Brief Bioinform 2007, 8(5):358-375.
3. Rubinstein R, Simon I: MILANO--custom annotation of microarray results using 
automatic literature searches. BMC Bioinformatics 2005, 6:12.
4. Alako BT, Veldhoven A, van Baal S, Jelier R, Verhoeven S, Rullmann T, Polman J, 
Jenster G: CoPub Mapper: mining MEDLINE based on search term co-publication. 
BMC Bioinformatics 2005, 6:51.
5. Maier H, Dohr S, Grote K, O'Keeffe S, Werner T, Hrabe de Angelis M, Schneider 
R: LitMiner and WikiGene: identifying problem-related key players of gene 
regulation using publication abstracts. Nucleic Acids Res 2005, 33(Web Server 
issue):W779-782.
6. Blaschke C, Hoffmann R, Oliveros JC, Valencia A: Extracting information 
automatically from biological literature. Comp Funct Genomics 2001, 2(5):310- 
313.
7. Muller H, Mancuso F: Identification and analysis of co-occurrence networks with 
NetCutter. PLoS One 2008, 3(9):e3178.
8. Garten Y, Tatonetti NP, Altman RB: Improving the prediction of pharmacogenes 
using text-derived drug-gene relationships. Pac Symp Biocomput 2010:305-314.
9. Li S, Wu L, Zhang Z: Constructing biological networks through combined literature 
mining and microarray analysis: a LMMA approach. Bioinformatics 2006, 
22(17):2143-2150.
10. Jelier R, Schuemie MJ, Veldhoven A, Dorssers LC, Jenster G, Kors JA: Anni 2.0: a 
multipurpose text-mining tool for the life sciences. Genome Biol 2008, 9(6):R96.
11. Morgan AA, Lu Z, Wang X, Cohen AM, Fluck J, Ruch P, Divoli A, Fundel K, Leaman 
R, Hakenberg J et al: Overview of BioCreative II gene normalization. Genome Biol
2008, 9 Suppl 2:S3.
12. Bandy J, Milward D, McQuay S: Mining protein-protein interactions from published 
literature using Linguamatics I2E. Methods Mol Biol 2009, 563:3-13.
13. Oda K, Kim JD, Ohta T, Okanohara D, Matsuzaki T, Tateisi Y, Tsujii J: New challenges 
for text mining: mapping between text and manually curated pathways. BMC 
Bioinformatics 2008, 9 Suppl 3:S5.
14. Jiang G, Ogasawara K, Endoh A, Sakurai T: Context-based ontology building support 
in clinical domains using formal concept analysis. Int J Med Inform 2003, 71(1):71-
81.
15. Le Moigno S, Charlet J, Bourigault D, Degoulet P, Jaulent MC: Terminology
General discussion 147
extraction from text to build an ontology in surgical intensive care. Proc AMIA 
Symp 2002:430-434.
16. Miyao Y, Sagae K, Saetre R, Matsuzaki T, Tsujii J: Evaluating contributions of natural 
language parsers to protein-protein interaction extraction. Bioinformatics 2009, 
25(3):394-400.
17. Yuryev A, Mulyukov Z, Kotelnikova E, Maslov S, Egorov S, Nikitin A, Daraselia N, 
Mazo I: Automatic pathway building in biological association networks. BMC 
Bioinformatics 2006, 7:171.
18. Mons B, Ashburner M, Chichester C, van Mulligen E, Weeber M, den Dunnen J, 
van Ommen GJ, Musen M, Cockerill M, Hermjakob H et al: Calling on a million 
minds for community annotation in WikiProteins. Genome Biol 2008, 9(5):R89.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, 
Paulovich A, Pomeroy SL, Golub TR, Lander ES et al: Gene set enrichment analysis: 
a knowledge-based approach for interpreting genome-wide expression profiles. 
Proc Natl Acad Sci U S A 2005, 102(43):15545-15550.
20. Shah PK, Perez-Iratxeta C, Bork P, Andrade MA: Information extraction from full 
text scientific articles: where are the keywords? BMC Bioinformatics 2003, 4:20.
21. Schuemie MJ, Weeber M, Schijvenaars BJ, van Mulligen EM, van der Eijk CC, Jelier 
R, Mons B, Kors JA: Distribution of information in biomedical abstracts and full- 
text publications. Bioinformatics 2004, 20(16):2597-2604.
22. Rhodes J, Boyer S, Kreulen J, Chen Y, Ordonez P: Mining patents using molecular 
similarity search. Pac Symp Biocomput 2007:304-315.
23. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P: Drug target identification using 
side-effect similarity. Science 2008, 321(5886):263-266.
24. Yang H, Spasic I, Keane JA, Nenadic G: A text mining approach to the prediction of 
disease status from clinical discharge summaries. J Am Med Inform Assoc 2009, 
16(4):596-600.
25. Wren JD, Bekeredjian R, Stewart JA, Shohet RV, Garner HR: Knowledge discovery 
by automated identification and ranking of implicit relationships. Bioinformatics 
2004, 20(3):389-398.
26. Ahlers CB, Hristovski D, Kilicoglu H, Rindflesch TC: Using the literature-based 
discovery paradigm to investigate drug mechanisms. AMIA Annu Symp Proc 
2007:6-10.
27. Davis AP, Murphy CG, Saraceni-Richards CA, Rosenstein MC, Wiegers TC, Mattingly 
CJ: Comparative Toxicogenomics Database: a knowledgebase and discovery 
tool for chemical-gene-disease networks. Nucleic Acids Res 2009, 37(Database 
issue):D786-792.
28. Davis AP, Murphy CG, Saraceni-Richards CA, Rosenstein MC, Wiegers TC, Hampton 
TH, Mattingly CJ: GeneComps and ChemComps: a new CTD metric to identify 
genes and chemicals with shared toxicogenomic profiles. Bioinformation 2009,
148
4(4):173-174.
29. Davis AP, Murphy CG, Rosenstein MC, Wiegers TC, Mattingly CJ: The Comparative 
Toxicogenomics Database facilitates identification and understanding of chemical- 
gene-disease associations: arsenic as a case study. BMC Med Genomics 2008, 
1:48.
30. Scott DK, Stromstedt PE, Wang JC, Granner DK: Further characterization of the 
glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. The 
role of the glucocorticoid receptor-binding sites. Mol Endocrinol 1998, 12(4):482- 
491.
31. Barthel A, Schmoll D: Novel concepts in insulin regulation of hepatic 
gluconeogenesis. Am J Physiol Endocrinol Metab 2003, 285(4):E685-692.
32. Alexandrova M: Stress induced tyrosine aminotransferase activity via glucocorticoid 
receptor. Horm Metab Res 1994, 26(2):97-99.
33. Rogatsky I, Trowbridge JM, Garabedian MJ: Glucocorticoid receptor-mediated cell 
cycle arrest is achieved through distinct cell-specific transcriptional regulatory 
mechanisms. Mol Cell Biol 1997, 17(6):3181-3193.
34. Sionov RV, Kfir S, Zafrir E, Cohen O, Zilberman Y, Yefenof E: Glucocorticoid-induced 
apoptosis revisited: a novel role for glucocorticoid receptor translocation to the 
mitochondria. Cell Cycle 2006, 5(10):1017-1026.
35. Ma J, Xie Y, Shi Y, Qin W, Zhao B, Jin Y: Glucocorticoid-induced apoptosis requires 
FOXO3A activity. Biochem Biophys Res Commun 2008, 377(3):894-898.
36. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, 
Schmid W, Herrlich P, Angel P et al: DNA binding of the glucocorticoid receptor is 
not essential for survival. Cell 1998, 93(4):531-541.
Chapter 7
General discussion 149

Summary
152
Summary 153
SUMMARY
The biomedical literature is an important source of knowledge on the function of genes 
and on the mechanisms by which these genes regulate cellular processes. It provides 
fundamental information needed in the drug discovery and development process. The 
rapid accumulation of new publications, however, makes it difficult to keep up-to-date 
with all relevant literature. The bottleneck is often not the lack of information present 
in the literature on the topic of interest, but lies within the time-consuming task of 
processing, linking and filtering relevant information from the vast amount of data that 
is available. In order to automatically retrieve relevant information from articles, text 
mining systems have been developed to capture and structure biomedical knowledge 
from literature. In this thesis, we demonstrate how text mining can be applied to extract 
biological information from the scientific literature and how it can aid drug development 
to gain insight in drug mode of action and to find novel applications for known drugs.
Chapter 2 describes the in-house developed and publicly available CoPub web server. 
CoPub is a text mining tool that uses thesaurus-based keyword matching to extract 
relationships between genes, diseases, pathways and drugs from Medline abstracts based 
on co-occurrence. The CoPub web server offers three analysis methods; the Microarray 
data analysis, the Gene search and the BioConcept search. The Microarray data analysis 
option calculates keyword over-representation in a set of differentially regulated genes, 
and offers graphical visualization of the analysis results in a literature-based network. The 
Gene and BioConcept search identifies genes and keywords that share co-occurrences in 
Medline abstracts with a gene (Gene search) or keyword (BioConcept search) of interest.
Chapter 3 deals with the question whether Medline abstracts represent an adequate 
source for capturing most of the in literature described biomedical concept associations. 
To answer this question, biomedical facts extracted from abstracts are compared with 
biomedical facts extracted from full-text articles. This was done using three different 
approaches; pathway reconstruction, comparing ft-scaled scoring of co-occurrences and 
microarray data analysis. The results show that text mining in full-text articles identified 
a higher number of associations between biomedical concepts than when abstracts were 
used for text mining, but that most of the biologically relevant associations can also be 
captured by text mining in abstracts only.
Chapter 4 demonstrates that the CoPub database is not only well suited for knowledge 
retrieval but can also be used to infer novel, hidden relationships from literature. The 
method of predicting novel relationships in literature is based on a simple ABC-principle, in 
which A and C have no direct relationship, but are connected via shared B-intermediates. 
This method was implemented in a novel web server, called CoPub Discovery. We applied 
CoPub Discovery to predict novel gene-disease, gene-pathway and gene-biological process 
associations from literature, which were validated and confirmed using independent 
literature-sources, as well as experimentally in an in vitro cell proliferation assay.
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In Chapter 5 we show how literature information can be used for compound profiling to 
evaluate the toxicity and mode of toxicity of compounds. In this study, CoPub was applied 
to analyze microarray data sets of rat liver treated with eleven hepatotoxicants. Keyword 
over-representation analyses showed that each compound produced a specific keyword 
fingerprint that correlated with the experimentally observed histopathological events 
induced by the individual compounds. Furthermore, the study also demonstrated that 
visualization of over-represented keywords together with differentially expressed genes 
in a literature network, enables the construction of a proposed model for compound 
toxicity.
Chapter 6 describes the genome wide gene expression profiling in liver of prednisolone- 
treated wild type (WT) mice, and of genetically engineered mice that have lost the ability 
to form glucocorticoid receptor (GR) dimers (GRdim). This study aimed to examine the 
importance of GR dimerization in regulation of gene expression in mouse liver. CoPub 
was used to identify the biological processes targeted by prednisolone in liver of WT mice 
and GRdim mice. The GR target genes identified in WT mice were predominantly related to 
glucose metabolism, the cell cycle, apoptosis and inflammation. Induction of differential 
gene expression by prednisolone in GRdim mice is significantly reduced as compared to 
WT mice, but is not completely absent. Interestingly, several genes were identified that 
are absolutely dependent on GR dimerization for the induction of gene expression by 
prednisolone. Furthermore, in this study several genes were identified that were not 
described as prednisolone-inducible before.
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SAMENVATTING
De biomedische literatuur vormt een belangrijke bron van kennis over de functie van 
genen en over hoe genen cellulaire processen beïnvloeden en reguleren, en biedt 
daardoor de onmisbare informatie die nodig is voor onderzoek naar nieuwe medicijnen. 
Echter, door de snelheid waarmee wetenschappelijke publicaties elkaar opvolgen is het 
haast onmogelijk geworden om de laatste ontwikkelingen bij te kunnen houden. Het 
knelpunt is niet het gebrek aan informatie, maar de tijdsintensieve taak van verwerken, 
koppelen en Alteren van alle relevante informatie uit de enorme hoeveelheid informatie 
die ter beschikking staat. Om deze taken te vereenvoudigen zijn zogenaamde text mining 
systemen ontwikkeld waarmee biomedische kennis automatisch uit de wetenschappelijke 
literatuur gedestilleerd en gestructureerd kan worden. In dit proefschrift laten we zien 
hoe text mining toegepast kan worden om biologische informatie automatisch uit de 
wetenschappelijke literatuur te halen, en hoe deze informatie gebruikt kan worden voor 
medicijnonderzoek om beter inzicht te krijgen in de werking van kandidaat medicijnen en 
om nieuwe medische toepassingen te vinden voor bestaande medicijnen.
Hoofdstuk 2 beschrijft de in-house ontwikkelde en publiekelijk toegankelijke CoPub 
webserver. CoPub is een text mining systeem dat zoekt naar trefwoorden (keywords) 
in samenvattingen van wetenschappelijke artikelen (abstracts) om relaties te leggen 
tussen genen, ziektes, biologische netwerken (pathways) en medicijnen op basis van 
het samen voorkomen van keywords. De CoPub webserver omvat drie analyse opties; 
de 'Microarray data analysis', de 'Gene Search' en de 'BioConcept search' optie. Met de 
'Microarray data analysis' optie kan keyword overrepresentatie berekend worden in een 
set van differentieel tot expressie komende genen en kan het resultaat getoond worden 
in een literatuur gebaseerd netwerk. Met de 'Gene search' of 'BioConcept search' optie 
kan naar genen of biomedische keywords gezocht worden die samen in abstracts met 
een gen ('Gene search') of biomedisch keyword ('BioConcept search') van interesse 
genoemd worden.
Hoofdstuk 3 behandelt de vraag of dat abstracts uit de Medline database een adequate 
bron vormen van waaruit de meeste op dit moment bekende associaties tussen 
biomedische concepten (bijv. genen, medicijnen en pathways) geïdentificeerd kunnen 
worden. Om deze vraag te beantwoorden werd biomedische informatie, verkregen uit 
abstracts, vergeleken met dat uit volledige artikelen. Dit werd gedaan aan de hand van 
drie benaderingen; door pathway reconstructie, door het vergelijken van R-scaled scores 
tussen twee samen voorkomende keyword sets en door analyse van microarray data. 
De resultaten laten zien dat text mining in volledige artikelen meer associaties tussen 
biomedische concepten opleverd, dan wanneer abstracts worden gebruikt, maar dat de 
meest relevante associaties ook door text mining in abstracts kunnen worden vergaard.
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Hoofdstuk 4 laat zien dat de CoPub database niet alleen gebruikt kan worden voor 
kennisvergaring, maar ook gebruikt kan worden om nieuwe, nog onontdekte relaties in 
de literatuur af te leiden. De methode om onontdekte relaties in de literatuur te vinden 
is gebaseerd op een simpel ABC principe, waarin A en C geen directe relatie hebben 
maar indirect verbonden zijn door B die door A en C gezamenlijk wordt gedeeld. Deze 
methode werd geïmplementeerd in een nieuwe webserver genaamd CoPub Discovery en 
werd vervolgens toegepast om nieuwe relaties tussen genen en ziektes, tussen genen en 
pathways, en tussen genen en biologische processen te voorspellen. Deze voorspellingen 
werden daarna gevalideerd en bevestigd in onafhankelijke literatuurbronnen alsmede 
experimenteel in een in vitro celproliferatie assay.
Hoofdstuk 5 laat zien hoe informatie uit de literatuur gebruikt kan worden bij het 
analyseren van chemische verbindingen op toxiciteit alsmede voor het ontrafelen van 
het mechanisme wat ten grondslag ligt aan de toxiciteit. CoPub werd in deze studie 
gebruikt om microarray data te analyseren van ratte levers, welke behandeld werden met 
elf verschillende hepatotoxische verbindingen. Keyword overrepresentatie analyse van 
deze hepatotoxische verbindingen bracht naar voren dat iedere verbinding een specifiek 
keyword patroon opleverde dat correleerde met de waargenomen histopathologische 
veranderingen na toediening van de desbetreffende verbinding. Tevens liet deze studie 
zien dat visualisatie van overgerepresenteerde keywords samen met differentieel tot 
expressie komende genen in een literatuurnetwerk, het mogelijk maakt om tot een 
ontwerp toxiciteitsmodel te komen voor de verbinding in kwestie.
Hoofdstuk 6 beschrijft de genoomwijde genexpressie studie gericht op de lever van 
prednisolon behandelde wildtype (WT) muizen, en dat van genetisch gemodificeerde 
muizen die het vermogen hebben verloren om dimeren van de glucocorticoide receptor 
(GR) te vormen (GRdim). Deze studie had als doel om het belang van GR-dimerisatie op 
de regulatie van genexpressie in de muize lever te bestuderen. CoPub werd gebruikt om 
de biologische processen in kaart te brengen die door prednisolon gereguleerd worden 
in WT en GRdim muizen. Genen die door de GR gereguleerd worden in de lever van WT 
muizen bleken voornamelijk gerelateerd te zijn aan glucose metabolisme, de celcyclus, 
apoptose en de ontstekingsreactie. De inductie van differentieel tot expressie komende 
genen door toediening van prednisolon in GRdim muizen bleek significant gereduceerd te 
zijn vergeleken met dat in WT muizen, maar was niet geheel verdwenen. Verder werden 
een aantal genen geïdentificeerd die volledig afhankelijk bleken te zijn van GR-dimerisatie 
om inductie van genexpressie door prednisolon te bewerkstelligen. Daarnaast werden 
nog een aantal genen geïdentificeerd waarvan nog niet eerder was vastgesteld dat ze 
door prednisolon geïnduceerd kunnen worden.
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DANKWOORD
Dan nu eindelijk aangekomen bij het dankwoord. Dit gedeelte staat alom bekend als het 
meest gelezen gedeelte van een proefschrift, dus ik ga nog éénmaal diep voordat we dit 
proefschrift als definitief afgerond kunnen beschouwen. Vanaf deze plaats wil ik iedereen 
bedanken die betrokken is geweest bij de voltooiing van dit proefschrift. Zonder de hulp, 
steun en belangstelling van een groot aantal mensen, waarvan ik hieronder een aantal 
met name wil noemen, was mijn promotieonderzoek gegarandeerd heel anders verlopen.
Allereerst wil ik mijn promotor Jacob de Vlieg bedanken, die mij de mogelijkheid heeft 
geboden om mijn promotieonderzoek binnen de Computational Drug Discovery (CDD) 
groep van het CMBI in Nijmegen te verrichten, waarbij het dagelijkse werk op de 
Molecular Design & Informatics (MDI) afdeling in Oss werd uitgevoerd. Ik heb tijdens 
deze periode veel bewondering gehad voor de manier waarop je mensen kon motiveren 
en de visie en missie van de afdeling naar buiten toe uitdroeg, met name tijdens de 
overnameperikelen die we helaas tweemaal hebben moeten ondergaan. Daarnaast wil 
ik ook mijn copromotor Wynand Alkema bedanken voor het tot stand komen van dit 
proefschrift. Wynand, ik heb veel van je geleerd. Met name hoe onderzoek op het gebied 
van de bioinformatica uitgevoerd dient te worden en hoe je de resultaten overzichtelijk 
in een wetenschappelijk artikel formuleerd. Mede dankzij jouw hulp heb ik het feitelijke 
onderzoek, met vier gepubliceerde artikelen, succesvol binnen vier jaar kunnen afronden. 
Verder was het natuurlijk altijd erg leuk om op dinsdag na het werk met ons 'sterrenelftal' 
in de interne zaalvoetbalcompetitie van Organon uit te komen (de naam 'Silicon Balley' 
en het winnen van de sportiviteitsprijs zegt natuurlijk al genoeg over hoe wij schitterden 
in deze competitie). Veel succes in de toekomst als groepsleider bij NIZO Food Research.
Voor het mogelijk maken van mijn promotieonderzoek moet ik ook zeker René van Schaik 
bedanken. Jij hebt er immers voor gezorgd dat een postdoc positie omgezet kon worden 
in een promotieplaats van vier jaar. Het bleek achteraf nog een hele klus te zijn om alles 
juridisch rond te krijgen voordat Organon, alsmede de Radboud Universiteit Nijmegen, 
akkoord gingen. Als gevolg daarvan werd de officïele startdatum niet 1 september 2005, 
maar 1 april 2006. Gelukkig kon ik in de tussenliggende periode via Adecco toch als 
bioinformaticus aan de slag bij de MDI, waarvoor mijn dank.
Het hele promotietraject had nooit plaatsgevonden wanneer Jan Polman mij niet als 
student van de Wageningen Universiteit de mogelijkheid bood om mijn afstudeerstage 
bij Organon te doen. Deze afstudeerstage was in feite een opstap naar dit proefschrift, 
aangezien ik tijdens die periode kennis maakte met text mining en CoPub. Jan, het was 
altijd prettig om met jou samen te werken. Je nam altijd de tijd om met mij van gedachten 
te wisselen over hoe we text mining data het beste konden koppelen aan toxicogenomics 
data. Dit leverde zoveel nieuwe ideeën op, dat het afstuderen bijna een inkoppertje werd. 
Het heeft tevens een belangrijke rol gespeeld bij het publiceren van ons toxicogenomics 
artikel (Hoofdstuk 5 van dit proefschrift).
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Mijn afstuderen en promoveren was zonder hulp van Stefan 'ik download alles van het 
internet, gewoon omdat het kan' Verhoeven, de whizzkid van de MDI, zeker moeilijker 
verlopen. Hoe vaak moet jij niet gedacht hebben 'staat ie nou weer aan mijn bureau?' 
toen ik weer eens langs kwam met een vraag over Unix, Perl, R, MySQL, etc, etc. Ik ben je 
dankbaar dat je me altijd geduldig hebt geholpen, ik heb er veel van mijn (bio)informatica 
kennis mee opgedaan.
Wilco Fleuren, wielrenner ('op zijn minst met 35 km/u de Tivoli op'), mede AIO en de 
nieuwe bewaker van de CoPub legacy, bedankt dat je mijn paranimf wil zijn. Ik ken je vanaf 
de eerste dag dat ik als stagiaire begon bij Organon en het was altijd gezellig om met je 
samen te werken. Op zijn minst zo gezellig waren de spontane borrels op vrijdagmiddag 
in Nijmegen, beginnend met de klassieke 'frietje waterfiets', om ten slotte bier te gaan 
proeven in de Blauwe Hand en/of (meestal en) brouwerij De Hemel. Veel succes bij je 
promotieonderzoek, maar nog belangrijker; veel geluk als aanstaande vader.
Simon 'koetje' Folkertsma, Fries, wielrenner, oudcollega bij Organon en huidige collega 
bij Skyline, bedankt voor de leuke tijd in onze kamer bij Organon (tot diep in maart elkaar 
iedere ochtend 'de beste wensen' toe te wensen is toch een hele prestatie). Simon heeft 
de Brabantse inburgeringscursus succesvol doorlopen; hij weet waar Wolluk ligt en hij is 
inmiddels fervent aanhanger van RKC (die uitwedstrijd met het busje naar Zwolle vond ik 
toch één van de mooiste wedstrijden van de afgelopen jaren). Ik vind het mooi om nog 
steeds/weer je collega te zijn. 'Ik zeg Rooo....'.
Als ik aan Marijn Sanders denk, moet ik toch automatisch denken aan ons weekendje 
met Wilco en Simon in het Zweedse Uppsala. Bedankt dat je ons hebt uitgenodigd toen 
je daar een half jaartje onderzoek deed, ik denk er nog met veel plezier aan terug. Vooral 
het lokale Birger Jarl was legendarisch (een must voor iedere natuurliefhebber, wanneer 
gaan we weer?). Veel succes verder met je promotieonderzoek.
Tim "jaaa, dat zou jij wel willen weten he?!" Hulsen, NEC supporter in hart en nieren, en 
goalgetter van Silicon Balley. Bedankt voor de samenwerking en de gezelligheid. Greetje 
Groenendaal, trouwe reisgenote en fervent post-it plakster. Greetje, ik vond het altijd erg 
gezellig met jou in de trein naar huis, ik heb tijdens deze treinritjes veel nieuwe inzichten 
opgedaan. Ik wacht in spanning op jouw boekje.
Overige mensen die ik nog wil bedanken voor de prettige werksfeer en voor de goede 
tijd die ik bij Organon heb gehad: de MDI'ers Peter Groenen, Maarten Sollewijn Gelpke, 
Ton Rullman, Susanne Bauerschmidt, Cas Meijer, Cees Meeuwisse, Payman Hanifi 
Moghaddam, Eugene van Someren, Anneke Sijbers, Tinka Spronk, Ruud Ross, Jan 
Wertenbroek, vanuit het secretariaat: Thea van Grunsven, Karin Uylen, Ria de Vaan en 
Barbara van Kampen, de protein structure modelers Sander Nabuurs, Dave Wood en 
Tina Ritschel, Mark van Roosmalen en Joost van Dieten die bij mij als studenten van de 
Hogeschool Arnhem en Nijmegen (HAN) stage hebben gelopen, Bart Heupers en Pieter
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van Beek van het Reken- en netwerkcentrum SARA voor het onderhouden van de CoPub 
webserver en Arno van Geloof als reisgenoot tussen Oss en Tilburg (zo kom je toch nog 
op de valreep in mijn boekje terecht).
Mijn wetenschappelijke carrière ben ik in september 1997 begonnen bij de Anatomie 
en Embryologie afdeling in het AMC te Amsterdam. Toendertijd deed ik mijn HLO 
afstudeerstage bij prof. dr. Wout Lamers en dr. Theo Hakvoort. Wout, ik vind het erg 
leuk dat je in de leescommissie en oppositie plaats wilde nemen. Jij en Theo hebben 
mij de kneepjes van de moleculaire biologie bijgebracht. Deze kennis komt mij als 
bioinformaticus, ondanks dat ik tegenwoordig geen pipet meer aanraak, nog steeds 
zeer van pas. Na mijn stage ben ik als research analist gaan werken voor het AMC Lever 
Centrum (ALC). Zonder namen te noemen wil ik ook iedereen van het ALC bedanken voor 
de geweldige tijd daar.
Ut 4e van Unitas'30 uit Etten-Leur, mijn voetbalmaten, bedankt voor de wekelijkse 
afleiding op de zondagochtend. Unitas'30 4; niet alleen uitblinkers in de 1e en 2e helft (3x 
kampioen in de afgelopen 4 jaar, komend seizoen de beker?), maar ook altijd goed op 
dreef in de 3e helft.
Mijn huidige collega's bij Skyline Diagnostics in Rotterdam, bedankt voor de leuke en 
motiverende werkomgeving. Dit heeft beslist een positieve bijdrage geleverd aan dit 
proefschrift; het leverde de nodige energie om 's-avonds dit boekje af te schrijven.
Dennis Verschuur en Martin van Ast, bedankt voor jullie vriendschap en steun de 
afgelopen jaren. Dennis, er komt zeker weer een tijd dat we weer eens wat gaan drinken 
met zijn drieën, en dat je je dromen gaat vervullen, daar ben ik van overtuigd.
Tenslotte diegenen die er altijd geweest zijn voor mij: pa en ma, Remco (bedankt dat je 
mijn paranimf wil zijn), Leonie, Delano en Giovanni. Pa en ma, misschien was mijn uitleg 
over wat voor werk ik nou precies deed bij Organon niet altijd even duidelijk, maar jullie 
waren altijd geïnteresseerd. Wellicht verduidelijkt de verschijning van dit proefschrift 
iets van wat ik de afgelopen tijd allemaal heb uitgevoerd. Bedankt voor alle steun de 
afgelopen jaren!
Houdoe en bedankt!
Raoul
Breda, juni 2011.
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Raoul Frijters werd geboren op 10 juli 1975 te Etten-Leur. In juli 1994 behaalde hij het 
VWO diploma aan de Katholieke Scholengemeenschap Etten-Leur (KSE). In datzelfde 
jaar begon hij aan de voltijd studie Biochemie van het Hoger Laboratorium Onderwijs 
(HLO) aan de Hogeschool Brabant te Etten-Leur, waarvan hij in juli 1998 het diploma cum 
laude behaalde. Zijn afstudeerstage verrichte hij op de afdeling Anatomie en Embryologie 
in het Academisch Medisch Centrum (AMC) / Universiteit van Amsterdam (UvA) in 
Amsterdam. Onder leiding van dr. Theo Hakvoort en prof. dr. Wout Lamers is hij tijdens 
zijn afstudeerstage betrokken geweest bij het onderzoek naar de expressieregulatie 
van het glutamine synthetase gen. Van augustus 1998 t/m augustus 2003 heeft hij als 
research analist moleculaire biologie op de Experimentele Hepatologie afdeling gewerkt 
in het AMC Lever Centrum (ALC) te Amsterdam. Onder leiding van dr. Bert Groen en prof. 
dr. Ronald Oude Elferink is hij betrokken geweest bij het onderzoek naar het mechanisme 
van cholesteroltransport in de darm en de lever. In september 1999 begon hij aan de 
deeltijdstudie Hogere Informatica aan de Hogeschool van Amsterdam te Amsterdam, 
waarvan hij het diploma in maart 2003 behaalde. In september 2003 is hij begonnen 
aan de voltijd Masteropleiding Bioinformatica aan de Wageningen Universiteit en 
Researchcentrum (WUR) in Wageningen, waarvan hij het diploma in maart 2005 cum 
laude behaalde. Zijn afstudeerstage heeft hij bij de Molecular Design & Informatics 
(MDI) afdeling van Organon gedaan in Oss. Onder leiding van Jan Polman en prof. dr. 
Jacob de Vlieg heeft hij de text mining applicatie CoPub doorontwikkelt en gebruikt voor 
toxicogenomics onderzoek. Voor het afstudeerverslag heeft hij in 2005 een scriptieprijs 
gewonnen van de Wageningen Universiteit voor de praktische toepasbaarheid van 
CoPub. Vanaf maart 2005 t/m maart 2006 heeft hij bij de MDI afdeling van Schering- 
Plough (voormalig Organon) als bioinformaticus gewerkt. In april 2006 is hij als junior 
onderzoeker aan zijn promotieonderzoek begonnen bij de Computational Drug Discovery 
(CDD) groep van het Centre for Molecular and Biomolecular Informatics (CMBI) aan 
de Radboud Universiteit Nijmegen (RUN) te Nijmegen. Dit promotieonderzoek, een 
samenwerking tussen de Radboud Universiteit Nijmegen en MSD (voormalig Organon 
en Schering-Plough), stond onder leiding van prof. dr. Jacob de Vlieg (promotor) en dr. 
Wynand Alkema (copromotor). Dit promotieonderzoek had als doel om methodes en tools 
te ontwikkelen, om gedetailleerd de cellulaire werking van pharmacologisch werkzame 
stoffen in kaart te brengen. De resultaten van dat onderzoek staan beschreven in dit 
proefschrift. Sinds mei 2010 is hij werkzaam als bioinformaticus bij Skyline Diagnostics 
te Rotterdam, waar hij betrokken is bij het ontwikkelen van diagnostische testen voor 
kanker, waaronder verschillende vormen van bloedkanker zoals acute myeloïde leukemie 
(AML).
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